OPTICAL COATING LABORATORY INC
10-K/A, 1998-05-05
OPTICAL INSTRUMENTS & LENSES
Previous: OHIO NATIONAL VARIABLE ACCOUNT B, 497J, 1998-05-05
Next: OWENS CORNING, 8-K, 1998-05-05



   
             UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549
                                 FORM 10-K/A
    
Mark one
[x]   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

      For the fiscal year ended OCTOBER 31, 1997

[ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
      SECURITIES EXCHANGE ACT OF 1934

      For the transition period from            to


                                  [LOGO]
                     OPTICAL COATING LABORATORY, INC.
           (Exact name of registrant as specified in its charter)

                       COMMISSION FILE NUMBER 0-2537

DELAWARE                                                 68-0164244
(State or other jurisdiction of                     (IRS Identification No.)
incorporation or organization)

2789 NORTHPOINT PARKWAY, SANTA ROSA CALIFORNIA            95407-7397
(Address of principal executive offices)                  (Zip code)

    Registrant's telephone number, including area code: (707) 545-6440
                                       
     SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:  NONE

        SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:

                       COMMON STOCK, $.01 PAR VALUE

                           (Title of each class)

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. [x]  Yes  [ ] No

Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [x]

At December 31, 1997, the aggregate market value of the registrant's common
stock (based upon the closing price of these shares on the NASDAQ National
Market System) held by non-affiliates, which excludes shares held by
officers and directors and the Employee Stock Ownership Plan of the
registrant (not all of whom claim to be affiliates), was approximately
$109.8 million.

At December 31, 1997, there were 10,631,712 shares of the registrant's
common stock, $.01 par value, issued and outstanding.

                    DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive Proxy Statement for the Company's Annual Meeting
of Stockholders to be held March 31,1998 are incorporated by reference
into Part III of this Form 10-K.

The Exhibit index appears on Pages 47-49.


 ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
           AND FINANCIAL DISCLOSURE

Not applicable.

                                 PART III

ITEM 10.   DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
ITEM 11.   EXECUTIVE COMPENSATION
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Pursuant to Paragraph G(3) of the General Instructions to Form 10-K, the
information called for in Part III, Items 10, 11, 12 and 13 of Form 10-K is
omitted since the Company will file with the Securities and Exchange
Commission, not later than 120 days after the close of the fiscal year
ended October 31, 1997, a definitive proxy statement pursuant to Regulation
14A in connection with its 1998 Annual Meeting of Stockholders. The
information contained under the caption "Executive Officers of the
Registrant" in Part I of this Form 10-K is incorporated by reference into
Item 10.

                                  PART IV

ITEM 14.   EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

(A)        1. CONSOLIDATED FINANCIAL STATEMENTS:

          The following consolidated financial statements of Optical
          Coating Laboratory, Inc. are included in Item 8:
                                                                     PAGE(S)
              Independent Auditors' Reports...........................24-25
              Consolidated Balance Sheets............................    26
              Consolidated Statements of Income..........................27
              Consolidated Statements of Cash Flows...................28-29
              Consolidated Statements of Common Stockholders'
              Equity ....................................................30
              Notes to Consolidated Financial Statements.................31
              Supplemental Financial Information.........................45

(A)       2.  FINANCIAL STATEMENT SCHEDULES

              The following consolidated financial statement schedules are
included in Item 14(d):

              Schedule II - Valuation and Qualifying accounts............50

All other schedules have been omitted since the required information is not
present or not present in amounts sufficient to require submission of the
schedule, or because the information required is included in the
consolidated financial statements or the accompanying notes.


(A)       3.  LISTING OF EXHIBITS

The following are filed as Exhibits to this Annual Report on Form 10-K. The
numbers refer to the Exhibit Table of Item 601 of Regulation S-K.

EXHIBIT
NO.                               DESCRIPTION

3.1   Restated Certificate of Incorporation. Incorporated by reference to
      Exhibit (4)(a) of the Registrant's Form 10-Q for the quarter ended
      July 31, 1988.

3.2   By-Laws.  Incorporated by reference to Exhibit (3)(b) of the
      Registrant's Form 8-K under Item 5 dated November 20, 1987.

4.1   Stockholder Rights Agreement between the Registrant and ChaseMellon
      Shareholder Services L.L.C. dated December 16, 1997.

4.2   Note Purchase Agreement(s) dated as of May 27, 1994 for the private
      placement of $18,000,000 of 8.71% Senior Notes due June 1, 2002
      between the Registrant and Connecticut Mutual Life Insurance
      Company, Modern Woodman of America and American Life and Casualty
      Insurance Company. Incorporated by reference to Exhibit (4)(a) of
      the Registrant's Form 10-Q for the quarter ended July 31, 1994.

4.3   Stock Purchase Agreement dated as of February 8, 1995 by and between 
      the Registrant, Netra Corporation and the Sellers as identified
      Corporation, for the purchase by the Registrant of all of the shares
      of common and preferred stock of Netra Corporation.  Incorporated by
      reference to Exhibit (4) of the Registrant's Form 10-Q for the
      quarter ended April 30, 1995.

4.4   Optical Coating Laboratory, Inc. 12,000 shares of 8% Series C
      Convertible Redeemable Preferred Stock Purchase Agreement among the
      Registrant and the investors named therein dated as of May 1, 1995.
      Incorporated by reference to Exhibit 4(e) of Registrant's Form S-8
      dated July 6, 1995.

4.5   Certificate of Designation, Preferences and Rights of Series C
      Convertible Redeemable Preferred Stock of Optical Coating
      Laboratory, Inc. dated May 2, 1995.  Incorporated by reference to
      Exhibit 4(f) of Registrant's Form S-8 dated July 6, 1995.

4.6   Credit Agreement dated as of May 24, 1995 among the Registrant, Bank
      of America NT&SA as agent, and Letter of Credit Issuing Bank and the
      other Financial Institutions party thereto arranged by BA
      Securities, Inc. Incorporated by reference to Exhibit (4)(a) of the
      Registrant's Form 10-Q for the quarter ended July 31, 1995.

4.7   First Amendment to Credit Agreement dated as of May 24, 1995 between
      Optical Coating Laboratory, Inc., Bank of America, NT&SA, as agent
      for itself and the Banks, and the several financial institutions
      party to the Credit Agreement, which amendment is dated as of
      December 15, 1995. Incorporated by reference to Exhibit 4.9 of the
      Registrant's Form 10-K for the year ended October 31, 1995.

4.8   Second Amendment to Credit Agreement dated as of May 24, 1995
      between Optical Coating Laboratory, Inc. and Bank of America NT&SA,
      as agent for itself and the Banks, and the several financial
      institutions party to the Credit Agreement, which amendment is dated
      as of January 28, 1997.

4.9   Third Amendment to Credit Agreement dated as of May 24, 1995 between
      Optical Coating Laboratory, Inc. and Bank of America NT&SA, as agent
      for itself and the Banks, and the several financial institutions
      party to the Credit Agreement, which amendment is dated as of May
      23, 1997. Incorporated by reference to Exhibit (4.1) of the
      Registrant's Form 10-Q for the quarter ended April 30, 1997.


EXHIBIT
NO.                              DESCRIPTION

4.10  Secured Promissory Note between Optical Coating Laboratory, Inc. and
      Aid Association for Lutherans dated November 8, 1995.
      Incorporated by reference to Exhibit 4.8 of the Registrant's Form
      10-K for the year ended October 31, 1995.

4.11  Capital Equipment Lease Agreement dated as of February 20, 1996
      between Optical Coating Laboratory, Inc. and Fleet Credit
      Corporation. Incorporated by reference to Exhibit 4.10 of the
      Registrant's Form 10-K for the year ended October 31, 1996.

4.12  Capital Equipment Lease Agreement dated as of June 19, 1996 between
      Flex Products, Inc. and Fleet Credit Corporation.  Incorporated by
      reference to Exhibit 4.11 of the registrant's Form 10-K for the year
      ended October 31,1996.

4.13  Credit Agreement dated as of May 20, 1997 between Optical Coating
      Laboratory, Inc. as Borrower and ABN AMRO Bank N.V. as bank.
      Incorporated by reference to Exhibit 4.2 of the Registrant's form
      10-Q for the quarter ended April 30, 1997.

9     Not applicable.

10.0  Registrant's Employee Stock Ownership Plan (OCLI ESOP+), as amended.
      Incorporated by reference to Exhibit (10)(c) of the Registrant's
      Form 10-K for the year ended October 31, 1988.

10.1  Registrant's 1996 Incentive Compensation Plan. Incorporated by
      reference to Exhibit A of the Registrant's Proxy Statement dated
      March 8, 1996.(1)

10.2  Registrant's 1995 Incentive Compensation Plan. Incorporated by
      reference to Exhibit A of the Registrant's Proxy Statement dated
      March 10, 1995. (1)

10.3  Registrant's 1993 Incentive Compensation Plan. Incorporated by
      reference to Exhibit A of the Registrant's Proxy Statement dated
      March 8, 1993. (1)

10.4  Registrant's 1992 Incentive Compensation Plan. Incorporated by
      reference to Exhibit A of the Registrant's Proxy Statement dated
      March 8, 1992. (1)

10.5  Registrant's 1991 Incentive Compensation Plan. Incorporated by
      reference to Exhibit A of the Registrant's Proxy Statement dated
      February 25, 1991. (1)

10.6  Form of Directors' and Officers' Indemnification Agreement.
      Incorporated by reference to Exhibit (10)(j) of the Registrant's
      Form 10-K for the year ended October 31, 1987. (1)

10.7  Form of Change in Control Employment Agreements between the
      Registrant and its Executive Officers dated November 20, 1997.(1)

10.8  Form of Employment Assurance Agreements between the Registrant and
      its key technical and professional employees dated as of November
      20, 1997. (1)

10.9  Mortgage Agreement between the Scottish Development Agency and
      Registrant's Scottish Subsidiary. Incorporated by reference to
      Exhibit (10)(o) of the Registrant's Form 10-K for the year ended
      October 31, 1987.

EXHIBIT
NO.                             DESCRIPTION

10.10 Stock and Note Purchase Agreement by and among OCLI, SICPA Holding
      S.A., ICIA, ICIAH and Flex Products, Inc. Incorporated by
      reference to the Registrant's Form 8-K dated May 23, 1995 and
      Registrant's Form 8-K/A dated April 11, 1996.
   
10.11*Settlement agreement between the Registrant, SICPA Holding S.A. and
      Flex Products, Inc. dated November 27, 1997. (Confidential treatment
      has been requested on portions of this document.)

10.12*Agreement by and between JDS FITEL Inc. and Optical Coating
      Laboratory, Inc. dated February 1, 1997. (Confidential treatment has
      been requested on portions of this document.)

10.13*First Amendment, dated February 2, 1997, to Agreement by and Between
      JDS FITEL, Inc. and Optical Coating Laboratory, Inc. dated February
      1, 1997. (Confidential treatment has been requested on portions of
      this document.)

10.14*Second Amendment, dated June 1, 1997, to Agreement by and Between
      JDS FITEL, Inc. and Optical Coating Laboratory, Inc. dated February
      1, 1997. (Confidential treatment has been requested on portions of
      this document.)
    

10.15 Employment Agreement Letter between John McCullough and the Registrant
      dated October 31, 1995. Incorporated by reference to Exhibit 10.18 of
      the Registrant's Form 10-K for the year ended October 31, 1995.

10.16 1998 Management Incentive Plan (1)

11    Computation of earnings (loss) per share for the years ended October
      31, 1997, 1996 and 1995.

12    Not applicable
13    Not applicable
16    Not applicable
18    Not applicable
21    Subsidiaries of the Registrant
22    Not applicable
23    Independent Auditors' Consent and Report on Schedules
24    Not applicable
27    Financial Data Schedule
28    Not applicable
99    Not applicable

*     Items not previously filed are designated by an asterisk.

(1)   Designates management contracts or compensatory plan arrangements
      required to be filed as exhibits pursuant to Item 14(c) of Form
      10-K.

(b)   REPORTS ON FORM 8-K

      None

   

                                SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.

DATE: MAY 5, 1998                          OPTICAL COATING LABORATORY, INC.


                                           BY: /S/CRAIG B. COLLINS
                                                Craig B. Collins
                                                Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated:

SIGNATURE                             TITLE                        DATE

                                 DIRECTOR, PRESIDENT
                             AND CHIEF EXECUTIVE OFFICER
/S/CHARLES J. ABBE           (Principal Executive Officer)      MAY 5, 1998

Charles J. Abbe

                                VICE PRESIDENT, FINANCE
/S/CRAIG B. COLLINS           AND CHIEF FINANCIAL OFFICER       MAY 5, 1998
Craig B. Collins             (Principal Financial Officer)


/S/HOLLY D. NEAL                 CORPORATE CONTROLLER           MAY 5, 1998
Holly D. Neal                (Principal Accounting Officer)



/S/HERBERT M. DWIGHT, JR         CHAIRMAN OF THE BOARD          MAY 5, 1998
Herbert M. Dwight, Jr.


/S/JOHN MCCULLOUGH                    DIRECTOR                  MAY 5, 1998
John McCullough

    


/S/ DOUGLAS C. CHANCE                 DIRECTOR                 MAY 5, 1998
Douglas C. Chance


/S/ SHOEI KATAOKA                     DIRECTOR                 MAY 5, 1998
Shoei Kataoka


/S/JULIAN SCHROEDER                   DIRECTOR                 MAY 5, 1998
Julian Schroeder


/S/RENN ZAPHIROPOULOS                DIRECTOR                 MAY 5, 1998
Renn Zaphiropoulos



                                    AGREEMENT

                                 BY AND BETWEEN
                                 JDS FITEL, INC.
                                       AND
                        OPTICAL COATING LABORATORY, INC.


                               TABLE OF CONTENTS





ARTICLE I                                                              1
1.1 Definitions                                                        1

ARTICLE II
SCOPE OF RELATIONSHIP                                                  3

ARTICLE III
MANUFACTURE OF WDM PRODUCTS                                            4

          3.1  Manufacture of WDM Optical Filters by OCLI              4
          3.2  Supply of WDM Products by JDS                           4
          3.3  Supply of WDM Optical Filters                           5
          3.4  Price for JDS's Services                                5
          3.5  Terms and Conditions                                    5

ARTICLE IV
DISTRIBUTION AGREEMENT                                                 5

ARTICLE V
USE OF THIRD PARTY WDM OPTICAL FILTER SUPPLIERS                        5

          5.1  Price Competition                                       5
          5.2  Competition Other Than Price                            6
          5.3  Price of Third Party Filters Included in Costs          6

ARTICLE VI
PROFIT SHARING                                                         6

          6.1  Quarterly Profit Sharing Adjustments                    6
          6.2  Profit Sharing for Non-Optical Filter WDMs              6
          6.3  Failure of OCLI to Supply Filters                       7
          6.4  Right to Inspect and Audit Records                      8
          6.5  Audit Costs Necessitated by Agreement                   8

ARTICLE VII
FORMATION OF JOINT VENTURE COMPANY                                     8

          7.1  Option to Form Joint Venture Company                    8
          7.2  Formation of Joint Venture Company                      8

                  (a) Form                                             9
                  (b) Location                                         9
                  (c) Capital                                          9
                  (d) Licensing of Technology                          9
                  (e)  Governance                                      9
                  (f)  Profit Sharing                                 10

          7.3    Assignment of Distribution Agreement                 10
          7.4    Assignment of Terms of the Agreement                 10
          7.5    Activities of the Company                            10
          7.6    Failure to Agree on Terms of the Company             10

ARTICLE VIII
EXCLUSIVITY                                                           11

          8.1  Scope of Exclusive Rights                              11
          8.2  Notification                                           12
          8.3  Sale of Planar Waveguide and Fiber Bragg Gratings      12

ARTICLE IX
TERMINATION                                                           12

          9.1  Termination for Cause                                  12

                  (a)  Termination by JDS                             12
                  (b)  Termination for Failure of OCLI
                       to Supply Filters                              13
                  (c)  Termination for Failure of JDS to
                       Supply Assembly Services                       13
                  (d)  Termination by Either party                    14
          9.2  [CONFIDENTIAL TREATMENT REQUESTED]                     14
          9.3  Effect of Termination                                  14


ARTICLE X
MANAGEMENT COMMITTEE                                                  14

          10.1  Management Committee                                  14
          10.2  Chairman of the Management Committee                  15
          10.3  Delegation                                            15

ARTICLE XI
RESEARCH AND DEVELOPMENT                                              15

          11.1  Funding of R&D                                        15
          11.2                                                        16

ARTICLE XII THIRD PARTY LICENSING                                     16

          12.1                                                        16

ARTICLE XIII ACQUISITIONS                                             17

          13.1                                                        17
          13.2                                                        17

ARTICLE XIV
CONFIDENTIAL INFORMATION                                              18

          14.1 "Confidential Information"                             18
          14.2                                                        19
          14.3                                                        19
          14.4                                                        19



ARTICLE XV

MISCELLANEOUS                                                         20

          15.1   Non-Supply of WDM Optical Filters to Third Parties   20
          15.2   21
          15.3   Order Backlog                                        21
          15.4   JDS's Inventory                                      22
          15.5   Constraints on Employee Transfers                    22
          15.6   Governing Law                                        22
          15.7   Disputes                                             23
          15.8   Attorneys' Fees                                      23
          15.9   Notices                                              24
          15.10  Public Announcements                                 25
          15.11  Counterparts                                         25
          15.12  Interpretation                                       26
          15.13  Successors and Assigns                               26
          15.14  Waiver                                               26
          15.15  Purchase By Competitor                               26
          15.16  Entire Agreement                                     27
          15.17  Agency                                               27
          15.18  Survival                                             27
          15.19  Further Assurances and Approvals                     27
          15.20  Intellectual Property Indemnity Liability            28
          15.21  Approval by Board of Directors                       28


                               AGREEMENT

     THIS AGREEMENT, made as of this 1st day of February, 1997, by and

between JDS FITEL Inc., a Canadian corporation, having its principal place

of business at 570 West Hunt Club Road, Nepean, Ontario K2G 5W8 Canada

("JDS" and "Distributor") and OPTICAL COATING LABORATORY, INC., a Delaware

corporation, having its principal place of business at 2789 Northpoint

Parkway, Santa Rosa, California 95407-7397 ("OCLI").

                         W I T N E S S E T H :

     WHEREAS, JDS and OCLI wish to combine their respective areas of

expertise and capabilities in a joint effort for WDM Product Business as

defined herein.

     NOW, THEREFORE, in consideration of the mutual promises contained

herein, the parties hereto agree to the following:

                              ARTICLE II
                              DEFINITIONS

     1.1  Definitions. For purposes of this Agreement, the following

definitions shall apply:

     "Backlog" shall mean the customer orders that JDS has on hand for

which WDM Products have not been shipped at (a) January 19, 1997 with

respect to Section 15.3(a) and at (b) the effective date of this Agreement

all other provisions under this Agreement;

     "Company" shall have the meaning as set out in Section 7.1;

     "Company Profit" with respect to the Company shall mean the Company's

revenues, including from transactions with the Distributor or with any

party to this Agreement, from the WDM Products Business, including related

activities such as licensing of WDM Product or WDM Optical Filter

technology, pursuant to this Agreement less Company related Costs.

"Company Profit" can be either a profit or a loss.

     "Confidential Information" shall have the meaning as set out in

Section 14.1;

     "Cost" shall be defined as set forth in Exhibit A attached hereto.

     "Fiscal Year" shall mean a 12 month period of time ended October 31.

"Fiscal Quarter" shall mean the quarters ended January 31, April 30, July

31 and October 31.

     "Management Committee" shall have the meaning as set out in Section

10.1;

     "Non-assignable" shall mean personal, non-transferable, indivisible

and non-assignable.

     "Passive" shall mean not electrically powered or electrically

controllable or adjustable;

     "Planar Waveguides" shall mean planar waveguides performing a

wavelength discrimination function;

     "Profit" shall mean the sum of the Transaction Profit of each party

plus Company Profit.  "Profit" can be either a profit or a loss.

     "Transaction Profit" with respect to any party shall mean that party's

revenues, including from transactions with the Company or with other

parties to this Agreement from the WDM Products Business, including related

activities such as licensing of WDM Product or WDM Optical Filter

technology, pursuant to this Agreement less such party's related Costs.

"Transaction Profit" can be either a profit or a loss.  For greater

certainty, Transaction Profit shall not include any revenue, Costs or

Company Profit recognized by either party as a result of either

consolidating, equity accounting or cost accounting for a party's ownership

interest share in the Company.

     "WDM Optical Filters" shall mean WDM Optical Filters A and WDM Optical

Filters B;

     "WDM Optical Filters A" shall mean any and all optical filters that

are intended to be used in WDM Products A;

     "WDM Optical Filters B" shall mean any and all optical filters that

are intended to be used in WDM Products B;

     [CONFIDENTIAL TREATMENT REQUESTED]


     "WDM Product Business" shall mean the business of design, development,

manufacture, supply of WDM Optical Filters or WDM Products, sales to

Distributor and technical product marketing support to assist Distributor

in sales and marketing of WDM Products, all related to WDM Optical Filters

or WDM Products.

                                   ARTICLE II
                             SCOPE OF RELATIONSHIP

     2.1  The relationship created between JDS and OCLI as described in

more detail herein encompasses  a joint venture activity relating to the

design and manufacture of WDM Optical Filters; the design and manufacture

of WDM Products; and the marketing and sale of WDM Products.  From this

joint venture activity JDS will realize [CONFIDENTIAL TREATMENT REQUESTED]

of all Profits and OCLI will realize [CONFIDENTIAL TREATMENT REQUESTED]

of all Profits, subject to adjustment as set out herein.  The activities

for the design, test and manufacture of WDM Optical Filters are to be provided

by OCLI and the design, assembly, test and manufacture and test of WDM

Products are to be provided by JDS and upon the occurrence of certain

circumstances as set out herein, these activities may be transferred to

a separate legal entity. JDS shall be the exclusive entity through which

all WDM Products from this joint venture activity are sold and JDS will

perform all marketing and sale activities for WDM Products, with technical

assistance from OCLI as set out herein.

     OCLI represents that it has expertise in optical coating technology and

optical design capabilities for making optical filters and is currently

developing technology to address current and future market demands for

telecommunications applications.  JDS represents that it has know-how and

expertise in fiber optic component technology including packaging and

development, design and test, and manufacturing capabilities for fiber

optic components, including WDM Products, for telecommunications

applications, and is currently developing technology to address current and

future market demands for telecommunications applications, and also has

marketing and sales expertise relating to such optical components.  At

least until the establishment of the Company, it is intended that OCLI will

use its expertise and facilities for manufacturing WDM Optical Filters for

the joint venture, and JDS will use its expertise and facilities for

manufacturing WDM Products for the joint venture.


                                 ARTICLE III
                           MANUFACTURE OF WDM PRODUCTS
 
     3.1  Manufacture of WDM Optical Filters by OCLI.  Subject to

Sections 7.5 and 9.1(b), and except for WDM Optical Filters supplied by JDS

from inventory existing on the effective date of this Agreement pursuant to

Section 15.4, OCLI agrees to commit all resources necessary and appropriate

to provide manufacturing services to manufacture and supply WDM Optical

Filters for use by JDS or the Company in WDM Products which are based on

Distributor's customer requirements which have been translated into

product, proof of concept product or prototype product specifications by

Distributor where the required WDM Optical Filters specifications have been

determined in consultation with OCLI with respect to WDM Optical Filters

provided by OCLI.

     3.2  Supply of WDM Products by JDS. Subject to Sections

7.5 and 9.1(c), JDS agrees to commit all resources necessary and

appropriate to provide services to design, assemble, test and supply to

OCLI or the Company WDM Products which are based on Distributor's customer

requirements which have been translated into product, proof of concept

product or prototype product specifications by Distributor in consultation

with JDS with respect to WDM Products provided by JDS.

     3.3  Supply of WDM Optical Filters. Prior to formation

of the Company, OCLI shall provide WDM Optical Filters at no charge to JDS

for use in the manufacture of the WDM Products.

     3.4  Price for JDS's Services. Prior to formation of the Company, and

subject to Section 6.1 JDS shall charge OCLI for the  design, assembly and

testing of the WDM Products at JDS's Cost to design, assemble and test the

WDM Products plus a percentage mark up fee of such Cost as agreed by the

Management Committee. JDS shall invoice OCLI for WDM Products for which

testing has been completed and are ready for shipment to Distributor or

Distributor's customers.

     3.5  Terms and Conditions. Payment terms for the sale of WDM Products

and services by JDS to OCLI shall be net 45 days from the date of invoice.

All payments not received when due shall be subject to an additional charge

of 1.5% per month of the unpaid amount until the date of payment.

                                  ARTICLE IV
                             DISTRIBUTION AGREEMENT

     4.1 Contemporaneously with the execution of this Agreement, OCLI and

Distributor shall enter into that certain Distribution Agreement attached

hereto as Exhibit B pursuant to which OCLI shall sell WDM Products only to

Distributor as the sole and exclusive distributor of WDM Products at a

price equal to OCLI's Cost of WDM Products plus a percentage mark up fee of

such Cost as agreed by the Management Committee.

                                   ARTICLE V
                 USE OF THIRD PARTY WDM OPTICAL FILTER SUPPLIERS

     5.1  Price Competition.  The Management Committee may decide whether JDS

or the Company may purchase WDM Optical Filters from third parties if it

determines that the Profits would be greater than if equivalent WDM

Optical Filters were supplied by OCLI.


     5.2  Competition Other Than Price. In the event that OCLI

or the Company is unable to provide WDM Optical Filters, as required by

Distributor's customers, based on lack of technology, including but not

limited to capacity, yield or delivery timeframes, JDS or the Company may

purchase WDM Optical Filters from third parties.


     5.3  Price of Third Party Filters Included in Costs. In the event WDM

Optical Filters are purchased from third parties pursuant to Section 5.1

or 5.2, the price paid for such filters are to be included in Costs for the

purpose of determining profit sharing under Article VI.


                                  ARTICLE VI
                                PROFIT SHARING


     6.1   Quarterly Profit Sharing Adjustments.  Within 30 days from

the end of each Fiscal Quarter thereafter, OCLI, JDS, Distributor and

the Company when formed will exchange accounting information regarding

each party's respective Costs incurred and Profits realized from the

WDM Products Business.  The sale price of WDM Products from OCLI or

the Company to Distributor under the Distribution Agreement or alternately

prior to formation of the Company the mark-up fee under Section 3.4,

shall be adjusted such that the portion of Profits realized by OCLI are

equal to [CONFIDENTIAL TREATMENT REQUESTED] and the portion of Profits

realized by JDS and Distributor combined are equal to [CONFIDENTIAL TREATMENT

REQUESTED] of the Profits realized pursuant to the terms of this Agreement,

subject to adjustment under Sections 6.2 and 6.3. The profit sharing

adjustment of each party's portion of Profits shall be made retroactively

for the Fiscal Quarter just ended in the form of a credit from one party to 

the other and prospectively such that the profit sharing expected for the

current Fiscal Quarter will conform to the requirements of this section.

     6.2  Profit Sharing for Non-Optical Filter WDMs.  In the

event the amount of sales of WDM Products by Distributor that incorporate

means of wavelength selection other than WDM Optical Filters or other

elements providing means of wavelength discrimination which all have

originated from OCLI during any Fiscal Quarter constitute more than

[CONFIDENTIAL TREATMENT REQUESTED] of the amount of all sales of WDM Products

by Distributor, then the adjustment called for by Section 6.1 shall be such

that the portion of Profits realized by OCLI are equal to [CONFIDENTIAL

TREATMENT REQUESTED] and the portion of Profits realized by JDS and

Distributor combined are equal to [CONFIDENTIAL TREATMENT REQUESTED] of

the Profits realized pursuant to the terms of this Agreement.  In the case

of WDM Products containing both WDM Optical Filters and other means of

wavelength selection, sales by Distributor shall be allocated to WDM

Products sales in accordance with the relative value of the WDM Optical

Filter elements or other elements providing means of wavelength 

discrimination which all have originated from OCLI to the total

value of all wavelength selection elements employed in the WDM Products, as

determined by the Management Committee.  Notwithstanding the foregoing, the

said other elements providing means of wavelength discrimination

in WDM Products which all have originated from OCLI, shall only be used in

the calculation in this subsection if such elements were not available from

JDS at the time introduced by OCLI.

     6.3.  Failure of OCLI to Supply Filters. In the event, OCLI and the

Company fail in any Fiscal Quarter to supply JDS or the Company with:

     (i) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters A, then the profit sharing adjustment pursuant to Section

6.1 shall be further adjusted such that the portion of Profits that are

realized during the next Fiscal Quarter by OCLI are equal to [CONFIDENTIAL

TREATMENT REQUESTED] and the portion of Profits realized by JDS and

Distributor combined are equal to [CONFIDENTIAL TREATMENT REQUESTED] of

the Profits realized pursuant to the terms of this Agreement with respect

to WDM Products A. This further profit sharing adjustment shall continue to

apply until the Fiscal Quarter in which OCLI and the Company supplies the

said [CONFIDENTIAL TREATMENT REQUESTED] of JDS's or the Company's

requirements after which the profit sharing shall return to that specified

pursuant to Section 6.1 in the next Fiscal Quarter; or

     (ii) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters B, then the profit sharing adjustment pursuant to Section

6.1 shall be further adjusted such that the portion of Profits that are

realized during the next Fiscal Quarter by OCLI are equal to [CONFIDENTIAL

TREATMENT REQUESTED] and the portion of Profits realized by JDS and

Distributor combined are equal to [CONFIDENTIAL TREATMENT REQUESTED] of the

Profits realized pursuant to the terms of this Agreement with respect to

WDM Products B. This further profit sharing adjustment shall continue to

apply until the Fiscal Quarter in which OCLI and the Company supplies the

said [CONFIDENTIAL TREATMENT REQUESTED] of Distributor's or the Company's

requirements after which the profit sharing shall return to that specified

pursuant to Section 6.1 in the next Fiscal Quarter; or

     (iii) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters, then the profit sharing adjustment pursuant to Section 6.1

shall be further adjusted such that the portion of Profits that are realized

during the next Fiscal Quarter by OCLI are equal to [CONFIDENTIAL

TREATMENT REQUESTED] and the portion of Profits realized by JDS and

Distributor combined are equal to [CONFIDENTIAL TREATMENT REQUESTED] of the

Profits realized pursuant to the terms of this Agreement with respect to

WDM Products. This further profit sharing adjustment shall continue to

apply until the Fiscal Quarter in which OCLI and the Company supplies the

said [CONFIDENTIAL TREATMENT REQUESTED] of JDS's or the Company's

requirements after which the profit sharing shall return to that specified

pursuant to Section 6.1 in the next Fiscal Quarter.

     The following formula shall be used to determine whether OCLI or OCLI

and the Company have satisfied the requirements set out in this Section 6.3

to supply WDM Optical Filters A, WDM Optical Filters B or WDM Optical

Filters:

     S = A/B

Where:

     (i) "S" represents the percentage of the requirements for WDM Optical

Filters A, WDM Optical Filters B or WDM Optical Filters, as the case may

be, supplied by OCLI and the Company;
 
     (ii) "A" represents the number of WDM Optical Filters A, WDM Optical

Filters B or WDM Optical Filters, as the case may be, supplied by OCLI and

the Company and incorporated into WDM Products shipped by the Distributor

in the relevant Fiscal Quarter; and

     (iii) "B" represents the number of WDM Optical Filters A, WDM Optical

Filters B or WDM Optical Filters, as the case may be, that are required by

the Distributor in the relevant Fiscal Quarter to satisfy (a) purchase

order delivery commitments for WDM Optical Filters incorporated into WDM

Products and (b) reasonable requirements to qualify, test and market

prototype or demonstration products but excluding any delivery commitments

not satisfied due to causes other than OCLI's failure to supply WDM Optical

Filters that meet the required WDM Optical Filter specifications based on

Distributor's customer requirements.

     In any event, this Section 6.3 shall cease to apply after January 31,

2002.

     6.4  Right to Inspect Audit Records.  Each party hereto shall have the

right, upon reasonable notice and during normal business hours, to

inspect and conduct an audit of any other party's or the Company's

accounting records for the purpose of verifying such party's Costs

and Profits.

     6.5  Audit Costs Necessitated by Agreements. Except for Section

6.4, in the event a financial audit other than a party's normal annual or

quarterly audit required for its own business, is required at any time

to determine any matter or calculation hereunder, the costs of such

audit shall be included in Costs.
                                        

                                 ARTICLE VII
                       FORMATION OF JOINT VENTURE COMPANY

     7.1  Option to Form Joint Venture Company. Subject to Section 7.2

and only where the sales of WDM Products by Distributor exceeds

[CONFIDENTIAL TREATMENT REQUESTED] for any four consecutive Fiscal Quarters,

either party hereto may exercise an option to cause to be formed a

joint venture company (the "Company"). Such option shall be exercisable

by either party by giving sixty (60) days written notice thereof to

the other party.

     7.2  Formation of Joint Venture Company. Prior to either party

exercising the option under Section 7.1, OCLI and JDS shall upon

written notice negotiate in good faith for a period of sixty (60)

days following such notice and agree upon all the terms and conditions

relating  to the formation and operation of the Company, including but

not limited to the terms set forth below. Where the parties are not able

to agree on all such terms or conditions, the terms and conditions the

parties have not agreed upon shall be addressed in accordance with

Section 7.6 below.

     (a)  Form.  The Company will be formed as a general partnership,

limited liability company or other "flow-through" entity [CONFIDENTIAL

TREATMENT REQUESTED].

     (b)  Location.  The Company will be located in a location agreed

upon by OCLI and JDS which provides a favorable tax treatment for all

parties, location to competent labor force, access to markets and

convenience to the management of OCLI and JDS.

     (c)  Capital.  OCLI and JDS will provide capital in the form of

equity or working capital loans on commercially reasonable terms as needed.

     (d)  Licensing of Technology.  Subject to Sections 11 and 13.1,

OCLI and JDS shall license the Company on a royalty free, nonexclusive, Non-

assignable basis all intellectual property rights, excluding trademarks,

service marks and tradenames, owned by either party for WDM Products

Business. OCLI and JDS shall at no charge provide technical assistance to

the Company to help the Company to implement, and utilize in the Company's

WDM Product Business, such licensed intellectual property rights. JDS will

use reasonable efforts to obtain a nonexclusive license of intellectual

property rights owned by Furukawa but only if agreeable to Furukawa and

necessary to enable the Company to conduct WDM Product Business for a

commercially reasonable royalty, provided same are Non-assignable by the

Company.  Intellectual property rights owned by either party's subsidiaries

in which the party has majority ownership and where the party has control

to cause said subsidiaries to grant an intellectual property rights license

relating to the WDM Products Business which is necessary to enable the

Company to conduct WDM Product Business, shall be offered to the Company on

a nonexclusive, Non-assignable basis for a commercially reasonable royalty.

     (e)  Governance. The governance and control of the Company will

be negotiated by the parties acting in good faith prior to the exercise of

the option under Section 7.1, by taking into consideration, in addition to

all other factors: [CONFIDENTIAL TREATMENT REQUESTED]

     (f)  Profit Sharing.  The parties' respective percentage interest

in the earnings and profits of the Company shall be such as to reflect

the sharing of Profits provided for in Article VI of this Agreement.

     7.3  Assignment of Distribution Agreement. Upon formation of the

Company, the Distribution Agreement shall be assigned by OCLI to the

Company.

     7.4    Assignment of Terms of the Agreement. The Company, shall also

agree to be bound by the same obligations that JDS and OCLI have to

each other before the formation of the Company that relate to protecting

each party's interests, including but not limited to, Sections 3.1 and

3.2, Article IV Distribution; Article VI Profit Sharing; Article VIII

Exclusivity; Article IX Termination; Article XI Research and Development;

Article XIII Acquisitions; Article XIV Confidential Information and

Article XV Miscellaneous.

     7.5  Activities of the Company.  After the formation of the

Company, the parties shall determine what activities as set out in Article

III shall be assumed by the Company or shall continue to be provided by one

or both of the parties.

     7.6  Failure to Agree on Terms of the Company.  In the event the

parties do not reach agreement on all the terms and conditions relating to

the formation and operation of the Company within the 60-day notice period

or any extensions of time mutually agreed to by the parties, the parties

agree to immediately submit any such terms and conditions that the parties

have failed to agree on to arbitration pursuant to Section 15.7 except that

such arbitration shall not be binding on the parties save as expressly set

out in this Article VII.  The factors set forth in Section 7.2(e)(i) and

(ii) shall not in any manner be disclosed to the arbitrators.  The

arbitrators shall determine such terms and conditions taking into account:

     (a) all of the factors listed in Section 7.2 but without any reference

to the factors set forth in Section 7.2(e)(i) and (ii), (b) other

provisions of this Agreement and (c) the conduct of the parties under this

Agreement.  The arbitration proceeding shall be completed within 90 days

following the conclusion of good faith negotiations.  After conclusion of

the arbitration of all such terms and conditions that the parties had

failed to agree on, and where OCLI is not satisfied with the arbitrators'

decision OCLI shall have the option, exercisable by notice, given within 30

days of the date of the arbitrators' decision, to (i) terminate this

Agreement on six months notice provided notice is given after January 31,

1999, (ii) agree to form the Company upon the terms decided by the

arbitrators if, and only if, JDS also, in its sole and unfettered

discretion, whether or not acting reasonably, agrees to form the Company

upon such terms or (iii) continue this Agreement without the formation of

the Company.  In the event the parties continue this Agreement without the

formation of the Company, either of the parties may elect, on one

subsequent occasion only, to initiate the process to form the Company

pursuant to this Article VII any time after a date that is 24 months after

the date of the arbitrators' decision.  In no event shall either party have

any rights or obligations under this Article VII upon the conclusion of the

second arbitration and this Article VII shall thereafter be null and void.

                                   ARTICLE VIII
                                   EXCLUSIVITY

     8.1  [CONFIDENTIAL TREATMENT REQUESTED]

     Notwithstanding any term to the contrary, all such activities for

making for or selling to third parties by either OCLI or JDS, in compliance

with this section, are deemed to be completely outside of the scope of this

Agreement and for greater certainty, Costs and that party's Transaction

Profits associated with such sales shall not be considered in calculation

of Profits under this Agreement.


     8.2  [CONFIDENTIAL TREATMENT REQUESTED]


     8.3  Sale of Planar Waveguide and Fiber Bragg Gratings.  Either party

may at anytime make for or resell to third parties Fiber Bragg grating

or Planar Waveguide or other technology based WDM Products where the

party's Transaction Profit on such sales is included in calculating

Profits under this Agreement.

                                   ARTICLE IX
                                   TERMINATION

     9.1  Termination for Cause.

     a)  Termination by JDS.  JDS may terminate this Agreement upon 30 days

written notice, unless within such period OCLI cures the condition giving

rise to JDS's right to terminate this Agreement (whereupon all intellectual

property rights owned by each party shall be retained by such party and all

intellectual property rights jointly owned shall continue to be jointly

owned provided however that either party may thereafter exploit such joint

intellectual property rights without the consent or accounting to the other

party) in the event that OCLI fails to either provide: [CONFIDENTIAL

TREATMENT REQUESTED] or (ii) in sufficient quantities for proof of

concept or prototype WDM Product samples for product qualification, system

and performance verification to meet Distributor's customers' requirements.


     b)  Termination for Failure of OCLI to Supply Filters. (If OCLI and

the Company fail for any two consecutive Fiscal Quarters to supply the

Distributor or the Company with:


     (i) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters A, then JDS may immediately terminate this Agreement

upon 30 days notice given within 30 days following the end of the said

two consecutive Fiscal Quarters; or

     (ii) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters B, then JDS may immediately terminate the parties rights and

obligations herein with respect to WDM Products B upon 30 days notice given

within 30 days following the end of the said two consecutive Fiscal

Quarters; or

     (ii) [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for WDM

Optical Filters, JDS may terminate this Agreement upon 30 days notice given

within 30 days following the end of the said two consecutive Fiscal Quarters.

     The said two consecutive Fiscal Quarter period described above shall not

commence until such filters become commercially available to the

Distributor or the Company.

     The following formula shall be used to determine whether OCLI or OCLI and

the Company have satisfied the requirements set out in this provision to

supply WDM Optical Filters A, WDM Optical Filters B or WDM Optical Filters,

as the case may be,:

     S = A/B

Where:

     (i) "S" represent the percentage of the requirements for WDM Optical

Filters A, WDM Optical Filters B or WDM Optical Filters, as the case may

be, supplied by OCLI and the Company;

     (ii) "A" represents the number of WDM Optical Filters A, WDM Optical

Filters B or WDM Optical Filters, as the case may be, supplied by OCLI and

the Company and incorporated into WDM Products shipped by the Distributor

in the relevant two consecutive Fiscal Quarter; and

     (iii) "B" represents the number of WDM Optical Filters A, WDM Optical

Filters B or WDM Optical Filters, as the case may be, that are required by

the Distributor in the relevant two consecutive Fiscal Quarter to satisfy

(a) purchase order delivery commitments for WDM Optical Filters

incorporated into WDM Products and (b) reasonable requirements to qualify,

test and market prototype or demonstration products but excluding any

delivery commitments not satisfied due to causes other than OCLI's failure

to supply WDM Optical Filters that meet the required WDM Optical Filter

specifications based on Distributor's customer requirements [CONFIDENTIAL

TREATMENT REQUESTED].

     Once the Company has demonstrated that it has the ability in any Fiscal

Quarter to supply [CONFIDENTIAL TREATMENT REQUESTED] of the requirements for

WDM Optical Filters and [CONFIDENTIAL TREATMENT REQUESTED]

of the requirements for WDM Optical Filters A, then this provision and

Section 3.1 shall cease to apply.  In any event, this provision shall cease

to apply after January 31, 2000 provided that if the right to terminate

this Agreement pursuant to this subsection 9.1(b) arises prior to January

31, 2000, then this subsection continues until January 31, 2002.

      (c)  Termination for Failure of JDS to Supply Assembly Services.  If

JDS, or JDS and the Company combined, has not supplied [CONFIDENTIAL

TREATMENT REQUESTED] of the requirements for WDM Product assembly services

for WDM Products A or [CONFIDENTIAL TREATMENT REQUESTED] of the requirements

for WDM Products B for two consecutive Fiscal Quarters, and provided that

such assembly services are or have been commercially available to third

parties, then OCLI may terminate this Agreement upon 30 days notice given

within 30 days following the end of the said two consecutive Fiscal Quarters.

If such assembly services are not or have not been commercially available,

the said two consecutive Fiscal Quarter period described above shall not

commence until such assembly services become commercially available.  Once

the Company has demonstrated that it has the ability to supply 85% of the

requirements for such WDM product assembly services for a Fiscal Quarter,

then this provision and Section 3.2 shall cease to apply.  In any event,

this provision shall cease to apply after January 31, 2000.

     d)  Termination by Either party. Beginning on [CONFIDENTIAL

TREATMENT REQUESTED], either party may at anytime terminate this Agreement

upon 30 days notice unless prior to such notice sales of WDM Products by

Distributor for any four consecutive Fiscal Quarter period exceed

[CONFIDENTIAL TREATMENT REQUESTED] ("the Sales Goal").  Either party may

also terminate this Agreement pursuant to this provision if, for such

period, Profits are not positive.

     9.2  [CONFIDENTIAL TREATMENT REQUESTED]

     9.3  Effect of Termination. Subject to Section 14.4, in the event that

either this Agreement or the Distributor Agreement, Exhibit C, is

terminated pursuant to any provision hereunder or for breach,, both this

Agreement and said Distributor Agreement shall terminate and all

intellectual property rights owned by each party shall be retained by such

party and all intellectual property rights jointly owned shall continue to

be jointly owned provided however that either party may thereafter exploit

such joint intellectual property rights without the consent or accounting

to the other party.  In addition, in the event the Company has been formed,

the parties shall use their best efforts to effect an orderly dissolution

and wind-up of the Company by  discharging all debts and obligations of the

Company with the remaining equity to be  distributed to the parties in

accordance with their respective interests in Profits; provided that all

assets of the Company are dealt with as follows.  All assets of the Company

shall be transferred to the parties as mutually agreed.  No Company asset

shall be conveyed, sold, leased or otherwise disposed of to a third party

unless both parties agree in writing to such disposal in their respective

sole discretion.  Should the Company not have sufficient monetary assets to

discharge all debts and all obligations of the Company, each of the parties

shall share in the discharge of such debts and obligations in accordance

with their respective interests in Company.

                               ARTICLE X
                          MANAGEMENT COMMITTEE

     10.1  Management Committee. OCLI and JDS shall each appoint two

persons to serve as a Management Committee.  The Management Committee shall

have the authority, acting reasonably, to manage the design, development,

manufacture and technical product marketing support of WDM Products

Business pursuant to this Agreement and until the formation of the Company.

Meetings of the Management Committee may be called by any member thereof

upon one business day notice to the other Management Committee members and

attendance may be by telephone, video conference or other means agreed to

by such members.  Three members, or their designated representatives, must

be present for a quorum and no business shall be conducted by the

Management Committee except at such meetings where  a quorum is present.

The affirmative vote of three members is required to authorize all actions

of the Management Committee.  In the event the Management Committee reaches

a deadlock, including consistent failure or refusal of one or more party's

members to attend meetings, the chief executive officers then in office of

JDS and OCLI shall jointly appoint one non-affiliated business person to

serve as the fifth member of the Management Committee to break such

deadlock.  If the chief executive officers of OCLI and JDS are unable to

agree on who should serve as the fifth member of the Management Committee,

each shall select one non-affiliated business person, and the two non-

affiliated business persons so selected shall select a third non-affiliated

business person who alone will then join the Management Committee as the

fifth member to break such deadlock.

     10.2  Chairman of the Management Committee. A member of the Management

Committee initially selected by OCLI shall serve as chairman  for a nine-

month term.  Thereafter, JDS shall choose the chairman  to serve for a nine-

month term, and thereafter the parties shall continue to rotate in the

selection of the chairman  for succeeding nine-month terms.  The duties of

the chairman  shall be to organize and preside at meetings of the

Management Committee and to perform such other duties as from time to time

may be determined by the Management Committee.  The parties may adjust the

term of the chairman by mutual agreement.

     10.3  Delegation. The Management Committee may delegate duties to one

or more persons who need not be members of the Management Committee.

                               ARTICLE XI
                        RESEARCH AND DEVELOPMENT

     11.1  Funding of R&D. The parties may propose any R&D projects that

relate to WDM Products Business to the Management Committee or the Company.

Notwithstanding the voting provisions contained in Section 10.1, if the

Company or the Management Committee, acting through members or

representatives that are unaffiliated with the offering party, elects to

conduct the R&D project, the Company, or OCLI or JDS as determined by the

Management Committee, shall fund the R&D project which funding shall

constitute Costs and the results shall be owned by the Company or equally

by OCLI and JDS.  Where the Company or said members of the Management

Committee decline to undertake the R&D project, either party may conduct

the R&D project provided that the Company or said members of the Management

Committee shall have the right for a period of 60 days after declining to

conduct the R&D project to accept the R&D project in which case the total

cost of the R&D project shall be funded by the Company, or OCLI or JDS as

determined by the Management Committee, which funding  shall constitute

Costs.  In the event the Company or said members of the Management

Committee elect not to conduct the R&D project, or exercise the 60 day

option described above, either party is free to conduct the R&D project

with the results being owned by such party with no obligation to license or

otherwise share the results with the Company or the other party and any

products based on the R&D project shall be deemed to fall outside of the

definition of WDM Products.  In the event a party elects not to present an

R&D project to the Management Committee or the Company, and the results of

the R&D project has application in the WDM Products Business, at the end of

the R&D project such party will offer the Company a nonexclusive, Non-

assignable license limited to use the results of such R&D project solely

for the WDM Product Business, based on commercially reasonable terms

including lump sum and royalty terms, which amounts shall be included in

Costs but not be included in the licensing party's revenues for the purpose

of determining such party's Transaction Profits.  The Company shall have a

period of thirty (30) days from the date of such offer to accept such

license.  In the event the Company does not take a license within said time

period, any products based on such R&D project shall be deemed to fall

outside of the definition of WDM Products and the party owning such results

shall have no obligation to license or otherwise share the results with the

Company or the other party.

     11.2. All OCLI R&D, development and capital costs associated with or

related to OCLI complying with its obligations to develop WDM Optical

Filters as set out in Section 9.1(a), shall be paid for completely by OCLI

and not be included in Costs, and shall fall within the intellectual

property rights that OCLI must license under Section 7.2(d).

                                  ARTICLE XII
                              THIRD PARTY LICENSING

     12.1  Where the parties agree that a third party license of

intellectual property rights is needed to carry out the activities

hereunder,  the costs of such license shall be included in Costs for the

purpose of sharing Profits under Article VI.

                                  ARTICLE XIII
                                  ACQUISITIONS

     13.1  Where either party makes an acquisition in which it

has majority ownership and the acquiring party has control to cause the

acquisition to offer an intellectual property license relating to WDM

Products Business to the Company, immediately after the completion of the

acquisition the Company will be offered a nonexclusive, Non-assignable

license limited to use for the WDM Product Business based on commercially

reasonable terms including lump sum and royalty terms.  The Company shall

have a period of thirty (30) days from the date of such offer to accept

such license.  Neither party is otherwise obligated to license or otherwise

share such intellectual property with the Company or the other party.

     13.2 Notwithstanding the voting provision contained in

Section 10.1, Where either OCLI or JDS  makes an acquisition in which it

has majority ownership (the "Acquiring Party") and the acquisition's

existing business includes WDM Products Business, the Acquiring Party shall

offer to the joint venture, immediately after the completion of the

acquisition, acting through the members of the Management Committee or the

governing body of the Company who are unaffiliated with the Acquiring

Party, the right to have the Acquiring Party's share of Transaction Profits

of the acquisition's WDM Products Business included in the calculation of

Profit sharing between the parties pursuant to Article VI of this

Agreement.  If the joint venture so elects within thirty (30) days from the

date of such offer to so participate, as consideration for the right to so

share in such Transaction Profits, the Acquiring Party shall be compensated

by the non-acquiring party (the "Other Party"), in cash or other

consideration acceptable to the Acquiring Party, an amount that shall be

equal to the portion of the acquisition costs, including expenses

(including costs associated with determining the portion of the acquired

company's business allocable to the WDM Products Business), that is

attributed to the WDM Business of the acquired company times [CONFIDENTIAL

TREATMENT REQUESTED] where OCLI is the Other Party and [CONFIDENTIAL

TREATMENT REQUESTED] where JDS is the Other Party. Alternatively, the

Acquiring Party may at its sole option agree with the Other Party to adjust

the Profit sharing pursuant to Article VI to replace a portion or all of the

said cash amount.  If the joint venture does not so elect within the

specified time period, the acquired company's business shall be completely

outside the scope of this Agreement and not be included in the calculation

of Profit.  For greater certainty, where the Acquiring Party is OCLI, the

Other Party is JDS and vice-versa.

                                 ARTICLE XIV
                            CONFIDENTIAL INFORMATION

     14.1 "Confidential Information" shall mean any business,

marketing, technical, scientific, financial or other information,

specifications, designs, plans, drawings, software, prototypes or process

techniques, of a party, which at the time of disclosure, is designated as

confidential (or like designation), is disclosed in circumstances of

confidence, or would be understood by the parties, exercising reasonable

business judgement, to be confidential, but excludes any information which:

     (a)  is independently developed by or for the receiving party without

reference to or use of Confidential Information;

     (b)  is lawfully received free of restriction from another source

having the right to so furnish such confidential information;

     (c)  is or becomes lawfully in the public domain other than through a

breach of this Agreement;

     (d)  was known by the receiving party prior to disclosure, as

evidenced by its business records;

     (e)  disclosing party agrees in writing is free of such restrictions;

     (f)  is disclosed by the disclosing party to a third party without a

duty of confidentiality on such third party; or

     (g)  is required or compelled by law to be disclosed, provided that

the receiving party give all reasonable prior notice to the disclosing

party to allow it to seek protective or other court orders.

     14.2  Obligation to Keep in Confidence. Except as otherwise allowed

under this Agreement, Receiving party shall keep Confidential Information

of the disclosing party in confidence; disclose it only to individuals in

the receiving party with a need to know and who are under confidentiality

restrictions; and use or reproduce it only to the extent necessary for the

activities contemplated hereunder.  Each party shall protect Confidential

Information of disclosing party with at least the same degree of care as

it normally exercises to protect its own Confidential Information of a

similar nature, but no less than a reasonable degree of care.

     14.3  Irreparable Harm. Receiving party agrees that any violation or

threat of violation of this section will result in irreparable harm to

disclosing party for which damages would be an inadequate remedy and,

therefore, in addition to its rights and remedies otherwise available at

law, including without limitation the recovery of damages and expenses,

including attorney's fees for breach of this Agreement, disclosing party

shall be entitled to unilaterally seek equitable relief, including both

temporary and permanent injunctions, to prevent any unauthorized use or

disclosure, and to such other and further equitable relief as the court may

deem proper under the circumstances.

    14.4  [CONFIDENTIAL TREATMENT REQUESTED]

                                  ARTICLE XV
                                 MISCELLANEOUS

     15.1  Non-Supply of WDM Optical Filters to Third Parties. Except for

commitments to supply not more than a total of [CONFIDENTIAL INFORMATION]

of WDM Optical Filters to third parties which commitments to deliver do not

extend beyond June 1, 1997, OCLI represents and warrants to JDS that it is

under no obligations whatsoever to supply WDM Optical Filters to any third

party as of the date of this Agreement, and agrees not to supply any WDM

Optical Filters to any third party except as expressly provided for herein.

In addition, where OCLI provides optical filters for use in fiber optical

product applications other than WDM Products, to any third party where such

optical filters may also be used as a wavelength discrimination element,

OCLI shall obtain from such third party an enforceable representation and

warranty that such third party will not use such optical filter in WDM

Products.

     15.2  [CONFIDENTIAL TREATMENT REQUESTED]

     15.3  Order Backlog.  Notwithstanding any term to the contrary herein,

the portion of Profits that OCLI shall realize from Profits, where Profits

on Backlog shall be JDS' revenues from the sale of WDM Products less JDS'

related Costs, whether or not Costs were incurred before or after the date

of this Agreement and such JDS Costs related to Backlog shall be included

in Costs, shall be as follows:

     (a) where arising from Backlog from [CONFIDENTIAL TREATMENT REQUESTED]

for WDM Products B shall be calculated as follows.

          (i) where such Backlog is shipped in the two (2) months period

     from the date of this Agreement, five percent (5%) of Profits on such

     Backlog shipped during said period;

          (ii) where such Backlog is shipped within the period from the end

     of (2) months to four (4) months from the date of this Agreement, ten

     percent (10%) of Profits on such Backlog shipped during said period;

          (iii) where such Backlog is shipped within the period from the

     end of four (4) months to six (6) months from the date of this

     Agreement, fifteen percent (15%) of Profits on such Backlog shipped

     during said period;

          (iv) where such Backlog is shipped within the period from the end

     of six (6) months to eight (8) months from the date of this Agreement,

     twenty percent (20%) of Profits on such Backlog shipped during said

     period;

          (v) where such Backlog is shipped within the period from the end

     of eight (8) months to ten (10) months from the date of this

     Agreement, twenty-five percent (25%) of Profits on such Backlog

     shipped during said period;

          (vi) where such Backlog is shipped within the period from the end

     of ten (10) months to twelve (12) months from the date of this

     Agreement, thirty percent (30%) of Profits on such Backlog shipped

     during said period;

          (vii) where such Backlog is shipped after twelve (12) months from

     the date of this Agreement, the portion of Profits of OCLI shall be

     determined pursuant to the terms of this Agreement.

     (b) arising from Backlog from [CONFIDENTIAL TREATMENT REQUESTED] for

WDM Products A where such Backlog is shipped after the effective date of

this Agreement shall be included in this Agreement;

     (c) arising from purchase orders received by JDS on or after January

20, 1997 from [CONFIDENTIAL TREATMENT REQUESTED] for WDM Products B which

are shipped after the effective date of this Agreement, shall be included in

this Agreement;

     (d) all other Backlog shall be considered completely outside of this

Agreement; and

     15.4 JDS's Inventory. JDS's current inventory of WDM Optical Filters

on hand at the effective date of this Agreement ("JDS's Inventory Filters")

shall be treated as follows:

     (a) notwithstanding any term to the contrary herein, for sales of WDM

Products A that contain JDS's Inventory Filters after the effective date of

this Agreement to a maximum of the lesser of (i)[CONFIDENTIAL TREATMENT

REQUESTED], where Profits on Inventory Sales shall be JDS' revenues from

the sale of WDM Products A less JDS's related Costs, whether or not Costs

were incurred before or after the date of this Agreement and such JDS Costs

related to Inventory Orders shall be included in Costs, the portion of

Profits that OCLI shall realize from such Profits shall be as follows:

          (i) where Inventory Sales are shipped in the two (2) months

     period from the date of this Agreement, five percent (5%) of Profits

     on Inventory Orders shipped during said period;

          (ii) where Inventory Sales are shipped within the period from the

     end of two (2) months to four (4) months from the date of this

     Agreement, ten percent (10%) of Profits on Inventory Orders shipped

     during said period;

          (iii) where Inventory Sales are shipped within the period from

     the end of four (4) months to six (6) months from the date of this

     Agreement, fifteen percent (15%) of Profits on Inventory Orders

     shipped during said period;

          (iv) where Inventory Sales are shipped within the period from the

     end of six (6) months to eight (8) months from the date of this

     Agreement, twenty percent (20%) of Profits on Inventory Orders shipped

     during said period;

          (v) where Inventory Sales are shipped within the period from the

     end of eight (8) months to ten (10) months from the date of this

     Agreement, twenty-five percent (25%) of Profits on Inventory Orders

     shipped during said period;

          (vi) where Inventory Sales are shipped within the period from the

     end of ten (10) months to twelve (12) months from the date of this

     Agreement, thirty percent (30%) of Profits on Inventory Orders shipped

     during said period;

          (vii) where Inventory Sales are shipped after twelve (12) months

     from the date of this Agreement, the portion of Profits of OCLI shall

     be determined pursuant to the terms of this Agreement;

     (b)  Except with respect to WDM Products shipped prior to the

effective date of this Agreement, JDS shall receive a credit from OCLI at

the effective date of this Agreement for the current inventory of WDM

Optical Filters JDS has on hand at the effective date of this Agreement as

follows:

          (i) for all such WDM Optical Filters purchased from OCLI suitable

     for use under Section 15.3(b) for Backlog from [CONFIDENTIAL TREATMENT

     REQUESTED] for WDM Products A, OCLI shall provide JDS with a credit

     of [CONFIDENTIAL TREATMENT REQUESTED] per WDM Optical Filter A, and

     JDS shall be entitled to include [CONFIDENTIAL TREATMENT REQUESTED] per

     WDM Optical Filter A in Costs hereunder;

          (ii) for all such WDM Optical Filters purchased from OCLI

     suitable for use under Section 15.3(a) for Backlog from [CONFIDENTIAL

     TREATMENT REQUESTED] for WDM Products B, OCLI shall provide JDS with

     a credit of an amount equal to the purchase price JDS actually paid

     less the Costs (whether or not Costs were incurred before or after the

     date of this Agreement) of such WDM Optical Filters B, and JDS shall be

     entitled to include such WDM Optical Filters B Costs (whether or not

     Costs were incurred before or after the date of this Agreement) in

     Costs hereunder; and

          (iii) for all such WDM Optical Filters suitable for use under

     Section 15.4(a) for Inventory Orders for WDM Products A:

         (A) OCLI shall provide JDS with a credit of an amount equal to the

     purchase price JDS actually paid to OCLI less the Costs (whether or

     not Costs were incurred before or after the date of this Agreement) of

     such WDM Optical Filters A, and JDS shall be entitled to include such

     WDM Optical Filters A Costs (whether or not Costs were incurred before

     or after the date of this Agreement) in Costs hereunder, and

         (B) for such WDM Optical Filters made by JDS, JDS shall be

     entitled to include such WDM Optical Filters A Costs (whether or not

     Costs were incurred before or after the date of this Agreement) in

     Costs hereunder.

     15.5  Constraints on Employee.  For a period of two years following

the termination of employment of an employee of either party, the other

party shall be prohibited from employing such employee without prior

written consent of the other party; provided, however, that this

restriction shall terminate two years after the termination of this

Agreement.

     15.6  Governing Law.  This Agreement shall be construed

in accordance with and governed by the laws of the State of Delaware

without regard to the conflict of law principles or without regard to the

United Nations Convention on the Contracts for the International Sale of

Goods.

     15.7  Disputes.  Except for breach of Article XIV Confidential

Information, and subject to Sections 7.6 and 10.1, except where the

parties fail to take any required actions to resolve their differences

or there is no resolution under Section 10.1, if a dispute, breach

or failure to agree shall occur between the parties concerning this

Agreement, both parties may require the other party promptly to submit

the reasons for its position, in writing to the requesting party, and

then to enter into good faith negotiations, including the involvement,

if appropriate, of senior management of each of the Parties to attempt

to resolve the disagreement.  If such dispute, breach or failure to agree

cannot be settled by good faith negotiation between the parties within

30 days, the matter shall be finally settled by mandatory, binding

arbitration, in accordance with the rules and procedures

of the American Arbitration Association applicable to commercial

transactions then in force, provided that arbitration proceedings may not

be instituted until sixty (60) days after delivery of any such notice of

arbitration and where the other party has not remedied the matter within

said time period.  The arbitration panel shall consist of three (3)

arbitrators one of which shall be appointed by each party and the third

selected by the two so appointed.  Costs of arbitration shall be borne by

the parties in accordance with the decision of the arbitrators.  Judgment

upon the award rendered may be entered in any court having competent

jurisdiction thereof, or application may be made to such court for a

judicial acceptance of the award and an order of enforcement as the case

may be.  The arbitration proceedings shall be conducted at a reasonable

location selected by the parties or by the arbitrators.  The factors set

forth in Section 7.2(e)(i) shall not in any manner be disclosed to the

arbitrators.  Notwithstanding the foregoing, the parties may apply to any

court of competent jurisdiction to compel arbitration in accordance with

this paragraph, without breach of this arbitration provision.

     15.8  Attorneys' Fees.  In case suit is brought or arbitration

proceedings commenced by either party because of the

breach of any term, covenant or condition contained in this Agreement, the

prevailing party shall be entitled to recover against the other party the

full amount of its costs, including expert witness fees and reasonable

attorneys' fees.  If neither party prevails entirely, such fees and

expenses shall be prorated based upon the relative success of each party to

the relief being sought.

     15.9  Notices. All notices, offers, acceptances, approvals and other

communications under this Agreement shall be in writing and shall be given

to such party, addressed to it, at its address or telecopy number set

forth below or such other address or telecopy number as such party may

in the future specify for such purpose by notice to the other party.

Each such notice, information, request or communication shall be

effective upon actual receipt by the party at the address specified below:

     If to OCLI:

          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telephone:     707-525-7030
          Telecopier:    707-525-6840
          Attention:     General Counsel
                         (Joseph C. Zils, Esq.)

          With a copy to (which is not required to constitute notice to

OCLI):

          Collette & Erickson
          555 California Street, Suite 4350
          San Francisco, California 94104
          Telephone:     415-788-4646
          Telecopier:    415-788-6929
          Attention:     John V. Erickson, Esq.

     If to JDS or Distributor:

          JDS FITEL, Inc.
          570 West Hunt Club Road
          Nepean, ON K2G 5W8 Canada
          Telephone:     613-727-1303
          Telecopier:    613-727-1852
          Attention:     President (Jozef Straus, Ph.D.)

          With a copy to (which is not required to constitute notice to

JDS):

          JDS FITEL, Inc.
          570 West Hunt Club Road
          Nepean, ON K2G 5W8 Canada
          Telephone:     613-727-1303
          Telecopier:    613-727-8889
          Attention:     General Counsel
                         (Gordon Buchan, Esq.)

Any party may from time to time specify as its address or telecopy number

for purposes of this Agreement any other address or telecopy number upon

the given of 10 days notice thereof to the other party.

     15.10 Public Announcements.  The parties shall not issue a press

release or other publicly available document containing any information

regarding the other party, this Agreement, the transactions contemplated

herein or the operating or financial results of the Company without the

prior written approval of the other party.  At least 72 hours prior to

the issuance of such information, the issuing party shall provide the

other party with notice of its intention to disclose such information

as well as the draft wording of the information to be released.

Where a party refuses to approve the wording of the information to be

released, the party shall provide the reasons for such refusal and both

parties agree to use their best efforts to negotiate the appropriate

wording of the information to be released.  However, nothing contained

herein shall prevent a party from disclosing any information that is

required to be disclosed pursuant to Securities Law and the rules or

regulations promulgated thereunder.  Where a party issues a press release

containing any information regarding the other party, this Agreement,

the transactions contemplated herein or the operating or financial

results of the Company, a copy of such release shall be provided to the

other party forthwith.

     15.11  Counterparts.  This Agreement may be executed in two or more

counterparts, each of which shall be deemed an original.  A photocopy or

facsimile copy of the signatures of the parties to this Agreement shall

be considered authenticated signatures admissible into evidence where the

authenticity of the signatures are placed into question.

     15.12 Interpretation.  The table of contents and the headings to

the various subdivisions of this Agreement are for convenience of reference

only and shall not define or limit any of the terms or provisions hereof.

All pronouns shall be deemed to refer to the masculine, feminine, neuter,

singular or plural as the identity of the Person or Persons referred to

may require.  The language in all parts of this Agreement will in all

cases be construed as a whole and in accordance with its fair meaning

and not restricted for or against either party.

     15.13  Successors and Assigns.  This Agreement and any rights or

licenses granted herein are personal to each party and shall be binding

upon and inure to the benefit of the parties hereto and their respective

successors and permitted assigns, provided, however, neither party shall

assign any of its rights or privileges hereunder without the prior written

consent of the other party.  Should either party attempt an assignment in

derogation of the foregoing, the other party shall have the right to

immediately terminate this Agreement by written notice to the other party.

     15.14  Waiver. The failure of either party to give notice to the

other party of the breach or non-fulfillment of any term, clause,

provision or condition of this Agreement shall not constitute a waiver

thereof, nor shall the waiver of any breach or non-fulfillment of any

term, clause, provision or condition of this Agreement constitute a waiver

of any other breach or non-fulfillment of that or any other term, clause,

provision or condition of this Agreement.

     15.15  Purchase By Competitor.  [CONFIDENTIAL TREATMENT REQUESTED] 

     15.16  Entire Agreement. This Agreement sets forth the entire

agreement and understanding between the parties with respect to the subject

matter hereof and supersedes and cancels all previous negotiations,

agreements, commitments, and writings in respect to the subject matter

hereof, and neither party shall be bound by any term, clause, provision or

condition save as expressly provided in this Agreement or as duly set forth

on or subsequent to the date of execution hereof in writing, signed by duly

authorized officers of the parties.

     15.17  Agency.  Subject to Article VII, each party acknowledges that

it does not intend to create or imply a legal partnership with the other

parties by virtue of this Agreement and the parties agree that nothing in

this Agreement shall be construed as establishing or implying any legal

partnership between the parties hereto, and nothing in this Agreement shall

be deemed to constitute either of the parties hereto as the Agent of the

other party or authorize either party to incur any expenses on behalf of

the other party or to commit the other party in  any way whatsoever,

without obtaining the other party's prior written consent.  The parties

further agree that when any party hereto deals with a third party as a

result of this Agreement that such third party will be notified that every

party hereto is acting on its own behalf.

     15.18  Survival.  The provisions of Sections 9.3, 14 and 15.5,

15.6,15.7, 15.8, 15.9, 15.12, 15.13, 15.14, 15.18, 15.19 and 15.20,

and in Exhibit B, Article V and Article IX shall survive termination

of this Agreement.  The provisions of Section 6.4 shall survive for a

period of 18 months following termination of this Agreement.

Notwithstanding any term to the contrary: (a) where at the date of

termination of this Agreement, (i) the Profit is negative or (ii)

Costs exist but there is no Profit; or (b) where after the date of

termination of this Agreement (i) if any obligations, including but

not limited to customs and duties, arise with respect to any Cost that

would have been included in Costs if the obligation was identified

during the period that the Agreement was in effect,

(ii) if any liability arose during the period that the Agreement was in

effect, including but not limited to any liability under Section 15.20 or

Exhibit B Article V, but which was not identitifed or determined until

after the date of termination of this Agreement, or (iii) bona fides bad

debts arise for which revenues have been used in the calculation of Profits;

then in all cases the parties agree to share the Costs such that OCLI shall

be responsible for paying one-third and JDS and Distributor combined shall

be responsible for paying two-thirds of all such Costs, regardless of which

party actually paid such Costs.  The parties shall promptly make payment to

the other party as appropriate to ensure that each party has fulfilled its

obligation under this Section 15.18 with regard to such Costs.

     15.19  Further Assurances and Approvals.  The parties agree to make,

do, execute, endorse, acknowledge and deliver or cause and procure to be

made, done, executed, endorsed, acknowledged, filed, registered and

delivered any and all further acts and assurances including any conveyance,

deed, transfer, assignment, share certificate or other instrument in

writing as may be necessary to give effect to the terms and conditions

provided for and contemplated by this Agreement.  The parties further

agree that where any term, warranty, representation, option or condition

provided for or contemplated by this Agreement requires prior regulatory

or shareholder approval to give effect to such term, warranty,

representation, option or condition, the parties shall not enforce such

term, warranty, representation, option or condition unless and until

such approval is obtained.

     15.20  Intellectual Property Indemnity Liability. Where any threatened

or actual proceeding or claim against any party alleging that any WDM

Product or WDM Optical Filter furnished hereunder infringes

any third party intellectual property rights, including without limitation

any patents, trademarks and copyright, the parties agree to jointly (i)

defend or settle any such matter, (ii) equally share any costs, including

without limitation all legal or expert fees and disbursements which were

incurred as a result of such defense or settlement,  and (iii) equally

share in the payment of all damages and costs assessed by final judgment

against any party and attributable to such matter.

     15.21  Approvals. The signatures provided below shall not be

deemed effective unless and until all required or counseled government or

regulatory filings are made and all approvals or consents are obtained.

     15.22  Representations and Warranties.  Each party represents and

warrants that:

     (a) it has full right and title to all of the Confidential Information

it discloses to the other party under this Agreement;

     (b) to the best of its knowledge, there are no material liens,

encumbrances of any kind against its intellectual property which relates to

the WDM Product Business and that it is not subject to any outstanding

agreements, assignments or encumbrances that are inconsistent with the

provisions of this Agreement;

     (c) to the best of its knowledge, there are no material actual or

threatened suits, actions at law, proceedings in equity, arbitrations or

other proceedings or actions against the party; and

     (d) the execution, delivery and performanace of this Agreement by each

party are within each party's corporate powers.

     15.23  Force Majuere.  Neither party be responsible or liable for any

delay or failure to deliver goods or perform services under this Agreement

due to any unforeseen circumstances or causes beyond that party's control,

including but not limited to, acts of God, fire, flood, explosion,

earthquake, war, insurrection, embargo, acts of civil or military

authorities, delay in delivery by suppliers, accident, strike or other

labour dispute, inability to secure labour, material, facilities, energy or

transportation.  In the event of a force majeure condition, the time for

delivery or other performance will be extended for a period of time equal

to the duration of such force majeure condition.

     IN WITNESS WHEREOF, the parties have executed this Agreement to be

effective as of the date first above written.

                         OPTICAL COATING LABORATORY, INC.



                         By /S/HERBERT M. DWIGHT, JR.
                         Name Herbert M. Dwight, Jr.
                         Its Chairman, President & CEO


                         JDS FITEL Inc.



                         By /S/JOZEF STRAUSS
                         Name Jozef Straus
                         Its President & CEO




                            FIRST AMENDMENT TO
                                 AGREEMENT
                              BY AND BETWEEN
                              JDS FITEL, INC.
                                    AND
                     OPTICAL COATING LABORATORY, INC.

     WHEREAS, Optical Coating Laboratory, Inc. ("OCLI") and JDS FITEL, INC.
("JDS") entered into that certain Agreement by and between JDS FITEL, Inc.
and Optical Coating Laboratory, Inc., dated February 1, 1997 (the
"Agreement"), to combine their respective areas of expertise and
capabilities in a joint effort for WDM Product Business, as that term is
defined therein;

     WHEREAS, Section 15.16 of the Agreement provides that the OCLI and JDS
may amend the Agreement if such amendment is set forth in writing and
signed by duly authorized officers of each; and

     WHEREAS, the Company wishes to amend the Agreement effective February
2, 1997 (the "Effective Date");

     NOW, THEREFORE, the parties hereby agree to amend Section 3.1 of the
Agreement effective as of the Effective Date as follows:

          3.1  Manufacture of WDM Optical Filters by OCLI. Subject to
     Sections 7.5 and 9.1(b), and except for WDM Optical Filters supplied
     by JDS from inventory existing on the effective date of this Agreement
     pursuant to Section 15.4, OCLI agrees to commit all resources
     necessary and appropriate to provide manufacturing services to
     manufacture and supply WDM Optical Filters as requested and for use by
     JDS or the Company in WDM Products which are based on Distributor's
     customer requirements which have been translated into product, proof
     of concept product or prototype product specifications by Distributor
     where the required WDM Optical Filters specifications have been
     determined in consultation with OCLI with respect to WDM Optical
     Filters provided by OCLI.  For greater certainty, JDS may also make
     and supply WDM Optical Filters for use in WDM Products.

     FURTHER, the parties hereby agree to amend Exhibit A, "Cost
Definition," to the Agreement, effective as the Effective Date, as restated
in its entirety and set forth in Attachment A attached hereto.


     IN WITNESS WHEREOF, OCLI and JDS adopt this Amendment as of the
Effective Date.

                         OPTICAL COATING LABORATORY, INC.

                         By   /S/JOSEPH ZILS
                         Its  Vice President, General Counsel
                              and Corporate Secretary
                              Title

                         JDS FITEL, INC.

                         By     /S/M. ZITA COBB
                         Its    Chief Financial Officer and
                                VP Finance
                                Title



                          SECOND AMENDMENT TO
                               AGREEMENT
                             BY AND BETWEEN
                            JDS FITEL, INC.
                                  AND
                    OPTICAL COATING LABORATORY, INC.

     WHEREAS, Optical Coating Laboratory, Inc. ("OCLI") and JDS FITEL, INC.
("JDS") entered into that certain Agreement by and between JDS FITEL Inc.
and Optical Coating Laboratory, Inc. ("OCLI"), dated February 1, 1997 (the
"Agreement"), to combine their respective areas of expertise and
capabilities in a joint effort for WDM Product Business, as that term is
defined therein;

     WHEREAS, Section 15.16 of the Agreement provides that the OCLI and JDS
may amend the Agreement if such amendment is set forth in writing and
signed by duly authorized officers of each; and

     WHEREAS, the parties wish to amend the Agreement effective June 1,
1997 (the "Effective Date");

     NOW, THEREFORE, the parties hereby agree to amend the Agreement
effective as of the Effective Date as follows:

1.   In Section 1.1, Definitions, replace the definitions of "WDM Optical
Filters"; and "WDM Products" with the following definitions:

     "WDM Optical Filters" shall mean WDM Optical Filters A, WDM Optical
Filters B and WDM Optical Filters C;


     "WDM Products" shall mean:

     [CONFIDENTIAL TREATMENT REQUESTED]

2.   In Section 1.1, Definitions, add the following definitions:

     "WDM Optical Filters C" shall mean any and all optical filters that
are intended to be used in WDM Products C;

     [CONFIDENTIAL TREATMENT REQUESTED]

3.   In Section 15.1, Non-Supply of WDM Optical Filters to Third Parties,
replace the words "June 1, 1997" with the words "1 August 1997".

4.   In Section 9.1 (a)(i), Termination by JDS, replace the words "May 31,
1997" with the words "August 31,1997".  At its September 5, 1997 meeting,
the Joint Venture Management Committee determined that this obligation of
OCLI was satisfied effective August 31, 1997.

     IN WITNESS WHEREOF, OCLI and JDS adopt this Amendment as of the
Effective Date.


                         OPTICAL COATING LABORATORY, INC.



                         By    /S/CHARLES J. ABBE
                         ITS   PRESIDENT
                               Title                 


                         JDS FITEL INC.



                         By /S/M. ZITA COBB
                            Chief Financial Officier & V.P.
                            Finance




                           SETTLEMENT AGREEMENT

          This Agreement (including all exhibits and schedules, the
"Agreement") is made and entered into as of this 19th day of November 1997,
by and among SICPA Holding S.A., a company organized and existing under the
laws of Switzerland ("SICPA"), Optical Coating Laboratory, Inc., a
corporation organized and existing under the laws of the State of Delaware
("OCLI"), Flex Products, Inc., a corporation organized and existing under
the laws of the State of Delaware ("Flex"), Herbert M. Dwight, Jr., John
McCullough, James Seeser (Messrs. Dwight, McCullough and Seeser
collectively, the "OCLI Designated Directors"), Maurice A. Amon and Eduardo
Beruff (Messrs. Amon and Beruff collectively, the "SICPA Designated
Directors").
                                  RECITAL

          WHEREAS the undersigned parties to this Agreement desire to
compromise and settle that certain litigation entitled SICPA Holding S.A.
v. Optical Coating Laboratory, Inc., Herbert M. Dwight, Jr., John
McCullough, James Seeser and Flex Products, Inc., including counterclaims 
entitled Optical Coating Laboratory, Inc. and Flex Products, Inc. v. SICPA
Holding S.A., Maurice A. Amon and Eduardo Beruff, in the Court of Chancery
of the State of Delaware in and for New Castle County, C.A. No. 15129 (the
"Litigation");

          NOW THEREFORE, in consideration of the premises, and other good
and valuable consideration, the receipt of which is hereby acknowledged,
SICPA, OCLI , Flex, the SICPA Designated Directors and the OCLI Designated
Directors hereby agree as follows:


                                 ARTICLE I
                        DEFINITIONS; INTERPRETATION

          Section 1.01.  Definitions.  Except as otherwise specified herein
or as the context may otherwise require, the following terms have the
respective meanings set forth below for all purposes of this Agreement, and
the definitions of such terms are equally applicable both to the singular
and plural forms of such terms and to the masculine, feminine and neuter
genders of such terms.  The definition of terms in this Agreement is not
intended to and shall not be construed to affect the construction of
similar terms in other agreements involving the Parties.

          "Addendum No. 1" means that certain Addendum No. 1 to OCLI/SICPA
Agreement made and entered into by and between OCLI and SICPA, dated as of
May 1, 1997.

          "Agreement" has the meaning set forth in the preamble of this
Agreement.

          "Assigned Principal Amount" shall have the meaning set forth in
Section 3.02.

          "Business Day" means a day other than a Saturday, Sunday, U.S.
federal legal holiday or Swiss national holiday.

          "Common Stock" shall include any shares of Flex of any class or
series, which has no preference or priority in the payment of dividends or
in the distribution of assets upon any voluntary or involuntary
liquidation, dissolution or winding up of Flex and which is not subject to
redemption by Flex, and if at any time there shall be more than one such
class or series, all such shares, irrespective of class or series
designation, shall be treated as one class for purposes of calculating a
Flex Equity Interest.

          "Effective Date" means the date first above written.

          "Equity Ratio" means the ratio of the Flex Equity Interest of
OCLI divided by the Flex Equity Interest of SICPA.


          "Financial Advisor" means the managing underwriter(s) or
placement agent(s) engaged to sell or place securities, including debt and
equity securities

          "Flex" has the meaning set forth in the preamble of this
Agreement.

          "Flex Equity Interest" of a person means the quotient of (i) the
number of shares of the Common Stock of Flex beneficially owned by such
person on the date of calculation, divided by (ii) the aggregate number of
shares of the Common Stock of Flex beneficially owned by OCLI and SICPA on
the date of calculation.

          "Joint Acquisition Agreement" means that certain Agreement made
and entered into by and between OCLI and SICPA, dated as of December 13,
1994.
          "Litigation" has the meaning set forth in the Recital of this
Agreement.

          "Note Ratio" means the ratio of (i) the amount that is the sum of
the outstanding principal balance of the OCLI Note plus the unpaid balance

of the Assigned Principal Amount, divided by (ii) the amount that is the

remainder of the outstanding principal balance of the SICPA Note minus the

unpaid balance of the Assigned Principal Amount.

          "OCLI" has the meaning set forth in the preamble of this
Agreement.

          "OCLI Designated Directors" has the meaning set forth in the
preamble of this Agreement.

          "OCLI-Flex License Agreement" means that certain License
Agreement made and entered into by and between OCLI and Flex, dated
December 19, 1988.

          "OCLI Note" means that certain Multiple Advance Promissory Note,
Series 1997-II, No. 1, dated June 5, 1997, of the maximum principal amount
of $9,420,000 made by Flex to OCLI.

          "OCLI's Proportionate Share" means the percentage obtained by
dividing (i) the unpaid balance of the Assigned Principal Amount by

(ii) the outstanding principal amount of the SICPA Note.

          "OVI" means optically variable ink.

          "OVP" means optically variable pigment.

          "Parties" means OCLI, SICPA, Flex, the OCLI Designated Directors
and the SICPA Designated Directors.

          "Public Offering" means a sale by Flex of any shares of Common
Stock in an underwritten public offering registered under the Securities
Act of 1933.

          "Put-Call Agreement" means that certain Put and Call, Right of
First Refusal and Co-Sale Agreement by and between OCLI and SICPA, dated as
of May 8, 1995.

          "Retained Principal Amount" shall have the meaning set forth in
Section 3.02.

          "SICPA" has the meaning set forth in the preamble of this
Agreement.

          "SICPA Designated Director" has the meaning set forth in the
preamble of this Agreement.

          "SICPA-Flex License Agreement" means that certain License and
Supply Agreement by and among Flex and SICPA, dated December 2, 1994.

          "SICPA Note" means that certain Multiple Advance Promissory Note,
Series 1997-II, No. 2, dated June 5, 1997, of the maximum principal amount
of $6,280,000 made by Flex to SICPA.

          Section 1.02.  Interpretation.  All references in this Agreement
to designated Sections, Articles, Exhibits and Schedules are to the
designated sections and articles of and exhibits and schedules to this
Agreement, unless otherwise specified.  The headings and captions used in
this Agreement are for convenience of reference only and do not define,
limit or describe the scope or intent of the provisions of this Agreement.
The terms "includes" or "including" are intended to be inclusive rather
than exclusive.

                                ARTICLE II
                            RELEASES; DISMISSAL

          Section 2.01.  Releases.  Effective on the Effective Date, each
of OCLI, SICPA, Flex, each of the OCLI Designated Directors and each of the
SICPA Designated Directors hereby unconditionally releases and discharges
each of the other Parties and each of the predecessors, parents,
subsidiaries, corporate affiliates, officers, directors, employees,
stockholders, agents, attorneys, successors, assigns, heirs, administrators
and executors of each of the respective Parties from any and all claims,
causes of action, counterclaims or third party claims arising out of or in
any way relating to the subject matter of the Litigation, whether known or
unknown, which was, or could have been, asserted in the Litigation, now and
forever.

          Section 2.02.  Dismissal of Litigation.  Promptly following the
Effective Date, but in no event later than the third Business Day following
the Effective Date, the Parties shall cause their respective counsel to
file such documents and take such other steps as may be necessary to cause
the Litigation to be dismissed, with prejudice.


                                ARTICLE III
                                 COVENANTS

          Section 3.01.  Deletion of Put-Call.  Effective upon the
Effective Date, SICPA and OCLI hereby agree to amend the Put-Call Agreement
to delete Section 6 of the Put-Call Agreement.

          Section 3.02  Assignment of a Portion of SICPA Note Payments.
Effective upon the Effective Date, SICPA hereby assigns to OCLI the right
of SICPA to receive payments of principal and interest in respect of that
portion of the SICPA Note that is equal in principal amount to
$2,600,000.00 (the "Assigned Principal Amount") in consideration of the
payment by OCLI to SICPA of the amount of $2,600,000.00 (the "Purchase
Price").  OCLI shall pay the Purchase Price to SICPA on the Effective Date
by wire transfer of immediately available funds to an account designated by
SICPA.  SICPA retains the right to receive payments of principal and
interest in respect of the remainder of the principal amount of the SICPA
Note.  The right to receive all payments of interest on the Assigned
Principal Amount that are accrued but unpaid through but excluding the
Effective Date shall be and remain the property of SICPA.  From and
including the Effective Date, all payments by Flex of interest accruing in
respect of the SICPA Note shall be allocated (i) to OCLI, in an amount
equal to the portion of such interest payment allocable to the remaining
unpaid balance of the Assigned Principal Amount and (ii) to SICPA, the
remainder.  From and including the Effective Date, all payments of
principal on the SICPA Note shall be allocated (i) until the Equity Ratio
is first equal to or greater than the Note Ratio, to OCLI, in reduction of
the remaining unpaid balance of the Assigned Principal Amount, to the
extent necessary to cause the Equity Ratio to be equal to the Note Ratio,
and thereafter and at all other times (ii) (a) to OCLI, an amount equal to
OCLI's Proportionate Share of such payments, and (b) to SICPA, the
remainder, provided, that, in all events, OCLI's right to receive any
allocation of payments of principal on the SICPA Note shall cease when the
unpaid balance of the Assigned Principal Amount is reduced to zero (i.e.,
once OCLI has been allocated the amount of $2,600,000.00 of principal
payments).  Flex shall, and SICPA hereby directs Flex to, make all payments
of principal and interest in respect of the SICPA Note in accordance with
the allocations set forth in this Section 3.02.

          Section 3.03.  Working Capital Loans.


          (a)  Effective upon the Effective Date, OCLI and SICPA agree to
               amend the Joint Acquisition Agreement by adding the
               following at the end of Section 3.d. thereof:

                  "Notwithstanding anything to the contrary in this
                  Section 3.d., SICPA shall have no obligation to provide
                  any Working Capital Loan to Flex from and after the
                  first date on which SICPA owns less than twenty percent
                  (20%) of the common stock of Flex (treating all classes
                  of Flex common stock as one class for purposes of this
                  calculation)."

          (b)  Subject to the approval of Flex's Financial Advisor, which
               approval OCLI and Flex shall use good faith efforts to
               obtain, Flex will, and OCLI will cause Flex to, use the
               proceeds of any debt financing by Flex or sale of equity
               securities (or rights exercisable for equity securities) by
               Flex to redeem Flex's Series C Preferred Stock held by SICPA
               and to repay the principal of Working Capital Loans (as
               defined in the Joint Acquisition Agreement) held by SICPA
               (with any redemption of Series C Preferred Stock or
               repayment of Working Capital Loans to be made to OCLI and
               SICPA on a pro rata basis in accordance with the proportions
               of the Series C Preferred Stock and Working Capital Loans,
               as the case may be, then held by each of OCLI and SICPA).

          Section 3.04.  SICPA-Flex License Agreement.  On the Effective
Date, each of SICPA and Flex shall execute and deliver to the other the
Amendment to SICPA-Flex License Agreement attached hereto as Exhibit A and
incorporated by reference herein.

          Section 3.05.  Public Offering by Flex.  In the event, at any
time, Flex shall undertake an initial Public Offering, OCLI and Flex will
take all necessary actions to permit SICPA, at SICPA's sole election, to
sell a portion of the shares of the Common Stock of Flex then held by SICPA
in such Public Offering at Flex's sole cost and expense (other than any
underwriting discounts or commissions allocable to the shares of Common
Stock sold by SICPA in such Public Offering and other than the fees and
disbursements of any counsel retained solely by SICPA), provided that the
number of shares of Flex Common Stock that SICPA shall be permitted to sell
in any such Public Offering shall be the number of shares that is not more
than the lesser of (i) twenty-five percent (25%) of the total number of
shares sold in such Public Offering and (ii) ten percent (10%) of Flex's
Common Stock issued and outstanding immediately prior to the Public
Offering.

          Section 3.06.  SICPA Registration Rights.  Flex shall provide to
SICPA the registration rights (the "Registration Rights") set forth in
Exhibit B attached hereto and incorporated by reference herein.


          Section 3.07.  Flex Certificate of Incorporation.  On the
Effective Date, Flex shall cause to be filed with the Secretary of State of
Delaware the Second Amended and Restated Certificate of Incorporation of
Flex attached hereto as Exhibit C and incorporated by reference herein.  In
connection therewith, in order to minimize the number of shares of Class B
Common Stock (as defined in Exhibit C) that might be issued or issuable
pursuant to the exercise of employee stock options, Flex and OCLI agree
promptly following the Effective Date to use their best efforts to obtain
an amendment to Flex's permit from the California Commissioner of
Corporations covering Flex's Stock Option Plan to allow options to be
granted under the Plan that are exercisable for shares of Class A Common
Stock.  In the event such a permit is obtained, OCLI and Flex agree that
all options granted under the Plan to acquire Class B Common Stock shall be
in an aggregate amount not to exceed 10% of Flex's issued and outstanding
Class B Common Stock at the time of grant of the options.  In addition,
OCLI and Flex will make good faith reasonable efforts to cause the holders
of employee stock options exercisable to acquire Class B Common Stock to
convert such options to options exercisable to acquire Class A Common
Stock.  In the event such a permit cannot be obtained, options to purchase
shares of Class B Common Stock in excess of 10% of the then issued and
outstanding Class B Common Stock may be granted under the Plan, and in that
event Flex agrees that it will exercise its right under the Plan to either
purchase from optionees options that are about to be exercised or purchase
shares of Class B Common Stock issued to optionees such that at no time
will there be shares of Class B Common Stock issued to optionees or former
optionees that exceed 10% of the issued and outstanding Class B Common
Stock.  If, at any time, Flex shall undertake a Public Offering, OCLI, Flex
and SICPA will take all necessary action to cause Flex to file with the
Secretary of State of Delaware a further amended and restated Certificate
of Incorporation of Flex to delete from Flex's Certificate of Incorporation
all shareholder supermajority approval requirements effective upon the
closing of such Public Offering.

          Section 3.08.  Audit Committee.  Effective upon the Effective
Date, the by-laws of Flex shall be amended to add to Flex's by-laws the
provisions of the By-Law Amendment attached as Exhibit D hereto and
incorporated by reference herein.

          Section 3.09.  OCLI-Flex License Agreement.  On the Effective
Date, each of OCLI and Flex shall execute and deliver the Amendment to
OCLI-Flex License Agreement attached hereto as Exhibit E and incorporated
by reference herein.

          Section 3.10.  Flex's Future Operations.  OCLI desires to have
better access to the use of Flex's roll-to-roll coating technology for
applications other than color-shifting pigments and other existing and
planned products of Flex and other than in security, anticounterfeiting and
solar control fields, in a manner that is fair to Flex, including through
revisions to the OCLI-Flex License Agreement that would permit OCLI, on a
shared, non-exclusive basis with Flex, to manufacture, use and sell
products using such roll-to-roll technology other than existing products of
Flex or extensions thereof and planned products for the security and
anticounterfeiting fields and for solar control.  SICPA desires to preserve
for Flex exclusive rights to use roll-to-roll coating technology in the
manufacture, use and sale of color-shifting pigments and other existing and
planned products of Flex or extensions thereof and in the security and
anticounterfeiting fields and for solar control.  Promptly following the
Effective Date, OCLI and SICPA agree to negotiate in good faith in an
effort to reach mutual agreement concerning the desires of OCLI and SICPA
set forth in this Section 3.10.

          Section 3.11.  Product Acceptance.  Promptly following the
Effective Date, OCLI, SICPA and Flex will engage in good faith negotiations
involving the senior management and senior technical personnel of each of
OCLI, SICPA and Flex in an effort to resolve by mutual agreement the
acceptance by SICPA of OVP produced by Flex utilizing Flex's Beta III
equipment (and to resolve disputes concerning invoices for such product)
and to formulate on an expeditious basis a mutually agreeable objective
standard for measuring the acceptance criteria of OVP, in each case using
reasonable efforts and satisfying the requirements of SICPA's customers for
OVI.  Flex shall not be deemed to have waived any rights it has under the
SICPA-Flex License Agreement based upon its agreement to negotiate in
accordance with this Section 3.11, but Flex hereby agrees not to exercise
any rights it may have pertaining to the subject matter of this Section
3.11 (i) with respect to the colors of green-to-blue and magenta-to-green,
for a period of thirty (30) days following the Effective Date and (ii) with
respect to the colors of Liberty Green (green-to-magenta), green-to-
magenta, gold-to-green and blue-to-red, for a period of four (4) months
following the Effective Date.

          Section 3.12. Fourth Fiscal Quarter Orders.  SICPA shall not make
any change to decrease below an aggregate of 1,590 kilograms the quantity
of OVP ordered by SICPA for Flex's current fourth fiscal quarter (i.e. for
the months of August, September and October 1997).

          Section 3.13.  Marketing Campaigns.  OCLI and SICPA will consult
in good faith at SICPA's request to address and to cause Flex to address
significant sales opportunities for OVI, it being understood that SICPA
will have the burden of persuading OCLI whether or not to cooperate in
pursuing any such opportunity.


                                       12
          Section 3.14.  Additional OVP Production Facilities.  OCLI, Flex
and SICPA agree to negotiate in good faith, at SICPA's request, concerning
the establishment of an additional facility for the manufacture of OVP in
order to satisfy the demonstrated requirements of SICPA's customers and on
terms and conditions to be mutually agreed by OCLI, Flex and SICPA.

          Section 3.15.  Representations and Warranties True on the
Effective Date.  The representations and warranties of each of the
respective Parties contained in Article IV shall be true and accurate on
the Effective Date as though made on the Effective Date.

          Section 3.16.  Strategic Technical Advisory Committee.  Effective
upon the Effective Date, SICPA and OCLI hereby agree to amend and replace
Section 3.h. of the Joint Acquisition Agreement as follows:

               "h.  Strategic Technical Advisory Committee.  Flex has
          established a Strategic Technical Advisory Committee ("STAC").
          The STAC shall consist of three (3) representatives appointed by
          OCLI, three (3) representatives appointed by Flex, and two (2)
          representatives appointed by SICPA.  The STAC shall oversee
          Flex's ongoing research and development activities, shall perform
          those duties enumerated in the License Agreement and the Research
          Development and Engineering Agreement described in Section 7.a.5.
          and shall implement all of the provisions of the Memorandum of
          Alliance between SICPA S.A. and Flex, dated March 9, 1993 and of
          the Joint Venture Agreement between Flex and SICPA Industries of
          America, Inc., dated as of July 1, 1993.  The STAC shall meet at
          least quarterly.  The agenda for such meetings shall include, but
          not be limited to, a review of intellectual property positions
          and strategies and long-term supply and demand issues.  If, at
          any time, SICPA shall own less than twenty percent (20%) of
          Flex's then issued and outstanding common stock (treating all
          shares of Flex's common stock as one class for purposes of this
          calculation), Flex shall have the option of whether or not to
          continue the operation of STAC, provided that Flex shall
          reinstate the Committee described in Section 1.1.1(b) of the
          License and Supply Agreement by and among Flex and SICPA, dated
          December 2, 1994, prior to amendment, in the event that Flex
          elects to discontinue the operation of STAC."


          Section 2.b. of Addendum No. 1 is deleted effective upon the
Effective Date.

          Section 3.17.  OCLI Services.  OCLI and SICPA agree that it would
be desirable to administer the operations of Flex in a manner that permits
Flex to take advantage of certain common facilities, resources and
technologies between the operations of OCLI and Flex in a manner that is
cost effective for Flex and improves the value of Flex for all of its
shareholders.  From and after the Effective Date, SICPA agrees that OCLI
may, without having to obtain shareholder approval from SICPA pursuant to
the provisions of Section VII.(xiv) of Flex's Second Amended and Restated
Certificate of Incorporation, take actions to implement these desired
objectives through the integration of Flex's administrative and research
and development operations with OCLI's administrative and research and
development operations, provided, that such actions (i) do not impair the
long term prospects of Flex or the ability of Flex to become an independent
public company, (ii) are implemented on commercially reasonable terms that
are fair to Flex, (iii) are no more costly to Flex than would be the case
if Flex provided the relevant service itself or obtained such service from
an unaffiliated third party, and (iv) will serve the best interests of all
of Flex's shareholders.  It is understood that OCLI will consult in advance
with SICPA concerning OCLI's plan in connection with the settlement of the
Litigation to implement a restructuring of the administrative operations of
Flex in accordance with this Section 3.17.  For purposes of determining
whether such restructuring satisfies the foregoing clause (iii), the cost
results for Flex of such restructuring shall be considered in the
aggregate.

          Section 3.18.  Confidentiality.  The provisions and terms of this
Agreement shall be summarized in a press release to be mutually agreed by
OCLI, SICPA and Flex (the "Approved Press Release").  Except as may be
specifically disclosed in the Approved Press Release, the Parties and their
respective counsel shall keep and maintain confidential all terms and
provisions of this Agreement, the course, substance, details and
particulars of all settlement negotiations and all terms and conditions of
the settlement of the Litigation, and they shall not disclose any of the
provisions or terms of such settlement or this Agreement except as may be
required by applicable law after prior consultation with OCLI, Flex and
SICPA, and then only to the extent required by applicable law following
best efforts by the disclosing Party to secure confidential treatment of
any information required to be disclosed.  In addition, the Parties agree
that the Amendment to SICPA-Flex License Agreement attached hereto as
Exhibit A and the Amendment to OCLI-Flex License Agreement attached hereto
as Exhibit E each contain sensitive confidential financial information that
shall be kept and maintained confidential and shall not be disclosed by any
Party except with the prior written consent (i) of SICPA as to the
Amendment to SICPA-Flex License Agreement, or (ii) of OCLI as to the
Amendment to OCLI-Flex License Agreement, which consent in each case may be
withheld in the sole discretion of SICPA or OCLI, as the case may be,
provided, that, in the event that OCLI or Flex determines that it is
required by U.S. federal securities law to file with the Securities and
Exchange Commission ("SEC") a copy of the Amendment to SICPA-Flex License
Agreement, then OCLI or Flex, as the case may be, shall be permitted to
make such filing but only after making best efforts to obtain confidential
treatment from the SEC of the Amendment to SICPA-Flex License Agreement to
the maximum extent possible (including, without limitation, as to pricing
and quantity terms).


                                ARTICLE IV
                      REPRESENTATIONS AND WARRANTIES

          Section 4.01.  Representations and Warranties of OCLI, Flex and
SICPA.  Each of OCLI, Flex and SICPA hereby represents and warrants to the
other Parties that as of the date of this Agreement (and, for purposes of
Section 3.15, as of the Effective Date):

          (a)  Organization.  It is a corporation or, in the case of SICPA,
               a societe annonyme, duly organized, validly existing and in
               good standing under the laws of its jurisdiction of
               incorporation.  It is duly licensed, registered or qualified
               to do business and is in good standing in all jurisdictions
               in which the character or nature of its business requires it
               to be so licensed, registered or qualified and the failure
               to be so licensed, registered or qualified would have a
               material adverse effect on its business.

          (b)  Authority; Enforceability.  It has the corporate power and
               authority to enter into this Agreement and to carry out its
               obligations hereunder.  The execution and delivery of this
               Agreement and the consummation and performance of the
               transactions contemplated hereby have been duly authorized
               by all necessary corporate action and no other proceeding on
               its part is necessary to authorize the consummation or
               performance of the transactions contemplated hereby.  This
               Agreement is legal, valid, binding and enforceable against
               it in accordance with its terms, subject to applicable
               bankruptcy, insolvency and similar laws affecting creditors'
               rights generally, and subject to general principles of
               equity (regardless of whether enforcement is sought in a
               proceeding in equity or at law).

          (c)  Consents.  No consent, waiver, approval, authorization,
               exemption, registration, license or declaration of or by, or
               filing with, any other person or any national, federal,
               state or local governmental or regulatory agency, bureau or
               authority within or without the United States is required
               with respect to it, other than those which have been
               obtained, in connection with (i) the execution, delivery or
               enforceability of this Agreement or (ii) the consummation or
               performance of the transactions contemplated hereby.

          (d)  No Breach.  The execution and delivery of this Agreement by
               it and the consummation and performance of the transactions
               provided for hereby does not and will not (i) conflict with
               or result in any breach or violation of, or loss of benefit
               under, any provision of its charter, certificate or articles
               of incorporation, by-laws or other governing documents or
               (ii) violate, conflict with or result in the breach of, or
               loss of benefit under, or constitute a default or an event
               which with notice, lapse of time, or both, would constitute
               a default or event of default under (A) the terms of any
               contract to which it is a party or by which it is bound, or
               (B) any judgment, statute, law, ordinance, rule or
               regulation or order of any governmental authority applicable
               to it.

          (e)  No Litigation.  There is no action, suit, proceeding,
               inquiry or investigation, at law or in equity, or before any
               court, public board or body pending, or to its knowledge
               threatened, involving it, wherein an unfavorable decision,
               ruling or finding would (i) materially and adversely affect
               the transactions contemplated by this Agreement or
               (ii) adversely affect the validity or enforceability of this
               Agreement or any document necessary to consummate or perform
               the transactions contemplated hereby.

          Section 4.02.  Representations and Warranties of OCLI-Designated
Directors and SICPA-Designated Directors.  Each of the OCLI-Designated
Directors and the SICPA-Designated Directors hereby represents and warrants
to the other Parties that as of the date of this Agreement (and, for
purposes of Section 3.15, as of the Effective Date):

          (a)  Capacity.  He has the legal capacity to enter into this
               Agreement and to carry out his obligations hereunder and is
               not suffering from any disability or impediment that
               diminishes such legal capacity.  This Agreement is legal,
               valid, binding and enforceable against him in accordance
               with its terms, subject to applicable bankruptcy, insolvency
               and similar laws affecting creditors' rights generally, and
               subject to general principles of equity (regardless of
               whether enforcement is sought in a proceeding in equity or
               at law).

          (b)  No consent, waiver, approval, authorization, exemption,
               registration, license or declaration of or by, or filing
               with, any other person or any national, federal, state or
               local governmental or regulatory agency, bureau or authority
               within or without the United States is required with respect
               to him, other than those which have been obtained, in
               connection with (i) the execution, delivery or
               enforceability of this Agreement or (ii) the consummation or
               performance of the transactions contemplated hereby.

          (c)  No Breach.  The execution and delivery of this Agreement by
               him and the consummation and performance of the transactions
               provided for hereby does not and will not violate, conflict
               with or result in the breach of, or loss of benefit under,
               or constitute a default or event of default under (i) the
               terms of any contract to which he is a party or by which he
               is bound, or (ii) any judgment, statute, law, ordinance,
               rule or regulation or order of any governmental authority
               applicable to him.

          (d)  No Litigation.  There is no action, suit, proceeding,
               inquiry or investigation, at law or in equity, or before any
               court, public board or body pending, or to his knowledge
               threatened, involving him, wherein an unfavorable decision,
               ruling or finding would materially and adversely affect the
               transactions contemplated by this Agreement or adversely
               affect the validity or enforceability of this Agreement or
               any document necessary to consummate or perform the
               transactions contemplated hereby.


                                      ARTICLE V
                                    MISCELLANEOUS

          Section 5.01.  GOVERNING LAW.  THIS AGREEMENT SHALL BE CONSTRUED
IN ACCORDANCE WITH, AND GOVERNED BY, THE LAWS OF THE STATE OF DELAWARE
WITHOUT REGARD TO CONFLICTS OF LAWS PROVISIONS.

          Section 5.02.  Waivers and Amendments.  No waiver shall be deemed
to have been made by any Party of any of its rights under this Agreement
unless the same shall be in writing and is signed on its behalf by an
authorized person.  Any such waiver shall constitute a waiver only with
respect to the specific matter described in such writing and shall in no
way impair the rights of the Party granting such waiver in any other
respect or at any other time.  Except as specifically provided herein, this
Agreement shall not be amended or modified except by an instrument in
writing signed by each Party.

          Section 5.03.  Costs and Expenses.  Each of the Parties to this
Agreement shall bear its own expenses incurred in connection with the
negotiation, preparation, execution, closing and performance of this
Agreement.

          Section 5.04.  Successors.  This Agreement shall be binding upon
and inure to the benefit of the Parties and their respective heirs and
successors.

          Section 5.05.  No Third Party Rights.  This Agreement is intended
to be solely for the benefit of the Parties and is not intended to confer
any benefits upon, or create any rights in favor of, any person other than
the Parties.

          Section 5.06.  Counterparts.  This Agreement may be executed in
any number of counterparts, each of which shall be deemed an original, but
all of which together shall constitute a single instrument.

          Section 5.07.  Entire Agreement.  This Agreement sets forth the
entire understanding and agreement between the Parties as to the matters
covered herein and supersedes and replaces any inconsistent prior
understanding, agreement or statement of intent, in each case, written or
oral, expressly addressed by this Agreement.

          Section 5.08.  Further Assurances.  Each of the Parties hereby
agrees to execute and deliver all such other and additional instruments and
documents and to do all such other acts and things as may be reasonably
necessary more fully to effectuate this Agreement and consummate the
transactions contemplated herein.

          Section 5.09.  Notices.  All notices to be delivered hereunder
shall be in writing and shall be sent by (i) hand delivery, against written
receipt thereof (ii) registered or certified mail, return receipt
requested, (iii) reputable overnight courier service, with receipt of
delivery acknowledged, or (iv) telecopier, to the other Parties at the
addresses shown below.  Any such demand, notice or communication hereunder
shall be deemed to have been given on the date received or on the date
delivered and refused:

                                       
          If to OCLI:

          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telecopier:  707-525-6840
          Attention:  President

          with a copy to:

          General Counsel
          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telecopier:  707-525-6840


          If to Herbert M. Dwight, Jr.:

          Mr. Herbert M. Dwight, Jr.
          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telecopier:  707-525-6840


          If to John McCullough:

          Mr. John McCullough
          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397

                                      
          Telecopier:  707-525-6840


          If to James Seeser:

          Dr. James Seeser
          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telecopier:  707-525-6840


          If to Flex:

          FLEX Products Inc.
          1402 Mariner Way
          Santa Rosa, California 95407-7370
          Telecopier:  707-525-7725
          Attention:  President


          with a copy to:

          General Counsel
          Optical Coating Laboratory, Inc.
          2789 Northpoint Parkway
          Santa Rosa, California 95407-7397
          Telecopier:  707-525-6840
                                      
          If to SICPA:

          SICPA Holding S.A.
          Avenue de Florissant 41
          1008 Prilly
          Switzerland
          Telecopier:  011-41-21-627-5505
          Attention:  President


          with a copy to:

          Linda J. Soldo
          Cleary, Gottlieb, Steen & Hamilton
          2000 Pennsylvania Avenue, N.W.
          Washington, D.C. 20006-1801
          Telecopier:  202-974-1999


          If to Maurice A. Amon:

          Mr. Maurice A. Amon
          SICPA Holding S.A.
          Avenue de Florissant 41
          1008 Prilly
          Switzerland
          Telecopier:  011-41-21-627-5915
                                      
          If to Eduardo Beruff:

          Mr. Eduardo Beruff
          SICPA Industries of America, Inc.
          8000 Research Way
          Springfield, Virginia 22153
          Telecopier:  703-440-2157

The address for any Party set forth above may be changed by written notice
to the other Parties in accordance with this Section 5.09.


                    IN WITNESS WHEREOF, the Parties have set their hands as
of the date first above written.


                              OPTICAL COATING LABORATORY, INC.



                              By: /s/Joseph Zils

                              Name:  Joseph Zils
                              Title: Vice President,
                                     General Counsel
                                     and Corporate Secretary



                              FLEX PRODUCTS, INC.

                                       

                              By: /s/Herbert M. Dwight, Jr.

                              Name:  Herbert M. Dwight,Jr.
                              Title:  Chairman of the Board and
                                      Chief Executive Officer


                              SICPA HOLDING S.A.



                              By:    /s/Maurice Amon

                              Name:  Maurice Amon
                              Title: Vice Chairman of the Board


                              By:    /s/Hans J. Loliger

                              Name:  Hans J. Loliger
                              Title: Chief Executive Officer



                                               HERBERT M. DWIGHT, JR.


                                      
                                               /s/Herbert M. Dwight, Jr.




                                               JOHN McCULLOUGH



                                               /s/John McCullough




                                               JAMES SEESER



                                               /s/James Seeser




                                               MAURICE A. AMON



                                               /s/Maurice A. Amon




                                       
                                               EDUARDO BERUFF



                                               /s/Eduardo Beruff


                                       
                                                                  EXHIBIT A



                 AMENDMENT TO SICPA-FLEX LICENSE AGREEMENT





                            FIRST AMENDMENT TO

                      LICENSE AND SUPPLY AGREEMENT

                              BY AND BETWEEN

                            FLEX PRODUCTS, INC.

                                    AND

                            SICPA HOLDING S.A.




                            NOVEMBER 19, 1997







                                       

                          FIRST AMENDMENT TO


                       LICENSE AND SUPPLY AGREEMENT


      FIRST AMENDMENT TO AGREEMENT dated November 19, 1997, by and between
Flex Products, Inc., a Delaware corporation ("Flex") and SICPA HOLDING
S.A., a Swiss corporation ("SICPA").
                                 W I T N E S S E T H:
      WHEREAS, Flex and SICPA are currently parties to a License and Supply
Agreement dated as of December 2, 1994 providing for the purchase and sale
of optically variable pigment ("OVP") (the "1994 Agreement");
      WHEREAS, Flex and SICPA wish to amend the 1994 Agreement by means of
this First Amendment to the 1994 Agreement;
      NOW, THEREFORE, in consideration of the mutual agreements hereinafter
set forth, the parties hereby agree as follows:
      Section 1.1.1(b) shall be amended and replaced to read in full as
follows:
           The parties agree to use the "STAC" referenced in Section 3.16
      of the Settlement Agreement, dated November 19, 1997, by and between
      SICPA, Flex, OCLI and the other parties named therein, during the
      term of this Agreement, to implement all of the provisions of the
      Memorandum of Alliance and the Joint Venture Agreement, copies of
      which are attached hereto as Exhibits I and J, respectively.  In the

      event the STAC is discontinued the parties agree to re-establish the
      Committee pursuant to the original provisions of Section 1.1.1(b)
      prior to this Amendment.  The parties agree that, notwithstanding the
      existing terms of the Memorandum of Alliance and the Joint Venture
      Agreement to the contrary, the Memorandum of Alliance and the Joint
      Venture Agreement shall remain in effect during the Term of this
      Agreement, and the parties shall execute such amendments thereto
      which may be proper to extend the length of the respective terms of
      the Memorandum of Alliance and the Joint Venture Agreement to conform
      to length of the Term (as such term is defined in Section 13 below).

      Section 3 of the 1994 Agreement shall be amended and replaced to read
in full as follows:

           3.  Changes to Price and Quantity.  During the period from
      March 1, 2000 through June 30, 2000 and the period March 1, 2005
      through June 30, 2005, the parties shall discuss what the price and
      quantity terms of this Agreement shall be for the period 11/1/2000
      through 10/31/2005 and 11/1/2005 through 12/31/2009 respectively.  In
      the event that the parties cannot agree to any other provisions, the
      price for OVP shall be the price set forth in Section 4, as adjusted
      by Section 5.6 for periods after 10/31/2000, the minimum and maximum
      quantities for the period 11/1/2000 through 10/31/2005 shall be the
      same as for the year ended 10/31/2000, and the minimum and maximum
      quantities for the period 11/1/2005 through 12/31/2009 shall be the
      same as for the year ended 10/31/2005 (prorated on a month-for-month
      basis for the period from 11/1/2009 to 12/31/2009).

      Section 4.3 of the 1994 Agreement shall be amended and replaced to
read in full as follows:

           4.3  Price Adjustment.  The price per kilogram set shall be as
      set forth below without adjustment pursuant to Sections 4.2 and 5.6
      from November 1, 1997 through October 31, 2000:

                                    Base Price/Kg (before
                                    increases pursuant to
      Purchases per Year            Sections 4.2 and 5.6)


                       [CONFIDENTIAL TREATMENT REQUESTED]


      The table set forth in 5.1(a) of the 1994 Agreement shall be amended
and replaced to read in full as follows:

           5.1  Minimum Annual Purchases.


                5.1(a) Minimum Purchases Necessary to Maintain Exclusive
      License.  The parties agree that SICPA shall purchase from Flex
      minimum amounts of OVP set forth below for the periods indicated:

           Year               Minimum                      Maximum


                     [CONFIDENTIAL TREATMENT REQUESTED]


            Section 14 of the 1994 Agreement shall be amended and replaced
                           to read in full as follows:

                       14. [CONFIDENTIAL TREATMENT REQUESTED]

        Section 17 of the 1994 Agreement shall be amended and replaced to
read in full as follows:

           17.  Notices.  All notices hereunder shall be in writing and
      shall be deemed to have been given either (i) when received, if
      delivered in person or transmitted by tested telex or facsimile, or
      (ii) three business days after having been mailed by registered or
      certified mail addressed as follows:


      To Flex:            Flex Products, Inc.
                          1402 Mariner Way
                          Santa Rosa, California 95407-7370
                          Attn:  Michael Sullivan
                          FAX: (707) 525-7725

      To SICPA:           SICPA Holding S.A.
                          Avenue de Florissant 41
                          1008 Prilly
                          Switzerland
                          Attention: President
                          FAX: 41-21-627-5505

      or to such changed address as such party may have fixed by notice
      provided that any notice of change of address shall be deemed to have
      been given when received.

                                       
      IN WITNESS WHEREOF, each of the parties hereto has caused this
Amendment to be duly executed, and intends this Agreement to be effective,
as of the date first set forth above.

                          FLEX PRODUCTS, INC., a Delaware corporation



                          By  /s/Herbert M. Dwight, Jr.



                          SICPA HOLDING S.A., a Swiss corporation


                          By  /s/Maurice A. Amon


                          By  /s/Hans J. Loliger




                                                                  EXHIBIT B



                            REGISTRATION RIGHTS



1.   Demand Registrations

     a.   Requests for Registration.

          (i)  Subject to the terms and conditions hereof, at any time and
     from time to time after the date of the first Public Offering of Flex
     Common Stock SICPA may request in writing registration under the
     Securities Act of 1933, as amended (the "Securities Act"), of all or
     part of its Common Stock (any such requested registration is
     hereinafter referred to as a "Demand Registration").  The number of
     Demand Registrations SICPA shall be entitled to request shall be two
     (2).

          (ii) An SEC registration of Common Stock shall not be counted as
     a Demand Registration for purposes of the limit in Section 1.a.(i) of
     this Exhibit B until such registration has become effective (unless
     such Demand Registration has not become effective due solely to the
     fault of SICPA).  Each request for a Demand Registration shall specify
     the approximate number of shares of Common Stock requested to be
     registered and the anticipated per share price range for such
     offering.

          (iii)     If, in connection with any Demand Registration, the
     managing underwriter(s) to Flex in connection with such SEC
     registration advises Flex in writing that, in its opinion, the number
     of shares of Common Stock to be registered would materially and
     adversely affect the success or price of the offering, then the number
     of shares to be included in such Demand Registration shall be reduced
     to the number recommended by such managing underwriter(s).  Any such
     reduction shall be effected by (1) first reducing or eliminating the
     number of shares of Common Stock (if any) requested to be included in
     such registration by any shareholders of Flex other than SICPA and (2)
     then, if and to the extent further reductions are necessary, by
     reducing the number of shares of Common Stock requested to be included
     therein by SICPA.  If by such reduction the number of shares of Common
     Stock included in such registration for SICPA represents less than
     one-third of the total number of shares requested to be registered by
     SICPA, then such registration shall not be counted against the number
     of Demand Registrations to which SICPA is entitled under Section
     1.a.(i) hereof.

     b.   Best Efforts.  Flex shall promptly and diligently use its best
efforts to effect the registration under the Securities Act of the Common
Stock which Flex has been so requested to register by SICPA.  Flex shall
use its best efforts to effect such registration on whichever registration
form the Board of Directors of Flex shall determine in its discretion is
appropriate in accordance with the intended method of disposition of such
shares; provided, however, that Flex shall use its best efforts to effect
such registration on SEC Form S-3 (or any successor form to Form S-3) if so
requested by SICPA unless (1) Form S-3 (or any successor form to Form S-3)
is not available for such offering, (2) the aggregate net offering price
(after deducting any underwriting discounts and commissions) of the shares
to be so registered is less than $1,000,000, or (3) Flex shall notify SICPA
that, in the good faith judgment of the Board of Directors of Flex, it
would not be in the best interests of Flex and its stockholders for a Form
S-3 registration to be effective at that time.

     c.   Restrictions on Demand Registrations.  Flex's obligation to use
its best efforts to effect a Demand Registration pursuant to this Section 1
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  Flex will not be obligated to effect any Demand Registration
     within any time period (not to exceed six months) requested by the
     managing underwriter(s) of any previous registered offering of Common
     Stock.

          (ii) Flex shall be entitled to postpone the filing of any
     registration statement otherwise required to be prepared and filed by
     Flex pursuant to any Demand Registration for a reasonable period of
     time, but not in excess of 90 days, if Flex determines in its
     reasonable judgment and in good faith that the registration and
     distribution of Common Stock under such Demand Registration would have
     an adverse effect on any pending or proposed equity or debt financing,
     acquisition, merger, consolidation, tender offer, corporate
     reorganization or similar transaction involving Flex or would require
     premature disclosure thereof.  In such event, Flex shall promptly give
     SICPA written notice of such determination, containing a general
     statement of the reasons for such postponement.  If Flex shall so
     postpone the filing of a registration statement, SICPA shall have the
     right to withdraw the Demand Registration by giving written notice to
     Flex within twenty (20) days after receipt of the postponement notice.
     In the event of such withdrawal, such Demand Registration shall not be
     counted for purposes of determining the number of Demand Registrations
     to which SICPA is entitled under Section 1.a.(i) of this Exhibit B.
     (d)  Selection of Underwriters.  Flex shall have the right to select

the managing underwriter(s) for any Demand Registration, subject to SICPA's
approval, which approval will not be unreasonably withheld.

2.   Piggyback Registrations

     a.   Right to Piggyback.  Subject to the limitations set forth in
Section 2.b. of this Exhibit B, at any time and from time to time after the
date of the first Public Offering of Flex Common Stock whenever Flex
proposes to register under the Securities Act any Common Stock, Flex will
give prompt written notice to SICPA of its intention to effect such a
registration and will use its best efforts to include in such registration
all shares of Common Stock with respect to which SICPA gives Flex written
request for inclusion therein within fifteen (15) days after the receipt of
Flex's notice (any such requested inclusion is hereinafter referred to as a
"Piggyback Registration").

     b.   Restrictions on Piggyback Registrations.  Flex's obligation to
use its best efforts to effect any registration pursuant to this Section 2
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  If, at any time before or after giving written notice
     pursuant to this Section 2 of its intention to register shares of
     Common Stock and prior to the effective date of the registration
     statement filed in connection with such registration, Flex shall
     determine for any reason not to proceed with such registration, Flex
     may give written notice of such determination to SICPA and thereupon
     shall be relieved of its obligation to use its best efforts to
     register any shares of Common Stock in connection with such
     registration, but without prejudice to the rights of SICPA to request
     that such registration be effected as a Demand Registration pursuant
     to the terms and conditions of Section 1.

          (ii) If, in the written opinion of the managing underwriter(s) of
     Flex in connection with any registration pursuant to this Section 2,
     the distribution of the additional securities requested to be included
     in such registration by SICPA ("Piggyback Shares") would materially
     and adversely affect the success or the price of the offering, then
     the number of shares to be included in such registration shall be
     reduced to the number recommended by such managing underwriter(s).
     Any such reduction shall be effected by (1) first reducing or
     eliminating the number of shares of Common Stock (if any) requested to
     be included in such registration by any shareholders of Flex other
     than SICPA, and (2) then, if and to the extent further reductions are
     necessary, by reducing the number of Piggyback Shares.

          (iii)     Flex shall not be obligated to effect any Piggyback
     Registration of Common Stock under this Section 2 incidental to the
     registration of any shares of Common Stock (A) filed on SEC Form S-4
     or any successor form thereto, (B) in connection with any merger,
     consolidation, acquisition, exchange offer, recapitalization or other
     reorganization of Flex or (C) in connection with any offering of
     securities made solely to stockholders of Flex.

     c.   Selection of Underwriters.  Flex shall have the right to select
the managing underwriter(s) for any Piggyback Registration, which selection
will be made by Flex in its sole discretion.

3.   Holdback Agreements

     SICPA agrees not to effect any public sale or distribution of Common
Stock during the seven (7) days prior to, and the ninety (90) day period
beginning on, the effective date of any Demand Registration or any
Piggyback Registration, as the case may be (except as part of such
registration), unless Flex and the underwriter(s) managing the registered
offering otherwise agree to a shorter period.

4.   Registration Procedures

     a.   Flex's Efforts.  Whenever SICPA requests that its shares of
Common Stock be registered pursuant to this Agreement, Flex will use its
best efforts to effect the registration and the sale of such shares in
accordance with the intended method of disposition thereof, and pursuant
thereto Flex will as expeditiously as possible:

          (i)  prepare and file with the SEC a registration statement with
     respect to such shares of Common Stock and use its best efforts to
     cause such registration statement to become effective (provided that,
     before filing a registration statement or prospectus or any amendments
     or supplements thereto, Flex will furnish to the counsel of SICPA such
     registration statement and copies of all such other documents proposed
     to be filed);

          (ii) prepare and file with the SEC such amendments and
     supplements to such registration statement and the prospectus used in
     connection therewith as may be necessary to keep such registration
     statement effective for a period of not less than ninety (90) days,
     and comply with the provisions of the Securities Act with respect to
     the disposition of all shares of Common Stock covered by such
     registration statement during such period and until the earlier of
     such time as all of such shares of Common Stock have been disposed of
     in accordance with the intended methods of disposition by SICPA set
     forth in such registration statement or the expiration of sixty (60)
     days after such registration statement becomes effective, SICPA being
     hereby required promptly to inform Flex in writing when the
     distribution of such securities pursuant to such registration
     statement has been completed);

          (iii)     furnish to SICPA such number of conformed copies of
     such registration statement, each amendment and supplement thereto,
     the prospectus included in such registration statement (including each
     preliminary prospectus) and such other documents as SICPA may
     reasonably request in order to facilitate the disposition of the
     shares of Common Stock owned by SICPA;

          (iv) use its best efforts to register or qualify such shares of
     Common Stock under such other securities or blue sky laws of such
     jurisdictions as SICPA may reasonably request and do any and all other
     acts and things which may be reasonably necessary or advisable to
     enable SICPA to consummate the disposition of Common Stock in such
     jurisdictions (provided that Flex will not be required to (A) qualify
     generally to do business in any jurisdiction where it would not
     otherwise be required to qualify but for this subparagraph, (B)
     subject itself to taxation in any such jurisdiction or (C) consent to
     general service of process in any such jurisdiction);

          (v)  use its best efforts to list all such shares of Common Stock
     on each securities exchange or quotation service on which similar
     securities issued by Flex are then listed, if any;

          (vi) provide a transfer agent and registrar for all such shares
     of Common Stock not later than the effective date of such registration
     statement;

          (vii)     enter into such customary agreements (including
     underwriting agreements in customary form) and take all such other
     actions as SICPA may reasonably request in order to expedite or
     facilitate the disposition of such shares of Common Stock (including,
     without limitation, effecting a stock split or a combination of shares
     applicable to all shareholders of Flex equally);

          (viii)    make available for inspection by SICPA, any
     underwriter(s) participating in any disposition pursuant to such
     registration statement, and any attorney, accountant or other agent
     retained by SICPA or the underwriter(s), all financial and other
     records, pertinent corporate documents and properties of Flex, and
     cause Flex's officers, directors, employees and independent
     accountants to supply all information reasonably requested by SICPA or
     the underwriter(s), or any attorney, accountant or agent of SICPA or
     the underwriter(s) in connection with such registration statement;

          (ix) otherwise use its best efforts to comply with all applicable
     rules and regulations of the SEC, and make available to its security
     holders, as soon as reasonably practicable, an earnings statement
     covering the period of at least twelve months beginning with the first
     day of Flex's first full calendar quarter after the effective date of
     the registration statement, which earnings statement shall satisfy the
     provisions of Section 11(a) of the Securities Act;

          (x)  in the event of the issuance of any stop order suspending
     the effectiveness of a registration statement, or of any order
     suspending or preventing the use of any related prospectus or
     suspending the qualification of any shares of Common Stock included in
     such registration statement for sale in any jurisdiction, Flex will
     use its best efforts promptly to obtain the withdrawal of such order;
                                       
          (xi) obtain a cold comfort letter from Flex's independent public
     accountants in customary form and covering such matters of the type
     customarily covered by cold comfort letters as SICPA may reasonably
     request; and

          (xii)     promptly notify SICPA:  (A) when any registration
     statement, any pre-effective amendment, the prospectus or any
     prospectus supplement related thereto or post-effective amendment to
     such registration statement has been filed, and, with respect to such
     registration statement or any post-effective amendment, when the same
     has become effective; (B) of any request by the SEC for amendments or
     supplements to such registration statement or the prospectus related
     thereto or for additional information; (C) of the issuance by the SEC
     of any stop order suspending the effectiveness of such registration
     statement or the initiation of any proceedings for that purpose; (D)
     of the receipt by Flex of any notification with respect to the
     suspension of the qualification of any of the shares of Common Stock
     for sale under the securities or blue sky laws of any jurisdiction or
     the initiation of any proceeding for such purpose; and (E) of the
     existence of any fact of which Flex becomes aware which results in
     such registration statement, the prospectus related thereto or any
     document incorporated therein by reference containing an untrue
     statement of a material fact or omitting to state a material fact
     required to be stated therein or necessary to make any statement
     therein in light of the circumstances under which they were made not
     misleading; and, in the case of the notification relating to an event
     described in clause (E) hereof, Flex shall promptly prepare and
     furnish to SICPA and each underwriter, if any, a reasonable number of
     copies of a prospectus supplemented or amended so that, as thereafter
     delivered to the purchasers of any such Common Stock, such prospectus
     shall not include an untrue statement of a material fact or omit to
     state a material fact required to be stated therein or necessary to
     make the statements therein in the light of the circumstances under
     which they were made not misleading.

     b.   SICPA's Efforts.  SICPA shall cooperate with Flex in the
registration of any shares of Common Stock owned by SICPA by (1) furnishing
promptly to Flex such information regarding SICPA, the distribution of the
shares to be registered and any other information that Flex may reasonably
request in connection with the registration and (2) completing and
executing all questionnaires, powers of attorney, underwriting agreements
and other documents reasonably required in connection with the
registration.  SICPA hereby agrees that, upon receipt of any notice of the
happening of: (x) any event of the kind described in clause (C) of Section
4.a.(xii), SICPA will discontinue its disposition of shares of Common Stock
pursuant to the registration statement relating to such shares until the
stop order shall have been lifted or rescinded; (y) any event of the kind
described in clause (D) of Section 4.a.(xii), SICPA will discontinue its
disposition of shares of Common Stock pursuant to the registration
statement relating to such shares in the jurisdiction with respect to which
the suspension of the qualification of any of the shares for sale has
occurred, until the suspension shall have been lifted or rescinded; and (z)
any event of the kind described in clause (E) of Section 4.a.(xii), SICPA
will discontinue  its disposition of shares of Common Stock pursuant to the
registration statement relating to such shares until the receipt by SICPA
of the copies of the supplemented or amended prospectus contemplated by
Section 4.a.(xii) and, if so directed by Flex, will deliver to Flex (at
Flex's expense) all copies, other than permanent file copies, then in the
possession of SICPA of the prospectus relating to such shares of Common
Stock.  In the case of a Demand Registration, if the disposition by SICPA
of its shares of Common Stock is discontinued pursuant to the foregoing
sentence, unless Flex extends the period of effectiveness of the
registration statement by the number of days during the period from and
including the date of the giving of such notice to and including the date
when either (I) the stop order or suspension of qualification shall have
been lifted or rescinded or (II) SICPA shall have received copies of the
supplemented or amended prospectus contemplated by Section 4.a.(xii), as
the case may be, and unless SICPA continues to participate in such
registration as extended, then SICPA shall be entitled to another Demand
Registration and such discontinued or extended registration shall not be
counted against the number of Demand Registrations to which SICPA is
entitled under Section 1.a.(i) hereof.

5.   Registration Expenses

     For purposes of this Exhibit B, "Registration Expenses" shall mean all
expenses incident to Flex's performance of or compliance with this Exhibit
B, including without limitation, (i) all registration and filing fees, (ii)
fees and expenses of compliance with securities or blue sky laws, (iii)
printing expenses, messenger and delivery expenses, (iv) fees for listing
the securities to be registered on securities exchanges or on the National
Association of Securities Dealers automated quotation system, (v) fees and
disbursements of counsel for Flex and all independent certified public
accountants, underwriters and other persons retained by Flex, and
(vi) underwriting discounts or commissions.  All Registration Expenses will
be borne by Flex, except that (i) any underwriting discounts or commissions
with respect to shares of Common Stock included either in any Demand
Registration or in any Piggyback Registration will be borne by and
allocated to SICPA in proportion to its shares so registered, (ii) SICPA
shall bear the expense of the fees and disbursements of any counsel
retained solely by SICPA and (iii) in the case of any Demand Registration,
SICPA shall bear a portion of the Registration Expenses (other than any
Registration Expenses of the type described in clauses (i) and (ii), which
are to be determined in accordance with clauses (i) and (ii)), which
portion shall be allocated to SICPA in proportion to its shares so
registered.


6.   Indemnification

     a.   By Flex.  Flex agrees to indemnify and hold harmless, to the
fullest extent permitted by law, SICPA and each of SICPA's officers and
directors and each person, if any, who controls SICPA within the meaning of
the Securities Act (each such person being hereinafter referred to as an
"Indemnified Party"), against any losses, claims, damages, liabilities and
expenses, joint or several, to which such Indemnified Party may become
subject under the Securities Act or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions or proceedings in
respect thereof) arise out of or are based upon (i) any untrue statement of
any material fact contained in any registration statement under which such
shares of Common Stock were registered under the Securities Act, any
preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, or any document incorporated by
reference therein, or (ii) any omission to state therein a material fact
required to be stated therein or necessary to make the statements therein
not misleading, and Flex will reimburse such Indemnified Party for any
legal or other expenses reasonably incurred by it, as and when incurred, in
connection with investigating or defending any such loss, claim, liability,
action or proceeding; provided, however, that Flex shall not be liable in
any such case to the extent that any such loss, claim, damage, liability
(or action or proceeding in respect thereof) or expense arises out of or is
based upon or is caused by (A) an untrue statement or alleged untrue
statement or omission or alleged omission made in such registration
statement, any such preliminary prospectus, final prospectus, amendment or
supplement in reliance upon and in conformity with written information
furnished to Flex by or on behalf of such Indemnified Party expressly for
use in the preparation thereof, or (B) such Indemnified Party's failure to
deliver a copy of such registration statement, prospectus, amendment or
supplement after Flex has furnished such Indemnified Party with such number
of copies of the same as such Indemnified Party may reasonably request.
Such indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of such Indemnified Party and shall
survive the transfer of such securities by such Indemnified Party.

     b.   By SICPA.  Flex may require, as a condition to including any of
SICPA's shares of Common Stock in any registration statement filed pursuant
to Section 1 or 2 hereof, that Flex shall have received an undertaking
reasonably satisfactory to it from SICPA to indemnify and hold harmless (in
the same manner and to the same extent as set forth in paragraph (a) of
this Section 6) Flex, each director of Flex, each person named as or about
to become a director of Flex, each officer of Flex and each other person,
if any, who controls Flex within the meaning of the Securities Act, with
respect to any statement in or omission from such registration statement,
any preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, if such statement or omission was
made in reliance upon and in conformity with written information expressly
furnished to Flex by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement; provided, however, that such indemnity shall be
limited to the amount of the net proceeds received by SICPA from the sale
of shares of Common Stock pursuant to such registration statement, except
in the case of any material misstatement or omission knowingly and
willfully made by SICPA in written information expressly furnished to Flex
or the underwriters by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement, as to which no such limitation shall apply.  Such
indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of Flex or any such director, officer or
controlling person and shall survive the transfer of such securities by
SICPA.


     c.   Procedural Matters.  A party from whom indemnity shall be sought
pursuant to the provisions of this Section 6 shall not be liable with
respect to such indemnity under paragraph (a) or (b) of this Section 6
unless the indemnified party shall have given written notice to such
indemnifying party of the nature of such claim promptly after receipt by
such indemnified party of notice of the commencement of any action or
proceeding involving such claim; provided, however, that the failure of any
indemnified party to give notice as provided herein shall not relieve such
indemnifying party from any liability which it may have to such indemnified
party (X) otherwise than on account of this Section 6 or (Y) except to the
extent that the failure to give such notice shall have been materially
prejudicial to such indemnifying party.  Unless in the reasonable judgment
of the indemnified party a conflict of interest between such indemnified
and indemnifying parties may exist with respect to such claim, the
indemnifying party shall be entitled to participate in and to assume the
defense of any such claim, jointly with any other indemnifying party
similarly notified, to the extent that it may wish, with counsel reasonably
satisfactory to such indemnified party, and after notice from the
indemnifying party to such indemnified party of its election so to assume
the defense thereof, the indemnifying party shall not be liable to such
indemnified party for any legal or other expenses subsequently incurred by
the indemnified party in connection with the defense thereof.  In the case
of conflict of interest as set forth above, the indemnifying party shall
pay the reasonable fees and expenses of one counsel for all parties
indemnified by such indemnifying party with respect to such claim.  In no
event will the indemnifying party be subject to any liability for any
settlement made by any indemnified party without its consent.

7.   Participation in Underwritten Registrations

     SICPA may not participate in any registration hereunder which is
underwritten unless SICPA (a) agrees to sell its securities on the basis
provided in any underwriting arrangements approved by the person or persons
entitled to approve such arrangements and (b) completes and executes all
questionnaires, powers of attorney, indemnities, underwriting agreements
and other documents required under the terms of such underwriting
arrangements.

8.   Definitions

     Unless otherwise defined herein, all capitalized terms shall have the
meaning ascribed thereto in the Settlement Agreement to which these
Registration Rights are an Exhibit.

9.   Assignment

     SICPA may assign its rights and duties hereunder to any person who
acquires from SICPA shares of Common Stock.


                                       
                                                                  EXHIBIT D



                             BY-LAW AMENDMENT


          Audit Committee.  The Board of Directors shall appoint an Audit
Committee, the responsibilities of which shall be (i) to review with
management and the corporation's independent public accountant the scope of
services required by its audit, significant accounting policies, and audit
conclusions regarding significant accounting estimates, (ii) to review with
management and the corporation's independent public accountant their
assessments of the adequacy of internal controls, and the resolution of
identified material weaknesses and reportable conditions in internal
controls, including the prevention or detection of management override or
compromise of the internal control system, (iii) to review with management
and the corporation's independent public accountant the institution's
compliance with applicable laws, (iv) to discuss with management the
selection and termination of the corporation's independent public
accountant and any significant disagreements between the accountants and
management, (v) to oversee the internal audit function, and (vi) such other
duties as the Board of Directors may designate.  The Audit Committee shall
maintain minutes and other relevant records of its meetings, shall meet at
any time upon the request of any member of the Board of Directors and shall
make a report to the full Board of Directors at the meeting of the Board of
Directors next succeeding any meeting of the Audit Committee.  The
composition of the Audit Committee shall be one director designated by
SICPA, one director designated by OCLI, and one member of senior management
of the corporation who is not otherwise employed by either SICPA or OCLI.
This provision may not be amended unless and until the corporation
consummates an underwritten public offering of its common stock registered
under the Securities Act of 1933.


                                                                  EXHIBIT B



                                REGISTRATION RIGHTS



1.   Demand Registrations


     a.   Requests for Registration.

          (i)  Subject to the terms and conditions hereof, at any time and
     from time to time after the date of the first Public Offering of Flex
     Common Stock SICPA may request in writing registration under the
     Securities Act of 1933, as amended (the "Securities Act"), of all or
     part of its Common Stock (any such requested registration is
     hereinafter referred to as a "Demand Registration").  The number of
     Demand Registrations SICPA shall be entitled to request shall be two
     (2).

          (ii) An SEC registration of Common Stock shall not be counted as
     a Demand Registration for purposes of the limit in Section 1.a.(i) of
     this Exhibit B until such registration has become effective (unless
     such Demand Registration has not become effective due solely to the
     fault of SICPA).  Each request for a Demand Registration shall specify
     the approximate number of shares of Common Stock requested to be
     registered and the anticipated per share price range for such
     offering.

          (iii)     If, in connection with any Demand Registration, the
     managing underwriter(s) to Flex in connection with such SEC
     registration advises Flex in writing that, in its opinion, the number
     of shares of Common Stock to be registered would materially and
     adversely affect the success or price of the offering, then the number
     of shares to be included in such Demand Registration shall be reduced
     to the number recommended by such managing underwriter(s).  Any such
     reduction shall be effected by (1) first reducing or eliminating the
     number of shares of Common Stock (if any) requested to be included in
     such registration by any shareholders of Flex other than SICPA and (2)
     then, if and to the extent further reductions are necessary, by
     reducing the number of shares of Common Stock requested to be included
     therein by SICPA.  If by such reduction the number of shares of Common
     Stock included in such registration for SICPA represents less than
     one-third of the total number of shares requested to be registered by
     SICPA, then such registration shall not be counted against the number
     of Demand Registrations to which SICPA is entitled under Section
     1.a.(i) hereof.

     b.   Best Efforts.  Flex shall promptly and diligently use its best
efforts to effect the registration under the Securities Act of the Common
Stock which Flex has been so requested to register by SICPA.  Flex shall
use its best efforts to effect such registration on whichever registration
form the Board of Directors of Flex shall determine in its discretion is
appropriate in accordance with the intended method of disposition of such
shares; provided, however, that Flex shall use its best efforts to effect
such registration on SEC Form S-3 (or any successor form to Form S-3) if so
requested by SICPA unless (1) Form S-3 (or any successor form to Form S-3)
is not available for such offering, (2) the aggregate net offering price
(after deducting any underwriting discounts and commissions) of the shares
to be so registered is less than $1,000,000, or (3) Flex shall notify SICPA
that, in the good faith judgment of the Board of Directors of Flex, it
would not be in the best interests of Flex and its stockholders for a Form
S-3 registration to be effective at that time.

     c.   Restrictions on Demand Registrations.  Flex's obligation to use
its best efforts to effect a Demand Registration pursuant to this Section 1
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  Flex will not be obligated to effect any Demand Registration
     within any time period (not to exceed six months) requested by the
     managing underwriter(s) of any previous registered offering of Common
     Stock.

          (ii) Flex shall be entitled to postpone the filing of any
     registration statement otherwise required to be prepared and filed by
     Flex pursuant to any Demand Registration for a reasonable period of
     time, but not in excess of 90 days, if Flex determines in its
     reasonable judgment and in good faith that the registration and
     distribution of Common Stock under such Demand Registration would have
     an adverse effect on any pending or proposed equity or debt financing,
     acquisition, merger, consolidation, tender offer, corporate
     reorganization or similar transaction involving Flex or would require
     premature disclosure thereof.  In such event, Flex shall promptly give
     SICPA written notice of such determination, containing a general
     statement of the reasons for such postponement.  If Flex shall so
     postpone the filing of a registration statement, SICPA shall have the
     right to withdraw the Demand Registration by giving written notice to
     Flex within twenty (20) days after receipt of the postponement notice.
     In the event of such withdrawal, such Demand Registration shall not be
     counted for purposes of determining the number of Demand Registrations
     to which SICPA is entitled under Section 1.a.(i) of this Exhibit B.

     (d)  Selection of Underwriters.  Flex shall have the right to select
the managing underwriter(s) for any Demand Registration, subject to SICPA's
approval, which approval will not be unreasonably withheld.

2.   Piggyback Registrations


     a.   Right to Piggyback.  Subject to the limitations set forth in
Section 2.b. of this Exhibit B, at any time and from time to time after the
date of the first Public Offering of Flex Common Stock whenever Flex
proposes to register under the Securities Act any Common Stock, Flex will
give prompt written notice to SICPA of its intention to effect such a
registration and will use its best efforts to include in such registration
all shares of Common Stock with respect to which SICPA gives Flex written
request for inclusion therein within fifteen (15) days after the receipt of
Flex's notice (any such requested inclusion is hereinafter referred to as a
"Piggyback Registration").

     b.   Restrictions on Piggyback Registrations.  Flex's obligation to use
its best efforts to effect any registration pursuant to this Section 2
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  If, at any time before or after giving written notice
     pursuant to this Section 2 of its intention to register shares of
     Common Stock and prior to the effective date of the registration
     statement filed in connection with such registration, Flex shall
     determine for any reason not to proceed with such registration, Flex
     may give written notice of such determination to SICPA and thereupon
     shall be relieved of its obligation to use its best efforts to
     register any shares of Common Stock in connection with such
     registration, but without prejudice to the rights of SICPA to request
     that such registration be effected as a Demand Registration pursuant
     to the terms and conditions of Section 1.

          (ii) If, in the written opinion of the managing underwriter(s) of
     Flex in connection with any registration pursuant to this Section 2,
     the distribution of the additional securities requested to be included
     in such registration by SICPA ("Piggyback Shares") would materially

     and adversely affect the success or the price of the offering, then
     the number of shares to be included in such registration shall be
     reduced to the number recommended by such managing underwriter(s).
     Any such reduction shall be effected by (1) first reducing or
     eliminating the number of shares of Common Stock (if any) requested to
     be included in such registration by any shareholders of Flex other
     than SICPA, and (2) then, if and to the extent further reductions are
     necessary, by reducing the number of Piggyback Shares.

          (iii)     Flex shall not be obligated to effect any Piggyback
     Registration of Common Stock under this Section 2 incidental to the
     registration of any shares of Common Stock (A) filed on SEC Form S-4
     or any successor form thereto, (B) in connection with any merger,
     consolidation, acquisition, exchange offer, recapitalization or other
     reorganization of Flex or (C) in connection with any offering of
     securities made solely to stockholders of Flex.

     c.   Selection of Underwriters.  Flex shall have the right to select
the managing underwriter(s) for any Piggyback Registration, which selection
will be made by Flex in its sole discretion.

3.   Holdback Agreements


     SICPA agrees not to effect any public sale or distribution of Common
Stock during the seven (7) days prior to, and the ninety (90) day period
beginning on, the effective date of any Demand Registration or any
Piggyback Registration, as the case may be (except as part of such
registration), unless Flex and the underwriter(s) managing the registered
offering otherwise agree to a shorter period.

4.   Registration Procedures


     a.   Flex's Efforts.  Whenever SICPA requests that its shares of
Common Stock be registered pursuant to this Agreement, Flex will use its
best efforts to effect the registration and the sale of such shares in
accordance with the intended method of disposition thereof, and pursuant
thereto Flex will as expeditiously as possible:

          (i)  prepare and file with the SEC a registration statement with
     respect to such shares of Common Stock and use its best efforts to
     cause such registration statement to become effective (provided that,

     before filing a registration statement or prospectus or any amendments
     or supplements thereto, Flex will furnish to the counsel of SICPA such
     registration statement and copies of all such other documents proposed
     to be filed);

          (ii) prepare and file with the SEC such amendments and
     supplements to such registration statement and the prospectus used in
     connection therewith as may be necessary to keep such registration
     statement effective for a period of not less than ninety (90) days,
     and comply with the provisions of the Securities Act with respect to
     the disposition of all shares of Common Stock covered by such
     registration statement during such period and until the earlier of
     such time as all of such shares of Common Stock have been disposed of
     in accordance with the intended methods of disposition by SICPA set
     forth in such registration statement or the expiration of sixty (60)
     days after such registration statement becomes effective, SICPA being
     hereby required promptly to inform Flex in writing when the
     distribution of such securities pursuant to such registration
     statement has been completed);

          (iii)     furnish to SICPA such number of conformed copies of
     such registration statement, each amendment and supplement thereto,
     the prospectus included in such registration statement (including each
     preliminary prospectus) and such other documents as SICPA may
     reasonably request in order to facilitate the disposition of the
     shares of Common Stock owned by SICPA;

          (iv) use its best efforts to register or qualify such shares of
     Common Stock under such other securities or blue sky laws of such
     jurisdictions as SICPA may reasonably request and do any and all other
     acts and things which may be reasonably necessary or advisable to
     enable SICPA to consummate the disposition of Common Stock in such
     jurisdictions (provided that Flex will not be required to (A) qualify
     generally to do business in any jurisdiction where it would not
     otherwise be required to qualify but for this subparagraph, (B)
     subject itself to taxation in any such jurisdiction or (C) consent to
     general service of process in any such jurisdiction);

          (v)  use its best efforts to list all such shares of Common Stock
     on each securities exchange or quotation service on which similar
     securities issued by Flex are then listed, if any;

          (vi) provide a transfer agent and registrar for all such shares
     of Common Stock not later than the effective date of such registration
     statement;

          (vii)     enter into such customary agreements (including
     underwriting agreements in customary form) and take all such other
     actions as SICPA may reasonably request in order to expedite or
     facilitate the disposition of such shares of Common Stock (including,
     without limitation, effecting a stock split or a combination of shares
     applicable to all shareholders of Flex equally);

          (viii)    make available for inspection by SICPA, any
     underwriter(s) participating in any disposition pursuant to such
     registration statement, and any attorney, accountant or other agent
     retained by SICPA or the underwriter(s), all financial and other
     records, pertinent corporate documents and properties of Flex, and
     cause Flex's officers, directors, employees and independent
     accountants to supply all information reasonably requested by SICPA or
     the underwriter(s), or any attorney, accountant or agent of SICPA or
     the underwriter(s) in connection with such registration statement;

          (ix) otherwise use its best efforts to comply with all applicable
     rules and regulations of the SEC, and make available to its security
     holders, as soon as reasonably practicable, an earnings statement
     covering the period of at least twelve months beginning with the first
     day of Flex's first full calendar quarter after the effective date of
     the registration statement, which earnings statement shall satisfy the
     provisions of Section 11(a) of the Securities Act;

          (x)  in the event of the issuance of any stop order suspending
     the effectiveness of a registration statement, or of any order
     suspending or preventing the use of any related prospectus or
     suspending the qualification of any shares of Common Stock included in
     such registration statement for sale in any jurisdiction, Flex will
     use its best efforts promptly to obtain the withdrawal of such order;

          (xi) obtain a cold comfort letter from Flex's independent public
     accountants in customary form and covering such matters of the type
     customarily covered by cold comfort letters as SICPA may reasonably
     request; and

          (xii)     promptly notify SICPA:  (A) when any registration
     statement, any pre-effective amendment, the prospectus or any
     prospectus supplement related thereto or post-effective amendment to
     such registration statement has been filed, and, with respect to such
     registration statement or any post-effective amendment, when the same
     has become effective; (B) of any request by the SEC for amendments or
     supplements to such registration statement or the prospectus related
     thereto or for additional information; (C) of the issuance by the SEC
     of any stop order suspending the effectiveness of such registration
     statement or the initiation of any proceedings for that purpose; (D)
     of the receipt by Flex of any notification with respect to the
     suspension of the qualification of any of the shares of Common Stock
     for sale under the securities or blue sky laws of any jurisdiction or
     the initiation of any proceeding for such purpose; and (E) of the
     existence of any fact of which Flex becomes aware which results in
     such registration statement, the prospectus related thereto or any
     document incorporated therein by reference containing an untrue
     statement of a material fact or omitting to state a material fact
     required to be stated therein or necessary to make any statement
     therein in light of the circumstances under which they were made not
     misleading; and, in the case of the notification relating to an event
     described in clause (E) hereof, Flex shall promptly prepare and
     furnish to SICPA and each underwriter, if any, a reasonable number of
     copies of a prospectus supplemented or amended so that, as thereafter
     delivered to the purchasers of any such Common Stock, such prospectus
     shall not include an untrue statement of a material fact or omit to
     state a material fact required to be stated therein or necessary to
     make the statements therein in the light of the circumstances under
     which they were made not misleading.

     b.   SICPA's Efforts.  SICPA shall cooperate with Flex in the
registration of any shares of Common Stock owned by SICPA by (1) furnishing
promptly to Flex such information regarding SICPA, the distribution of the
shares to be registered and any other information that Flex may reasonably
request in connection with the registration and (2) completing and
executing all questionnaires, powers of attorney, underwriting agreements
and other documents reasonably required in connection with the
registration.  SICPA hereby agrees that, upon receipt of any notice of the
happening of: (x) any event of the kind described in clause (C) of Section
4.a.(xii), SICPA will discontinue its disposition of shares of Common Stock
pursuant to the registration statement relating to such shares until the
stop order shall have been lifted or rescinded; (y) any event of the kind
described in clause (D) of Section 4.a.(xii), SICPA will discontinue its
disposition of shares of Common Stock pursuant to the registration
statement relating to such shares in the jurisdiction with respect to which
the suspension of the qualification of any of the shares for sale has
occurred, until the suspension shall have been lifted or rescinded; and (z)
any event of the kind described in clause (E) of Section 4.a.(xii), SICPA
will discontinue  its disposition of shares of Common Stock pursuant to the
registration statement relating to such shares until the receipt by SICPA
of the copies of the supplemented or amended prospectus contemplated by
Section 4.a.(xii) and, if so directed by Flex, will deliver to Flex (at
Flex's expense) all copies, other than permanent file copies, then in the
possession of SICPA of the prospectus relating to such shares of Common
Stock.  In the case of a Demand Registration, if the disposition by SICPA
of its shares of Common Stock is discontinued pursuant to the foregoing
sentence, unless Flex extends the period of effectiveness of the
registration statement by the number of days during the period from and
including the date of the giving of such notice to and including the date
when either (I) the stop order or suspension of qualification shall have
been lifted or rescinded or (II) SICPA shall have received copies of the
supplemented or amended prospectus contemplated by Section 4.a.(xii), as
the case may be, and unless SICPA continues to participate in such
registration as extended, then SICPA shall be entitled to another Demand
Registration and such discontinued or extended registration shall not be
counted against the number of Demand Registrations to which SICPA is
entitled under Section 1.a.(i) hereof.

5.   Registration Expenses

     For purposes of this Exhibit B, "Registration Expenses" shall mean all
expenses incident to Flex's performance of or compliance with this Exhibit
B, including without limitation, (i) all registration and filing fees, (ii)
fees and expenses of compliance with securities or blue sky laws, (iii)
printing expenses, messenger and delivery expenses, (iv) fees for listing
the securities to be registered on securities exchanges or on the National
Association of Securities Dealers automated quotation system, (v) fees and
disbursements of counsel for Flex and all independent certified public
accountants, underwriters and other persons retained by Flex, and
(vi) underwriting discounts or commissions.  All Registration Expenses will
be borne by Flex, except that (i) any underwriting discounts or commissions
with respect to shares of Common Stock included either in any Demand
Registration or in any Piggyback Registration will be borne by and
allocated to SICPA in proportion to its shares so registered, (ii) SICPA
shall bear the expense of the fees and disbursements of any counsel
retained solely by SICPA and (iii) in the case of any Demand Registration,
SICPA shall bear a portion of the Registration Expenses (other than any
Registration Expenses of the type described in clauses (i) and (ii), which
are to be determined in accordance with clauses (i) and (ii)), which
portion shall be allocated to SICPA in proportion to its shares so
registered.

6.   Indemnification

     a.   By Flex.  Flex agrees to indemnify and hold harmless, to the
fullest extent permitted by law, SICPA and each of SICPA's officers and
directors and each person, if any, who controls SICPA within the meaning of
the Securities Act (each such person being hereinafter referred to as an
"Indemnified Party"), against any losses, claims, damages, liabilities and
expenses, joint or several, to which such Indemnified Party may become
subject under the Securities Act or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions or proceedings in
respect thereof) arise out of or are based upon (i) any untrue statement of
any material fact contained in any registration statement under which such
shares of Common Stock were registered under the Securities Act, any
preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, or any document incorporated by
reference therein, or (ii) any omission to state therein a material fact
required to be stated therein or necessary to make the statements therein
not misleading, and Flex will reimburse such Indemnified Party for any
legal or other expenses reasonably incurred by it, as and when incurred, in
connection with investigating or defending any such loss, claim, liability,
action or proceeding; provided, however, that Flex shall not be liable in
any such case to the extent that any such loss, claim, damage, liability
(or action or proceeding in respect thereof) or expense arises out of or is
based upon or is caused by (A) an untrue statement or alleged untrue
statement or omission or alleged omission made in such registration
statement, any such preliminary prospectus, final prospectus, amendment or
supplement in reliance upon and in conformity with written information
furnished to Flex by or on behalf of such Indemnified Party expressly for
use in the preparation thereof, or (B) such Indemnified Party's failure to
deliver a copy of such registration statement, prospectus, amendment or
supplement after Flex has furnished such Indemnified Party with such number
of copies of the same as such Indemnified Party may reasonably request.
Such indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of such Indemnified Party and shall
survive the transfer of such securities by such Indemnified Party.

     b.   By SICPA.  Flex may require, as a condition to including any of
SICPA's shares of Common Stock in any registration statement filed pursuant
to Section 1 or 2 hereof, that Flex shall have received an undertaking
reasonably satisfactory to it from SICPA to indemnify and hold harmless (in
the same manner and to the same extent as set forth in paragraph (a) of
this Section 6) Flex, each director of Flex, each person named as or about
to become a director of Flex, each officer of Flex and each other person,
if any, who controls Flex within the meaning of the Securities Act, with
respect to any statement in or omission from such registration statement,
any preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, if such statement or omission was
made in reliance upon and in conformity with written information expressly
furnished to Flex by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement; provided, however, that such indemnity shall be
limited to the amount of the net proceeds received by SICPA from the sale
of shares of Common Stock pursuant to such registration statement, except
in the case of any material misstatement or omission knowingly and
willfully made by SICPA in written information expressly furnished to Flex
or the underwriters by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement, as to which no such limitation shall apply.  Such
indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of Flex or any such director, officer or
controlling person and shall survive the transfer of such securities by
SICPA.

     c.   Procedural Matters.  A party from whom indemnity shall be sought
pursuant to the provisions of this Section 6 shall not be liable with
respect to such indemnity under paragraph (a) or (b) of this Section 6
unless the indemnified party shall have given written notice to such
indemnifying party of the nature of such claim promptly after receipt by
such indemnified party of notice of the commencement of any action or
proceeding involving such claim; provided, however, that the failure of any
indemnified party to give notice as provided herein shall not relieve such
indemnifying party from any liability which it may have to such indemnified
party (X) otherwise than on account of this Section 6 or (Y) except to the
extent that the failure to give such notice shall have been materially
prejudicial to such indemnifying party.  Unless in the reasonable judgment
of the indemnified party a conflict of interest between such indemnified
and indemnifying parties may exist with respect to such claim, the
indemnifying party shall be entitled to participate in and to assume the
defense of any such claim, jointly with any other indemnifying party
similarly notified, to the extent that it may wish, with counsel reasonably
satisfactory to such indemnified party, and after notice from the
indemnifying party to such indemnified party of its election so to assume
the defense thereof, the indemnifying party shall not be liable to such
indemnified party for any legal or other expenses subsequently incurred by
the indemnified party in connection with the defense thereof.  In the case
of conflict of interest as set forth above, the indemnifying party shall
pay the reasonable fees and expenses of one counsel for all parties
indemnified by such indemnifying party with respect to such claim.  In no
event will the indemnifying party be subject to any liability for any
settlement made by any indemnified party without its consent.

7.   Participation in Underwritten Registrations

     SICPA may not participate in any registration hereunder which is
underwritten unless SICPA (a) agrees to sell its securities on the basis
provided in any underwriting arrangements approved by the person or persons
entitled to approve such arrangements and (b) completes and executes all
questionnaires, powers of attorney, indemnities, underwriting agreements
and other documents required under the terms of such underwriting
arrangements.

8.   Definitions


     Unless otherwise defined herein, all capitalized terms shall have the
meaning ascribed thereto in the Settlement Agreement to which these
Registration Rights are an Exhibit.

                                       
9.   Assignment


     SICPA may assign its rights and duties hereunder to any person who
acquires from SICPA shares of Common Stock.

                                                                  EXHIBIT A


                             FIRST AMENDMENT TO

                         LICENSE AND SUPPLY AGREEMENT

                              BY AND BETWEEN

                            FLEX PRODUCTS, INC.

                                 AND

                           SICPA HOLDING S.A.




                          NOVEMBER 19, 1997





                          FIRST AMENDMENT TO


                      LICENSE AND SUPPLY AGREEMENT


      FIRST AMENDMENT TO AGREEMENT dated November 19, 1997, by and between
Flex Products, Inc., a Delaware corporation ("Flex") and SICPA HOLDING
S.A., a Swiss corporation ("SICPA").

                          W I T N E S S E T H:

      WHEREAS, Flex and SICPA are currently parties to a License and Supply
Agreement dated as of December 2, 1994 providing for the purchase and sale
of optically variable pigment ("OVP") (the "1994 Agreement");

      WHEREAS, Flex and SICPA wish to amend the 1994 Agreement by means of
this First Amendment to the 1994 Agreement;

      NOW, THEREFORE, in consideration of the mutual agreements hereinafter
set forth, the parties hereby agree as follows:

      Section 1.1.1(b) shall be amended and replaced to read in full as
follows:
                                       
           The parties agree to use the "STAC" referenced in Section 3.16
      of the Settlement Agreement, dated November 19, 1997, by and between
      SICPA, Flex, OCLI and the other parties named therein, during the
      term of this Agreement, to implement all of the provisions of the
      Memorandum of Alliance and the Joint Venture Agreement, copies of
      which are attached hereto as Exhibits I and J, respectively.  In the
      event the STAC is discontinued the parties agree to re-establish the
      Committee pursuant to the original provisions of Section 1.1.1(b)
      prior to this Amendment.  The parties agree that, notwithstanding the
      existing terms of the Memorandum of Alliance and the Joint Venture
      Agreement to the contrary, the Memorandum of Alliance and the Joint
      Venture Agreement shall remain in effect during the Term of this
      Agreement, and the parties shall execute such amendments thereto
      which may be proper to extend the length of the respective terms of
      the Memorandum of Alliance and the Joint Venture Agreement to conform
      to length of the Term (as such term is defined in Section 13 below).

      Section 3 of the 1994 Agreement shall be amended and replaced to read
in full as follows:

           3.  Changes to Price and Quantity.  During the period from
      March 1, 2000 through June 30, 2000 and the period March 1, 2005
      through June 30, 2005, the parties shall discuss what the price and
      quantity terms of this Agreement shall be for the period 11/1/2000
      through 10/31/2005 and 11/1/2005 through 12/31/2009 respectively.  In
      the event that the parties cannot agree to any other provisions, the
      price for OVP shall be the price set forth in Section 4, as adjusted
      by Section 5.6 for periods after 10/31/2000, the minimum and maximum
      quantities for the period 11/1/2000 through 10/31/2005 shall be the
      same as for the year ended 10/31/2000, and the minimum and maximum
      quantities for the period 11/1/2005 through 12/31/2009 shall be the
      same as for the year ended 10/31/2005 (prorated on a month-for-month
      basis for the period from 11/1/2009 to 12/31/2009).

      Section 4.3 of the 1994 Agreement shall be amended and replaced to
read in full as follows:

           4.3  Price Adjustment.  The price per kilogram set shall be as

      set forth below without adjustment pursuant to Sections 4.2 and 5.6
      from November 1, 1997 through October 31, 2000:

                                    Base Price/Kg (before
                                    increases pursuant to
      Purchases per Year            Sections 4.2 and 5.6)


                       [CONFIDENTIAL TREATMENT REQUESTED]


      The table set forth in 5.1(a) of the 1994 Agreement shall be amended
and replaced to read in full as follows:

           5.1  Minimum Annual Purchases.


                5.1(a) Minimum Purchases Necessary to Maintain Exclusive

      License.  The parties agree that SICPA shall purchase from Flex

      minimum amounts of OVP set forth below for the periods indicated:

           Year               Minimum                      Maximum


                     [CONFIDENTIAL TREATMENT REQUESTED]


            Section 14 of the 1994 Agreement shall be amended and replaced
                           to read in full as follows:

                       14. [CONFIDENTIAL TREATMENT REQUESTED]

        Section 17 of the 1994 Agreement shall be amended and replaced to
read in full as follows:

           17.  Notices.  All notices hereunder shall be in writing and
      shall be deemed to have been given either (i) when received, if
      delivered in person or transmitted by tested telex or facsimile, or
      (ii) three business days after having been mailed by registered or
      certified mail addressed as follows:


      To Flex:            Flex Products, Inc.
                          1402 Mariner Way
                          Santa Rosa, California 95407-7370
                          Attn:  Michael Sullivan
                          FAX: (707) 525-7725

      To SICPA:           SICPA Holding S.A.
                          Avenue de Florissant 41
                          1008 Prilly
                          Switzerland
                          Attention: President
                          FAX: 41-21-627-5505

      or to such changed address as such party may have fixed by notice
      provided that any notice of change of address shall be deemed to have
      been given when received.
                                       

      IN WITNESS WHEREOF, each of the parties hereto has caused this
Amendment to be duly executed, and intends this Agreement to be effective,
as of the date first set forth above.

                          FLEX PRODUCTS, INC., a Delaware corporation



                          By


                          SICPA HOLDING S.A., a Swiss corporation



                          By

                                                                  EXHIBIT B



                            REGISTRATION RIGHTS



1.   Demand Registrations


     a.   Requests for Registration.


          (i)  Subject to the terms and conditions hereof, at any time and
     from time to time after the date of the first Public Offering of Flex
     Common Stock SICPA may request in writing registration under the
     Securities Act of 1933, as amended (the "Securities Act"), of all or
     part of its Common Stock (any such requested registration is
     hereinafter referred to as a "Demand Registration").  The number of
     Demand Registrations SICPA shall be entitled to request shall be two
     (2).
          (ii) An SEC registration of Common Stock shall not be counted as
     a Demand Registration for purposes of the limit in Section 1.a.(i) of
     this Exhibit B until such registration has become effective (unless
     such Demand Registration has not become effective due solely to the
     fault of SICPA).  Each request for a Demand Registration shall specify
     the approximate number of shares of Common Stock requested to be
     registered and the anticipated per share price range for such
     offering.

          (iii)     If, in connection with any Demand Registration, the
     managing underwriter(s) to Flex in connection with such SEC
     registration advises Flex in writing that, in its opinion, the number
     of shares of Common Stock to be registered would materially and
     adversely affect the success or price of the offering, then the number
     of shares to be included in such Demand Registration shall be reduced
     to the number recommended by such managing underwriter(s).  Any such
     reduction shall be effected by (1) first reducing or eliminating the
     number of shares of Common Stock (if any) requested to be included in
     such registration by any shareholders of Flex other than SICPA and (2)
     then, if and to the extent further reductions are necessary, by
     reducing the number of shares of Common Stock requested to be included
     therein by SICPA.  If by such reduction the number of shares of Common
     Stock included in such registration for SICPA represents less than
     one-third of the total number of shares requested to be registered by
     SICPA, then such registration shall not be counted against the number
     of Demand Registrations to which SICPA is entitled under Section
     1.a.(i) hereof.

     b.   Best Efforts.  Flex shall promptly and diligently use its best
efforts to effect the registration under the Securities Act of the Common
Stock which Flex has been so requested to register by SICPA.  Flex shall
use its best efforts to effect such registration on whichever registration
form the Board of Directors of Flex shall determine in its discretion is
appropriate in accordance with the intended method of disposition of such
shares; provided, however, that Flex shall use its best efforts to effect
such registration on SEC Form S-3 (or any successor form to Form S-3) if so
requested by SICPA unless (1) Form S-3 (or any successor form to Form S-3)
is not available for such offering, (2) the aggregate net offering price
(after deducting any underwriting discounts and commissions) of the shares
to be so registered is less than $1,000,000, or (3) Flex shall notify SICPA
that, in the good faith judgment of the Board of Directors of Flex, it
would not be in the best interests of Flex and its stockholders for a Form
S-3 registration to be effective at that time.

     c.   Restrictions on Demand Registrations.  Flex's obligation to use
its best efforts to effect a Demand Registration pursuant to this Section 1
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  Flex will not be obligated to effect any Demand Registration
     within any time period (not to exceed six months) requested by the
     managing underwriter(s) of any previous registered offering of Common
     Stock.
                                       
          (ii) Flex shall be entitled to postpone the filing of any
     registration statement otherwise required to be prepared and filed by
     Flex pursuant to any Demand Registration for a reasonable period of
     time, but not in excess of 90 days, if Flex determines in its
     reasonable judgment and in good faith that the registration and
     distribution of Common Stock under such Demand Registration would have
     an adverse effect on any pending or proposed equity or debt financing,
     acquisition, merger, consolidation, tender offer, corporate
     reorganization or similar transaction involving Flex or would require
     premature disclosure thereof.  In such event, Flex shall promptly give
     SICPA written notice of such determination, containing a general
     statement of the reasons for such postponement.  If Flex shall so
     postpone the filing of a registration statement, SICPA shall have the
     right to withdraw the Demand Registration by giving written notice to
     Flex within twenty (20) days after receipt of the postponement notice.
     In the event of such withdrawal, such Demand Registration shall not be
     counted for purposes of determining the number of Demand Registrations
     to which SICPA is entitled under Section 1.a.(i) of this Exhibit B.

     (d)  Selection of Underwriters.  Flex shall have the right to select
the managing underwriter(s) for any Demand Registration, subject to SICPA's
approval, which approval will not be unreasonably withheld.

2.   Piggyback Registrations

     a.   Right to Piggyback.  Subject to the limitations set forth in
Section 2.b. of this Exhibit B, at any time and from time to time after the
date of the first Public Offering of Flex Common Stock whenever Flex
proposes to register under the Securities Act any Common Stock, Flex will
give prompt written notice to SICPA of its intention to effect such a
registration and will use its best efforts to include in such registration
all shares of Common Stock with respect to which SICPA gives Flex written
request for inclusion therein within fifteen (15) days after the receipt of
Flex's notice (any such requested inclusion is hereinafter referred to as a
"Piggyback Registration").


     b.   Restrictions on Piggyback Registrations.  Flex's obligation to
use its best efforts to effect any registration pursuant to this Section 2
is subject to each of the following limitations, conditions, qualifications
and provisions:

          (i)  If, at any time before or after giving written notice
     pursuant to this Section 2 of its intention to register shares of
     Common Stock and prior to the effective date of the registration
     statement filed in connection with such registration, Flex shall
     determine for any reason not to proceed with such registration, Flex
     may give written notice of such determination to SICPA and thereupon
     shall be relieved of its obligation to use its best efforts to
     register any shares of Common Stock in connection with such
     registration, but without prejudice to the rights of SICPA to request
     that such registration be effected as a Demand Registration pursuant
     to the terms and conditions of Section 1.

          (ii) If, in the written opinion of the managing underwriter(s) of
     Flex in connection with any registration pursuant to this Section 2,
     the distribution of the additional securities requested to be included
     in such registration by SICPA ("Piggyback Shares") would materially

     and adversely affect the success or the price of the offering, then
     the number of shares to be included in such registration shall be
     reduced to the number recommended by such managing underwriter(s).
     Any such reduction shall be effected by (1) first reducing or
     eliminating the number of shares of Common Stock (if any) requested to
     be included in such registration by any shareholders of Flex other
     than SICPA, and (2) then, if and to the extent further reductions are
     necessary, by reducing the number of Piggyback Shares.

          (iii)     Flex shall not be obligated to effect any Piggyback
     Registration of Common Stock under this Section 2 incidental to the
     registration of any shares of Common Stock (A) filed on SEC Form S-4
     or any successor form thereto, (B) in connection with any merger,
     consolidation, acquisition, exchange offer, recapitalization or other
     reorganization of Flex or (C) in connection with any offering of
     securities made solely to stockholders of Flex.

     c.   Selection of Underwriters.  Flex shall have the right to select
the managing underwriter(s) for any Piggyback Registration, which selection
will be made by Flex in its sole discretion.

3.   Holdback Agreements

     SICPA agrees not to effect any public sale or distribution of Common
Stock during the seven (7) days prior to, and the ninety (90) day period
beginning on, the effective date of any Demand Registration or any
Piggyback Registration, as the case may be (except as part of such
registration), unless Flex and the underwriter(s) managing the registered
offering otherwise agree to a shorter period.

4.   Registration Procedures


     a.   Flex's Efforts.  Whenever SICPA requests that its shares of

Common Stock be registered pursuant to this Agreement, Flex will use its
best efforts to effect the registration and the sale of such shares in
accordance with the intended method of disposition thereof, and pursuant
thereto Flex will as expeditiously as possible:

          (i)  prepare and file with the SEC a registration statement with
     respect to such shares of Common Stock and use its best efforts to
     cause such registration statement to become effective (provided that,

     before filing a registration statement or prospectus or any amendments
     or supplements thereto, Flex will furnish to the counsel of SICPA such
     registration statement and copies of all such other documents proposed
     to be filed);

          (ii) prepare and file with the SEC such amendments and
     supplements to such registration statement and the prospectus used in
     connection therewith as may be necessary to keep such registration
     statement effective for a period of not less than ninety (90) days,
     and comply with the provisions of the Securities Act with respect to
     the disposition of all shares of Common Stock covered by such
     registration statement during such period and until the earlier of
     such time as all of such shares of Common Stock have been disposed of
     in accordance with the intended methods of disposition by SICPA set
     forth in such registration statement or the expiration of sixty (60)
     days after such registration statement becomes effective, SICPA being
     hereby required promptly to inform Flex in writing when the
     distribution of such securities pursuant to such registration
     statement has been completed);

          (iii)     furnish to SICPA such number of conformed copies of
     such registration statement, each amendment and supplement thereto,
     the prospectus included in such registration statement (including each
     preliminary prospectus) and such other documents as SICPA may
     reasonably request in order to facilitate the disposition of the
     shares of Common Stock owned by SICPA;

          (iv) use its best efforts to register or qualify such shares of
     Common Stock under such other securities or blue sky laws of such
     jurisdictions as SICPA may reasonably request and do any and all other
     acts and things which may be reasonably necessary or advisable to
     enable SICPA to consummate the disposition of Common Stock in such
     jurisdictions (provided that Flex will not be required to (A) qualify
     generally to do business in any jurisdiction where it would not
     otherwise be required to qualify but for this subparagraph, (B)
     subject itself to taxation in any such jurisdiction or (C) consent to
     general service of process in any such jurisdiction);

          (v)  use its best efforts to list all such shares of Common Stock
     on each securities exchange or quotation service on which similar
     securities issued by Flex are then listed, if any;

          (vi) provide a transfer agent and registrar for all such shares
     of Common Stock not later than the effective date of such registration
     statement;

          (vii)     enter into such customary agreements (including
     underwriting agreements in customary form) and take all such other
     actions as SICPA may reasonably request in order to expedite or
     facilitate the disposition of such shares of Common Stock (including,
     without limitation, effecting a stock split or a combination of shares
     applicable to all shareholders of Flex equally);

          (viii)    make available for inspection by SICPA, any
     underwriter(s) participating in any disposition pursuant to such
     registration statement, and any attorney, accountant or other agent
     retained by SICPA or the underwriter(s), all financial and other
     records, pertinent corporate documents and properties of Flex, and
     cause Flex's officers, directors, employees and independent
     accountants to supply all information reasonably requested by SICPA or
     the underwriter(s), or any attorney, accountant or agent of SICPA or
     the underwriter(s) in connection with such registration statement;

          (ix) otherwise use its best efforts to comply with all applicable
     rules and regulations of the SEC, and make available to its security
     holders, as soon as reasonably practicable, an earnings statement
     covering the period of at least twelve months beginning with the first
     day of Flex's first full calendar quarter after the effective date of
     the registration statement, which earnings statement shall satisfy the
     provisions of Section 11(a) of the Securities Act;

          (x)  in the event of the issuance of any stop order suspending
     the effectiveness of a registration statement, or of any order
     suspending or preventing the use of any related prospectus or
     suspending the qualification of any shares of Common Stock included in
     such registration statement for sale in any jurisdiction, Flex will
     use its best efforts promptly to obtain the withdrawal of such order;

          (xi) obtain a cold comfort letter from Flex's independent public
     accountants in customary form and covering such matters of the type
     customarily covered by cold comfort letters as SICPA may reasonably
     request; and

          (xii)     promptly notify SICPA:  (A) when any registration
     statement, any pre-effective amendment, the prospectus or any
     prospectus supplement related thereto or post-effective amendment to
     such registration statement has been filed, and, with respect to such
     registration statement or any post-effective amendment, when the same
     has become effective; (B) of any request by the SEC for amendments or
     supplements to such registration statement or the prospectus related
     thereto or for additional information; (C) of the issuance by the SEC
     of any stop order suspending the effectiveness of such registration
     statement or the initiation of any proceedings for that purpose; (D)
     of the receipt by Flex of any notification with respect to the
     suspension of the qualification of any of the shares of Common Stock
     for sale under the securities or blue sky laws of any jurisdiction or
     the initiation of any proceeding for such purpose; and (E) of the
     existence of any fact of which Flex becomes aware which results in
     such registration statement, the prospectus related thereto or any
     document incorporated therein by reference containing an untrue
     statement of a material fact or omitting to state a material fact
     required to be stated therein or necessary to make any statement
     therein in light of the circumstances under which they were made not
     misleading; and, in the case of the notification relating to an event
     described in clause (E) hereof, Flex shall promptly prepare and
     furnish to SICPA and each underwriter, if any, a reasonable number of
     copies of a prospectus supplemented or amended so that, as thereafter
     delivered to the purchasers of any such Common Stock, such prospectus
     shall not include an untrue statement of a material fact or omit to
     state a material fact required to be stated therein or necessary to
     make the statements therein in the light of the circumstances under
     which they were made not misleading.

     b.   SICPA's Efforts.  SICPA shall cooperate with Flex in the
registration of any shares of Common Stock owned by SICPA by (1) furnishing
promptly to Flex such information regarding SICPA, the distribution of the
shares to be registered and any other information that Flex may reasonably
request in connection with the registration and (2) completing and
executing all questionnaires, powers of attorney, underwriting agreements
and other documents reasonably required in connection with the
registration.  SICPA hereby agrees that, upon receipt of any notice of the
happening of: (x) any event of the kind described in clause (C) of Section
4.a.(xii), SICPA will discontinue its disposition of shares of Common Stock
pursuant to the registration statement relating to such shares until the
stop order shall have been lifted or rescinded; (y) any event of the kind
described in clause (D) of Section 4.a.(xii), SICPA will discontinue its
disposition of shares of Common Stock pursuant to the registration
statement relating to such shares in the jurisdiction with respect to which
the suspension of the qualification of any of the shares for sale has
occurred, until the suspension shall have been lifted or rescinded; and (z)
any event of the kind described in clause (E) of Section 4.a.(xii), SICPA
will discontinue  its disposition of shares of Common Stock pursuant to the
registration statement relating to such shares until the receipt by SICPA
of the copies of the supplemented or amended prospectus contemplated by
Section 4.a.(xii) and, if so directed by Flex, will deliver to Flex (at
Flex's expense) all copies, other than permanent file copies, then in the
possession of SICPA of the prospectus relating to such shares of Common
Stock.  In the case of a Demand Registration, if the disposition by SICPA
of its shares of Common Stock is discontinued pursuant to the foregoing
sentence, unless Flex extends the period of effectiveness of the
registration statement by the number of days during the period from and
including the date of the giving of such notice to and including the date
when either (I) the stop order or suspension of qualification shall have
been lifted or rescinded or (II) SICPA shall have received copies of the
supplemented or amended prospectus contemplated by Section 4.a.(xii), as
the case may be, and unless SICPA continues to participate in such
registration as extended, then SICPA shall be entitled to another Demand
Registration and such discontinued or extended registration shall not be
counted against the number of Demand Registrations to which SICPA is
entitled under Section 1.a.(i) hereof.
                                      
5.   Registration Expenses


     For purposes of this Exhibit B, "Registration Expenses" shall mean all
expenses incident to Flex's performance of or compliance with this Exhibit
B, including without limitation, (i) all registration and filing fees, (ii)
fees and expenses of compliance with securities or blue sky laws, (iii)
printing expenses, messenger and delivery expenses, (iv) fees for listing
the securities to be registered on securities exchanges or on the National
Association of Securities Dealers automated quotation system, (v) fees and
disbursements of counsel for Flex and all independent certified public
accountants, underwriters and other persons retained by Flex, and
(vi) underwriting discounts or commissions.  All Registration Expenses will
be borne by Flex, except that (i) any underwriting discounts or commissions
with respect to shares of Common Stock included either in any Demand
Registration or in any Piggyback Registration will be borne by and
allocated to SICPA in proportion to its shares so registered, (ii) SICPA
shall bear the expense of the fees and disbursements of any counsel
retained solely by SICPA and (iii) in the case of any Demand Registration,
SICPA shall bear a portion of the Registration Expenses (other than any
Registration Expenses of the type described in clauses (i) and (ii), which
are to be determined in accordance with clauses (i) and (ii)), which
portion shall be allocated to SICPA in proportion to its shares so
registered.

6.   Indemnification


     a.   By Flex.  Flex agrees to indemnify and hold harmless, to the
fullest extent permitted by law, SICPA and each of SICPA's officers and
directors and each person, if any, who controls SICPA within the meaning of
the Securities Act (each such person being hereinafter referred to as an
"Indemnified Party"), against any losses, claims, damages, liabilities and
expenses, joint or several, to which such Indemnified Party may become
subject under the Securities Act or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions or proceedings in
respect thereof) arise out of or are based upon (i) any untrue statement of
any material fact contained in any registration statement under which such
shares of Common Stock were registered under the Securities Act, any
preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, or any document incorporated by
reference therein, or (ii) any omission to state therein a material fact
required to be stated therein or necessary to make the statements therein
not misleading, and Flex will reimburse such Indemnified Party for any
legal or other expenses reasonably incurred by it, as and when incurred, in
connection with investigating or defending any such loss, claim, liability,
action or proceeding; provided, however, that Flex shall not be liable in
any such case to the extent that any such loss, claim, damage, liability
(or action or proceeding in respect thereof) or expense arises out of or is
based upon or is caused by (A) an untrue statement or alleged untrue
statement or omission or alleged omission made in such registration
statement, any such preliminary prospectus, final prospectus, amendment or
supplement in reliance upon and in conformity with written information
furnished to Flex by or on behalf of such Indemnified Party expressly for
use in the preparation thereof, or (B) such Indemnified Party's failure to
deliver a copy of such registration statement, prospectus, amendment or
supplement after Flex has furnished such Indemnified Party with such number
of copies of the same as such Indemnified Party may reasonably request.
Such indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of such Indemnified Party and shall
survive the transfer of such securities by such Indemnified Party.
 
     b.   By SICPA.  Flex may require, as a condition to including any of
SICPA's shares of Common Stock in any registration statement filed pursuant
to Section 1 or 2 hereof, that Flex shall have received an undertaking
reasonably satisfactory to it from SICPA to indemnify and hold harmless (in
the same manner and to the same extent as set forth in paragraph (a) of
this Section 6) Flex, each director of Flex, each person named as or about
to become a director of Flex, each officer of Flex and each other person,
if any, who controls Flex within the meaning of the Securities Act, with
respect to any statement in or omission from such registration statement,
any preliminary prospectus or final prospectus included therein, or any
amendment thereof or supplement thereto, if such statement or omission was
made in reliance upon and in conformity with written information expressly
furnished to Flex by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement; provided, however, that such indemnity shall be
limited to the amount of the net proceeds received by SICPA from the sale
of shares of Common Stock pursuant to such registration statement, except
in the case of any material misstatement or omission knowingly and
willfully made by SICPA in written information expressly furnished to Flex
or the underwriters by or on behalf of SICPA for use in the preparation of
such registration statement, preliminary prospectus, final prospectus,
amendment or supplement, as to which no such limitation shall apply.  Such
indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of Flex or any such director, officer or
controlling person and shall survive the transfer of such securities by
SICPA.

     c.   Procedural Matters.  A party from whom indemnity shall be sought
pursuant to the provisions of this Section 6 shall not be liable with
respect to such indemnity under paragraph (a) or (b) of this Section 6
unless the indemnified party shall have given written notice to such
indemnifying party of the nature of such claim promptly after receipt by
such indemnified party of notice of the commencement of any action or
proceeding involving such claim; provided, however, that the failure of any
indemnified party to give notice as provided herein shall not relieve such
indemnifying party from any liability which it may have to such indemnified
party (X) otherwise than on account of this Section 6 or (Y) except to the
extent that the failure to give such notice shall have been materially
prejudicial to such indemnifying party.  Unless in the reasonable judgment
of the indemnified party a conflict of interest between such indemnified
and indemnifying parties may exist with respect to such claim, the
indemnifying party shall be entitled to participate in and to assume the
defense of any such claim, jointly with any other indemnifying party
similarly notified, to the extent that it may wish, with counsel reasonably
satisfactory to such indemnified party, and after notice from the
indemnifying party to such indemnified party of its election so to assume
the defense thereof, the indemnifying party shall not be liable to such
indemnified party for any legal or other expenses subsequently incurred by
the indemnified party in connection with the defense thereof.  In the case
of conflict of interest as set forth above, the indemnifying party shall
pay the reasonable fees and expenses of one counsel for all parties
indemnified by such indemnifying party with respect to such claim.  In no
event will the indemnifying party be subject to any liability for any
settlement made by any indemnified party without its consent.

7.   Participation in Underwritten Registrations


     SICPA may not participate in any registration hereunder which is
underwritten unless SICPA (a) agrees to sell its securities on the basis
provided in any underwriting arrangements approved by the person or persons
entitled to approve such arrangements and (b) completes and executes all
questionnaires, powers of attorney, indemnities, underwriting agreements
and other documents required under the terms of such underwriting
arrangements.

8.   Definitions


     Unless otherwise defined herein, all capitalized terms shall have the
meaning ascribed thereto in the Settlement Agreement to which these
Registration Rights are an Exhibit.

9.   Assignment


     SICPA may assign its rights and duties hereunder to any person who
acquires from SICPA shares of Common Stock.

                                                                  EXHIBIT C


         SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
                                    OF
                            FLEX PRODUCTS, INC.


     JOSEPH C. ZILS, Secretary of FLEX PRODUCTS, INC., a corporation
organized and existing under the laws of the State of Delaware, hereby
certifies as follows:

     A.   The name of the corporation is FLEX PRODUCTS, INC.  FLEX
PRODUCTS, INC. was originally incorporated in the State of Delaware under
the same name, and the original Certificate of Incorporation of the
corporation was filed with the Delaware Secretary of State on October 28,
1988.

     B.   Pursuant to Sections 242 and 245 of the General Corporation Law
of the State of Delaware, this Restated Certificate of Incorporation
restates and integrates and further amends the provisions of the
Certificate of Incorporation of this corporation.

     C.   This Second Amended and Restated Certificate of Incorporation was
duly adopted by the Board of Directors with approval by the stockholders of
the corporation by the necessary number of shares as required by statute.

     D.   The text of the Certificate of Incorporation as heretofore
amended or supplemented is hereby restated and further amended to read in
its entirety as follows:


                                    I.
                                   NAME

     The name of the corporation is FLEX PRODUCTS, INC. (the
"Corporation").


                                    II.
                            AUTHORIZED BUSINESS

     The nature of the business or purposes to be conducted or promoted by
the Corporation is to engage in any lawful act or activity for which
corporations may be organized under the General Corporation Law of Delaware
(the "Delaware Law").
                                   III.

                               CAPITAL STOCK

     1.   This Corporation is authorized to issue two classes of shares
designated respectively as "Common Stock" and one class of shares
designated as "Preferred Stock," and referred to herein as Class A Common
Stock or Class A Common shares, Class B Common Stock or Class B Common
shares and Preferred Stock or Preferred shares, respectively.  The number
of shares of Class A Common Stock is 20,000,000, the number of shares of
Class B Common Stock is 12,500,000 and the number of shares of Preferred
Stock is 1,000.  Each share of Class A Common Stock, Class B Common Stock
and Preferred Stock shall have a par value of $.01.  Each share of common
stock of this Corporation, par value $.01, formerly issued and outstanding
immediately prior to the effective time of this Second Amended and Restated
Certificate of Incorporation is by this means reclassified and changed into
100 shares of Class B Common Stock, and the stated capital of this
Corporation shall be increased accordingly by an appropriate transfer from
earned surplus.

     2.   The Preferred shares may be issued from time to time in one or
more series.  Except for the Series B Preferred Stock and the Series C
Preferred Stock, the rights, privileges and preferences of which are set
forth in Section III.3 and III.4 below, respectively, the Board of
Directors is hereby authorized to fix or alter the dividend rights,
dividend rate, conversion rights, voting rights, rights and terms of
redemption (including sinking fund provisions), the redemption price or
prices, and the liquidation preferences of any wholly unissued series of
Preferred shares, and the number of shares constituting any such series and
the designation thereof, or any of them; and to increase or decrease the
number of shares of any series subsequent to the issue of shares of that
series, but not below the number of shares of such series then outstanding.
In case the number of shares of any series shall be so decreased, the
shares constituting such decrease shall resume the status in which they had
prior to the adoption of the resolution originally fixing the number of
shares of such series.

     3.   Of the Preferred shares, a total of 12 are designated as Series B
Preferred Stock, with the specific rights, privileges and preferences as
follows:

          a.   Voting Rights.  Except as otherwise provided in Sections
III.3.f and III.3.g below, the holders of Series B Preferred shares shall
have no voting rights.

          b.   Redemptions.

               i.   Mandatory Redemptions.  The Corporation will redeem all
or such lesser number of its Series B Preferred shares (or fractions
thereof), as, whenever and to the full extent that funds became lawfully
available therefor (but only to the extent of current or retained earnings
determined in accordance with generally accepted accounting principles
consistently applied) at a price per share of $150,000 (the "Redemption
Price").  The Corporation shall not declare or pay dividends on, make any
other distributions on, or redeem or purchase or otherwise acquire for
consideration any shares of any other class or series of its capital stock
other than a redemption of shares of Series C Preferred Stock until such
time as all Series B Preferred shares have been redeemed.  If the funds of
the Corporation legally available for redemption of Series B Preferred
Stock at the time of any such redemption are insufficient to redeem the
Series B Preferred shares in full, those funds which are legally available
shall be used to redeem the maximum number legally possible of shares or
fractions thereof of Series B Preferred Stock.

               ii.  Determination of Number of Redeemable Shares.  The
number of shares to be set forth in the redemption notice described in
Section III.3.b.iii below to be redeemed from each holder of Series B
Preferred Stock in redemptions under this Section III.3.b will be the
number of shares determined, as nearly as practicable to the nearest full
share, by multiplying the total number of Series B Preferred shares to be
redeemed times a fraction, (1) the numerator of which is the total number
of outstanding Series B Preferred shares then held by such holder and
(2) the denominator of which is the total number of Series B Preferred
shares then outstanding.

               iii. Notice of Redemption.  Notice of any redemption of
Series B Preferred Stock pursuant to this Section III.3.b specifying the
time and place of redemption and the redemption price will be mailed by
certified or registered mail, return receipt requested, to each holder of
record of Series B Preferred Stock at the address of such holder shown on
the Corporation's records, not more than 60 days nor less than 30 days
prior to the date on which such redemption is to be made.  If less than all
Series B Preferred Stock owned by a holder is then to be redeemed, the
notice will also specify the number of shares and the certificate numbers
thereof which are to be redeemed.  Upon mailing any such notice of
redemption, the Corporation will become obligated to redeem on the date of
redemption specified therein all Series B Preferred Stock specified
therein.  In case less than all Series B Preferred Stock represented by any
certificate are redeemed in any redemption pursuant to this Section
III.3.b, a new certificate will be issued representing the unredeemed
Series B Preferred Stock without cost to the holder thereof.

               iv.  Method of Redemption.  If on, prior to or after any
date fixed for redemption of the Series B Preferred Stock, the Corporation
shall deposit, with any bank or trust company in the State of California,
as a trust fund, a sum sufficient to redeem, as of the date fixed for
redemption thereof, the shares called for redemption, with irrevocable
instructions and authority to the bank or trust company to pay, on or after
the date fixed for redemption, the redemption price of the shares to their
respective holders upon surrender of their share certificates, then from
and after the later of the date fixed for redemption or the date of
deposit, but not until such date, the shares so called shall be redeemed
and dividends shall cease to accrue after the date fixed for redemption.
The deposit shall constitute full payment of the shares to their holders,
and from and after the date of the deposit the shares shall no longer be
outstanding, and the holders thereof shall cease to be stockholders with
respect to such shares, and shall have no rights with respect thereto
except the right to receive from the bank or trust company payment of the
redemption price of the shares without interest, upon the surrender of
their certificates therefor.  If the holders of Series B Preferred shares
so called for redemption shall not have claimed, at the end of six months
from the date fixed for redemption, any funds so deposited, such bank or
trust company shall thereupon pay over to the Corporation such unclaimed
funds, and such bank or trust company shall thereafter be relieved of all
responsibility in respect thereof to such holders, and such holders shall
look only to the Corporation for payment of the redemption price.

          c.   Conversion.  The Series B Preferred shares shall not be
convertible.

          d.   Reacquired Shares.  Any Series B Preferred shares purchased
or otherwise acquired by the Corporation in any manner whatsoever shall be
retired and cancelled promptly after the acquisition thereof.  All such
shares shall, upon their cancellation, become authorized but unissued
Preferred shares and may be reissued as part of a new series of Preferred
Stock to be created by resolution or resolutions of the Board of Directors,
subject to the conditions and restrictions on issuance set forth herein.

          e.   Liquidation, Dissolution, Winding Up or Merger, etc.  upon
any liquidation (voluntary or otherwise), dissolution or winding up of the
Corporation, no distribution shall be made to the holders of shares of any
other class or series of capital stock until all then outstanding Series B
Preferred shares shall have been redeemed (the "Series B Liquidation
Preference"); provided however, that the Series B Liquidation Preference
may only be paid out of, and only ranks prior to all other classes and
series of stock to the extent of current or retained earnings determined in
accordance with generally accepted accounting principles consistently
applied.

          f.   Ranking.  Except as set forth in Section III.4.f with
respect to the Corporation's Series C Preferred Stock, the Series B
Preferred Stock shall rank prior to all other series and classes of the
Corporation's capital stock as to the payment of dividends and the
distribution of assets, but only to the extent provided herein, and the
Corporation may not create any series or class of capital stock ranking
prior to or, as to the Series B Liquidation Preference or the preference of
the Series B Preferred Stock as to dividends and distributions, on a parity
with the Series B Preferred Stock unless the terms of any such series or
class shall first be approved by not less than 66 2/3% of the outstanding
shares of Series B Preferred Stock, voting separately as a class.

          g.   Amendment.  The Certificate of Incorporation of the
Corporation shall not be further amended in any manner which would
materially alter or change the powers, preferences or special rights of the
Series B Preferred Stock so as to affect them adversely without the
affirmative vote of the holders of not less than 66 2/3% of the outstanding
Series B Preferred shares, voting separately as a class.

          h.   Fractional Shares.  Series B Preferred Stock may be issued

in fractions of a share, which shall entitle the holder thereof, in
proportion to such holder's fractional shares, to exercise voting rights,
receive dividends, participate in distributions and to have the benefit of
all of the rights of holders of shares of Series B Preferred Stock.

     4.   Of the Preferred shares, a total of 10 are designated Series C
Preferred Stock, with the specific rights, privileges and preferences as
follows:

          a.   Voting Rights.  Except as otherwise provided in Section
III.4.f and III.4.g below, the holders of Series C Preferred Shares shall
have no voting rights.

          b.   Redemptions.

               i.   Mandatory Redemption.  The Corporation will redeem, at
a price per share of One Hundred Fifty Thousand Dollars ($150,000) (the
"Redemption Price") as soon as, whenever, and to the full extent that funds
become lawfully available therefor after February 1, 1998 (but only to the
extent of current or retained earnings determined in accordance with
generally accepted accounting principles consistently applied) shares of
Series C Preferred Stock (or fractions thereof).  The Corporation shall not
declare or pay dividends on, make any other distributions on, or redeem or
purchase or otherwise acquire for consideration any shares of any other
class or series of its capital stock other than a redemption of shares of
Series B Preferred Stock until such time as all shares of Series C
Preferred Stock have been redeemed.  If the funds of the Corporation
legally available for redemption of Series C Preferred Stock at the time of
any such redemption are insufficient to redeem the shares of Series C
Preferred Stock in full, those funds which are legally available shall be
used to redeem the maximum number legally possible of shares (or fractions
thereof) of Series C Preferred Stock.

               ii.  Determination of Number of Redeemable Shares.  The
number of shares to be set forth in the redemption notice described in
Section III.4.b.iii below to be redeemed from each holder of Series C
Preferred Stock in redemptions under this Section III.4.b will be the
number of shares determined, as nearly as practicable to the nearest share,
by multiplying the total number of shares of Series C Preferred Stock to be
redeemed times a fraction, (i) the numerator of which is the total number
of outstanding shares of Series C Preferred Stock then held by such holder
and (ii) the denominator of which is the total number of shares of Series C
Preferred Stock then outstanding.

               iii. Notice of Redemption.  Notice of any redemption of
Series C Preferred Stock pursuant to this Section III.4.b specifying the
time and place of redemption and the redemption price will be mailed by
certified or registered mail, return receipt requested, to each holder of
record of Series C Preferred Stock at the address of such holder shown on
the Corporation's records, not more than sixty (60) nor less than thirty
(30) days prior to the date on which such redemption is to be made.  If
less than all Series C Preferred Stock owned by a holder is then to be
redeemed, the notice will also specify the number of shares and the
certificate numbers thereof which are to be redeemed.  Upon mailing any
such notice of redemption, the Corporation will become obligated to redeem
on the date of redemption specified therein all Series C Preferred Stock
specified therein.  In case less than all Series C Preferred Stock
represented by any certificate is redeemed in any redemption pursuant to
this Section III.4.b, a new certificate will be issued representing the
unredeemed Series C Preferred Stock without cost to the holder thereof.

               iv.  Method of Redemption.  If on, prior to or after any
date fixed for redemption of the Series C Preferred Stock, the Corporation
shall deposit, with any bank or trust company in the State of California,
as a trust fund, a sum sufficient to redeem, as of the date fixed for
redemption thereof, the shares called for redemption, with irrevocable
instructions and authority to the bank or trust company to pay, on or after
the date fixed for redemption, the redemption price of the shares to their
respective holders upon surrender of their share certificates, then from
and after the later of the date fixed for redemption or the date of
deposit, but not until such date, the shares so called shall be redeemed
and dividends shall cease to accrue after the date fixed for redemption.
The deposit shall constitute full payment of the shares to their holders,
and from and after the date of the deposit the shares shall no longer be
outstanding, and the holders thereof shall cease to be stockholders with
respect to such shares, and shall have no rights with respect thereto
except the right to receive from the bank or trust company payment of the
redemption price of the shares without interest, upon the surrender of
their certificates therefor.  If the holders of shares of Series C
Preferred Stock so called for redemption shall not have claimed, at the end
of six (6) months from the date fixed for redemption, any funds so
deposited, such bank or trust company shall thereupon pay over to the
Corporation such unclaimed funds, and such bank or trust company shall
thereafter be relieved of all responsibility in respect thereof to such
holders, and such holders shall look only to the Corporation for payment of
the redemption price.

          c.   Conversion.  The shares of Series C Preferred Stock shall
not be convertible.

          d.   Reacquired Shares.  Any shares of Series C Preferred Stock
purchased or otherwise acquired by the Corporation in any manner whatsoever
shall be retired and cancelled promptly after the acquisition thereof.  All
such shares shall upon their cancellation become authorized but unissued
shares of Preferred Stock and may be reissued as part of a new series of
Preferred Stock to be created by resolution or resolution of the Board of
Directors, subject to the conditions and restrictions on issuance set forth
herein.

          e.   Liquidation, Dissolution, Winding Up or Merger, etc.  Upon
any liquidation (voluntary or otherwise), dissolution or winding up of the
Corporation, no distribution shall be made to the holders of shares of any
other class or series of capital stock until all then outstanding shares of
Series C Preferred Stock shall have been redeemed (the "Series C
Liquidation Preference"); provided, however, that the Series C Liquidation
Preference may only be paid out of, and only ranks prior to all other
classes and series of stock to the extent of, current or retained earnings
determined in accordance with generally accepted accounting principles
consistently applied.

          f.   Ranking.  Except as set forth in Section III.3.f. with
respect to the Corporation's Series B Preferred Stock, the Series C
Preferred Stock shall rank prior to all other series and classes of the
Corporation's capital stock as to the payment of dividends and the
distribution of assets, but only to the extent provided herein, and the
Corporation may not create any series or class of capital stock ranking
prior to or, as to the Series C Liquidation Preference or the preference of
the Series C Preferred Stock as to dividends and distributions, on a parity
with the Series C Preferred Stock unless the terms of any such series or
class shall be approved by not less than sixty-six and two-thirds percent
(66 2/3%) of the outstanding shares of Series C Preferred Stock, voting
separately as a class.

          g.   Amendment.  The Certificate of Incorporation of the
Corporation shall not be further amended in any manner which would
materially alter or change the powers, preferences or special rights of the
Series C Preferred Stock so as to affect them adversely without the
affirmative vote of the holders of not less than sixty-six and two-thirds
percent (66 2/3%) of the outstanding shares of Series C Preferred Stock,
voting separately as a class.

          h.   Fractional Shares.  Series C Preferred Stock may be issued
in fractions of a share which shall entitle the holder thereof, in
proportion to such holder's fractional shares, to exercise voting rights,
receive dividends, participate in distributions and to have the benefit of
all of the rights of holders of shares of Series C Preferred Stock.

     5.   Each share of the Class A Common Stock, par value $.01 (the
"Class A Common Stock), and each share of the Class B Common Stock, par
value $.01 per share (the "Class B Common Stock"), of the Corporation
shall, except as otherwise provided in this paragraph 5, be identical in
all respects and shall have equal rights and privileges.

          a.   Voting Rights.  Holders of Class A Common Stock shall be
entitled to one vote for each share of such stock held, and holders of
Class B Common Stock shall be entitled to ten votes for each share of such
stock held on all matters presented to such stockholders.  Except as may
otherwise be required by the laws of the State of Delaware or in the
instrument creating or evidencing any class or series of Preferred Stock,
the holders of shares of Class A Common Stock and the holders of shares of
Class B Common Stock shall vote with the holders of Preferred stock, if
any, as one class with respect to the election of directors and with
respect to all other matters to be voted on by stockholders of the
Corporation (including, without limitation, any proposed amendment to this
Certificate that would increase the number of authorized shares of Class A
Common Stock, of Class B Common Stock or of any class or series of stock
(but not below the number of shares thereof then outstanding), and no
separate vote or consent of the holders of shares of Class A Common Stock,
the holders of shares of Class B Common Stock or the holders of shares of
Preferred Stock shall be required for the approval of any such matter.

          b.   Conversion Rights.  Each share of Class B Common Stock shall
be convertible, at the option of the holder thereof, into one share of
Class A Common Stock.  Any such conversion may be effected by any holder of
Class B Common Stock by surrendering such holder's certificate or
certificates for the Class B Common Stock to be converted, duly endorsed,
at the office of the Corporation or any transfer agent for the Class B
Common Stock, together with a written notice to the Corporation at such
office that such holder elects to convert all or a specified number of
shares of Class B Common Stock represented by such certificate and stating
the name or names in which such holder desires the certificate or
certificates for Class A Common Stock to be issued.  If so required by the
Corporation, any certificate for shares surrendered for conversion shall be
accompanied by instruments of transfer, in form satisfactory to the
Corporation, duly executed by the holder of such shares or the duly
authorized representative of such holder.  Promptly thereafter, the
Corporation shall issue and deliver to such holder or such holder's
nominees, a certificate or certificates for the number of shares of Class A
Common Stock to which such holder shall be entitled as herein provided.
Such conversion shall be deemed to have been made at the close of business
on the date of receipt by the Corporation or any such transfer agent of the
certificate or certificates, notice and, if required, instruments of
transfer referred to above, and the person or persons entitled to receive
the Class A Common Stock issuable on such conversion shall be treated for
all purposes as the record holder or holders of such Class A Common Stock
on that date.  A number of shares of Class A Common Stock equal to the
number of shares of Class B Common Stock outstanding from time to time
shall be set aside and reserved for issuance upon conversion of shares of
Class B Common Stock.  Shares of Class B Common Stock that have been
converted hereunder shall remain treasury shares to be disposed of by
resolution of the Board of Directors.  Shares of Class A Common Stock shall
not be convertible into shares of Class B Common Stock.

          c.   Dividends.  Subject to paragraph d. of this paragraph 5,

whenever a dividend is paid to the holders of Class A Common Stock, the
Corporation also shall pay to the holders of Class B Common Stock a
dividend per share at least equal to the dividend per share paid to the
holders of the Class A Common Stock.  Subject to paragraph d. of this
paragraph 5, whenever a dividend is paid to the holders of Class B Common
Stock, the Corporation shall also pay to the holders of the Class A Common
Stock a dividend per share at least equal to the dividend per share paid to
the holders of the Class B Common Stock.  Dividends shall be payable only
as and when declared by the Board of Directors.

          d.   Share Distributions.  If at any time a distribution on the

Class A Common Stock or Class B Common Stock is to be paid in Class A
Common Stock, Class B Common Stock or any other securities of the
Corporation (hereinafter sometimes called a "share distribution"), such
share distribution may be declared and paid only as follows:

               (i)  a share distribution consisting of Class A Common Stock
to holders of Class A Common Stock and Class B Common Stock, on an equal
per share basis; or to holders of Class A Common Stock only, but in such
event there shall also be a simultaneous share distribution to holders of
Class B Common Stock consisting of shares of Class B Common Stock on an
equal per share basis:

               (ii) a share distribution consisting of Class A Common Stock
and Class B Common Stock, respectively, to holders of Class A Common Stock
and Class B Common Stock, respectively, on an equal per share basis;

               (iii)     a share distribution consisting of Class B Common
Stock to holders of Class B Common Stock only, but in such event there
shall also be a simultaneous share distribution to holders of Class A
Common Stock consisting of shares of Class A Common Stock on an equal per
share basis; and

               (iv) a share distribution consisting of any class of
securities of the Corporation other than Common Stock, to the holders of
Class A Common Stock and the holders of Class B Common Stock, on an equal
per share basis.

          The Corporation shall not reclassify, subdivide or combine one
class of its Common Stock without reclassifying, subdividing or combining
the other class of Common Stock, on an equal per share basis.

          e.   Liquidation and Mergers.  Subject to the prior payment in

full of the preferential amounts to which any Preferred Stock is entitled,
the holders of Class A Common Stock and the holders of Class B Common Stock
shall share equally, on a share for share basis, in any distribution of the
Corporation's assets upon any liquidation, dissolution or winding up of the
Corporation, whether voluntary or involuntary, after payment or provisions
                                       71
for payment of the debts and other liabilities of the Corporation.  Neither
the consolidation or merger of the Corporation with or into any other
corporation or corporations nor the sale, transfer or lease of all or
substantially all of the assets of the Corporation shall itself be deemed
to be a liquidation, dissolution or winding up of the Corporation within
the meaning of this subparagraph e.


                                    IV.
                                 DIRECTORS

     The number of directors which will constitute the whole Board of
Directors of the Corporation shall be specified or determined in the manner
provided in the Bylaws of the Corporation.


                                    V.
                       STOCKHOLDER MEETINGS, RECORDS

     Meetings of stockholders may be held within or without the State of
Delaware, as the Bylaws may provide.  The books of the Corporation may be
kept (subject to any provision contained in the Delaware Law) outside the
State of Delaware at such place or places as may be designated from time to
time by the Board of Directors or in the Bylaws of the Corporation.


                                    VI.
                             CUMULATIVE VOTING

     At all elections of directors of the Corporation, each holder of stock
entitled to vote for the election of directors shall be entitled to as many
votes as shall equal the number of votes which (except for this provision

                                       72
as to cumulative voting) he would be entitled to cast for the election of
directors with respect to his shares of stock multiplied by the number of
directors to be elected by him, and he may cast all of such votes for a
single director or may distribute them among the number to be voted for, or
for any two or more of them as he may see fit.


                                   VII.
                         SUPERMAJORITY PROVISIONS

     The consent of holders of at least 67% of the then issued and
outstanding Common Stock of the Corporation shall be required, either in
writing or by vote at a meeting of stockholders called for the purpose, in
order to do or effect any of the following:

          i.   Amendments to the Second Restated Certificate of
Incorporation (other than for purposes of authorizing additional shares of
Class A Common Stock to be issued in an underwritten initial public
offering registered pursuant to the Securities Act of 1933, as amended, or
to be issued upon the exercise of stock options granted in accordance with
Section VII.x. hereof), any Certificate of Designations or the Bylaws of
the Corporation.

          ii.  Material changes in or departures from the nature of the
Corporation's business of manufacturing or selling products made by
depositing one or more layers of materials onto flexible substrates by
Roll-to-Roll Coating.  For this purpose, "Roll-to-Roll Coating" shall mean
the serial steps of (1) the unwinding of a flexible substrate from a first
roll, (2) the deposition of one or more layers of materials onto the
flexible substrate and (3) the winding of the substrate onto a second roll,
provided that "Roll-to-Roll Coating" shall not include the deposition of
more than one layer of material to an area of the substrate during any
period that the substrate is motionless.

          iii. Merger or consolidation or other corporate reorganization.

          iv.  Sale of all or substantially all of the Corporation's assets
and business.

          v.   Redemptions of any of the Corporation's capital stock, other
than its Series B Preferred shares, and other than from any stockholders
holding more than 5% of the Corporation's voting capital stock.

          vi.  Unbudgeted borrowings or assumptions of liabilities in
excess of US $2,000,000 in any single transaction or related group of
transactions, unless the Corporation shall have provided prior written
notice to each of its stockholders describing any such proposed transaction
in detail as approved by the Corporation's Board of Directors and
requesting approval of the proposed transaction with specific reference to
this Section VII.vi. and no stockholder shall have objected to such
proposed transaction within ten (10) days after receipt of such notice (in
which event, such proposed transaction may be consummated, without further
stockholder approval, in accordance with the detailed description of such
transaction contained in the notice).

          vii. Unbudgeted long term lease obligations or material capital
expenditures, or other material contracts, which obligate the Corporation
to expenditures of over US $1,000,000 per year, or US $2,500,000 in the
aggregate, unless the Corporation shall have provided prior written notice
to each of its stockholders describing any such proposed transaction in
detail as approved by the Corporation's Board of Directors and requesting
approval of the proposed transaction with specific reference to this
Section VII.vii. and no such stockholder shall have objected to such
proposed transaction within ten (10) days after receipt of such notice (in
which event, such proposed transaction may be consummated, without further
stockholder approval, in accordance with the detailed description of such
transaction contained in the notice).

          viii.     The licensing or sale of any of the Corporation's
technology, any joint ventures, or shared research and development
projects, for uses involving the manufacture or sale of products made by
depositing one or more layers of materials onto flexible substrates by
Roll-to-Roll Coating.

          ix.  The issuance of any shares of the capital stock of the
Corporation, other than in an underwritten initial public offering of Class
A Common Stock registered pursuant to the Securities Act of 1933, as
amended, except upon the exercise of stock options granted in accordance
with Section VII.x hereof and except upon the exercise of warrants or other
securities convertible into Class A Common Stock, provided, that the number

of shares of Class A Common Stock issued in the aggregate upon all such
exercises may not reduce by more than seven percent (7%) the percentage of
ownership held of record by any stockholder of the Corporation on October
31, 1997 of the Class A Common Stock and Class B Common Stock, taken
together as one class for purposes of this calculation, issued and
outstanding on October 31, 1997.

          x.   The adoption of a stock option plan or other program
conferring rights to acquire shares of the Corporation's capital stock,
except for adoption of an employee stock option plan pursuant to which
options granted to purchase shares of the Corporation's Common Stock shall
conform to the following:  (A)(x) all options granted under such a
permitted plan shall be in an aggregate amount not to exceed 20% of the
Corporation's aggregate issued and outstanding Class A Common Stock and
Class B Common Stock at the time of grant of the options, (y) shares of
Class B Common Stock issued upon exercise of options granted under such a
permitted plan shall not exceed 10% of the Corporation's issued and
outstanding Class B Common Stock at any time, and (z) all options granted
under such a permitted Plan may be granted to employees and consultants but
not directors of the Corporation.  (B) All such options shall be
exercisable at an exercise price no less than fair market value on the date
of grant, and shall permit the option recipient to have the options vest no
more rapidly than ratably over a four-year period from the date of grant,
or in the alternative shall not permit the recipient to retain, free from
the Corporation's right of repurchase, any shares purchased by the option
recipient upon exercise of the option except pursuant to a vesting schedule
whereby the Corporation's right to repurchase such shares shall expire no
faster than ratably over a four-year period from the date of the grant.
(C) All of such option grants shall further provide for a right of first
refusal for the Corporation to purchase any of the shares offered for sale
by the option recipient or, if the Corporation should decline, then its
stockholders other than the option recipient, each pro rata to its
stockholdings, with the right to oversubscribe for any shares not purchased
by the other stockholders.

          xi.  The adoption of an annual budget, or the adoption of any
changes thereto, which anticipates a loss (provided, that for purposes of

determining whether an annual budget anticipates a loss, up to $1 million
of extraordinary losses shall be ignored) or which calls for capital
expenditures in excess of the total Operating Cash Flow for the year just
concluded and as projected for the current year, and the adoption of any
budget which allocates less funds to optically variable pigment research
and development for the current year than 3% of the optically variable
pigment sales for the preceding year. "Operating Cash Flow" for this
purpose shall mean the total of operating earnings, depreciation and
amortization.

           xii. Any declaration of dividends or other stockholder
distributions.

          xiii.     Any election to dissolve the Corporation except where
grounds for an involuntary dissolution exist, or where the electing
stockholder has first offered its shares to the other stockholders at a
price to be negotiated or determined by a neutral appraisal, and the other
stockholders have rejected the offer to purchase the electing stockholder's
shares.

          xiv. The execution of any contract or entering into of any
agreement between the Corporation and a stockholder or affiliate of a
stockholder.


                               VIII.
                         PREEMPTIVE RIGHTS

     Except as provided below in this Article VIII, the Corporation shall
not offer, issue or sell, or enter into any agreements or commitments
pursuant to which it may become obligated to issue, any shares of its
Common Stock or any warrants, options or other securities convertible into
shares of its capital stock, unless the Corporation shall first offer to
sell to each of the holders of its Common Stock, on the same terms and
conditions and at the same price, all such securities proposed to be
offered by the Corporation, each pro rata to its proportionate ownership of
such stock.  Each holder of Common Stock, without right of assignment,
shall have the right to purchase up to its pro rata interest of the shares
proposed to be offered by the Corporation.  Such offer shall remain
outstanding for at least 30 days following the date of notice.  The
foregoing preemptive rights shall not apply to the issuance by the
Corporation of (1) any stock options or stock bonuses to any employees,
directors or consultants of the Corporation or any stock sold to any
employees of the Corporation pursuant to an employee stock purchase plan;
(2) shares of stock issued pursuant to the exercise of any stock options
granted to employees, directors or consultants of the Corporation; or
(3) any shares of the Common Stock of the Corporation which are offered and
issued in an underwritten initial public offering and registered pursuant
to the Securities Act of 1933, as amended.


                                    IX.
                             REGISTERED AGENT

     The address of the Corporation's registered office in the State of
Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, New
Castle County, 19801.  The name of the Corporation's Registered Agent at
such address is The Corporation Trust Company.


                                    X.
                   LIMITATION OF LIABILITY OF DIRECTORS

     A director of the Corporation shall not be liable to the Corporation
or its stockholders for monetary damages for breach of fiduciary duty as
director except for liability which, by express provision of Delaware Law
cannot be eliminated.  Any repeal or amendment of the provisions of this
Article X shall not adversely affect any right or protection of any
director in respect of any act or omission occurring prior to the time of
such repeal or amendment.


                                    XI.
                              INDEMNIFICATION

                                       78

     The Corporation is authorized to provide indemnification to the
fullest extent permitted by Section 145 of the General Corporation Law of
Delaware, as the same may be amended and supplemented, to any and all
persons whom it shall have power to indemnify under said section, and to
advance expenses, as is provided in such section, including reasonable
attorney's fees, of any and all such persons, through Bylaw provisions, by
agreement or otherwise.

     IN WITNESS WHEREOF, this Restated Certificate of Incorporation has
been signed under the seal of the Corporation on November 19, 1997.




(Seal)





                                     /s/Joseph C. Zils
                                   Joseph C. Zils, Secretary


                                                            EXHIBIT D

                             By-Law Amendment

          Audit Committee.  The Board of Directors shall appoint an Audit
Committee, the responsibility of which shall be (i) to review with
management and the corporation's independent public accountant the scope of
services required by its audit, significant accounting policies, and audit
conclusions regarding significant accounting estimates, (ii) to review with
management and the corporation's independent public accountant their
assessments of the adequacy of internal controls, and the resolution of
identified material weaknesses and reportable conditions in internal
controls, including the prevention or detection of management override or
compromise of the internal control systems, (iii) to review with management
and the corporation's independent public accountant the institution's
compliance with applicable laws, (iv) to discuss with management the
selection and termination of the corporation's independent public
accountant and any significant disagreements between the accountants and
management, (v) to oversee the internal audit function, and (vi) such other
duties as the Board of Directors may designate.  The Audit Committee shall
maintain minutes and other relevant records of its meetings, shall meet at
any time upon the request of any member of the Board of Directors and shall
make a report to the full Board of Directors at the meeting of the Board of
Directors next succeeding any meeting of the Audit Committee.  The
composition of the Audit Committee shall be one director designated by
SICPA, one director designated by OCLI, and one member of senior management
of the corporation who is not otherwise employed by either SICPA or OCLI.
This provision may not be amended unless and until the corporation
consummates an underwritten public offering of its common stock registered
under the Securities Act of 1933.



                                                                  EXHIBIT E




                  FIRST AMENDMENT TO LICENSE AGREEMENT

                              BY AND BETWEEN

                     OPTICAL COATING LABORATORY, INC.

                                   AND

                           FLEX PRODUCTS, INC.




                            NOVEMBER 19, 1997


                  FIRST AMENDMENT TO LICENSE AGREEMENT


     FIRST AMENDMENT TO LICENSE AGREEMENT, made and entered into this 19th
day of November, 1997, by and between Optical Coating Laboratory, Inc., a
Delaware corporation, having its principal office at 2789 Northpoint
Parkway, Santa Rosa, California 95402-7397 (hereinafter referred to as
"OCLI") and Flex Products, Inc., a Delaware corporation, having its
principal place of business at 1402 Mariner Way, Santa Rosa, California
95407-7370  (hereinafter referred to as "FLEX").

                         W I T N E S S E T H:

     WHEREAS, OCLI and FLEX are currently parties to a License Agreement
dated as of December 19, 1988 (the "License Agreement"); and

     WHEREAS, OCLI and Flex wish to amend the License Agreement.

     NOW, THEREFORE, in consideration of the promises and mutual covenants
herein contained, OCLI and FLEX agree as follows:

     Section 2.2 of the License Agreement is hereby amended and replaced to
read in full as follows:

          2.2.  License to OCLI.  FLEX hereby grants to OCLI, in

     perpetuity, a worldwide and nontransferable (except such transfers as
     are provided for in Section 7.3 hereof as to OCLI) license and right
     under the FLEX TECHNOLOGY and FLEX RIGHTS exclusively in the OCLI
     FIELD and nonexclusively in the SHARED FIELD; and FLEX hereby further
     grants (subject to clause (ii) below) to OCLI, in perpetuity, a
     worldwide license and right under the FLEX TECHNOLOGY and FLEX RIGHTS
     (i) (A) on a transferable basis, to manufacture and subsequently sell
     on an exclusive basis products by means of multi-layer automatic
     continuous coating ("MAC") technology on rolls of extruded sheet
     aluminum and (B) on a nontransferable basis (except as provided below)
     to manufacture and subsequently sell on a nonexclusive basis
     antireflective film for display devices using roll-to-roll coating,
     and (ii) on an exclusive and nontransferable basis to manufacture and
     subsequently sell products within the United States which, but only
     for so long as, FLEX may neither manufacture nor sell under the laws
     of the United States, provided, however, that such license under this
     Section 2.2(ii) shall continue (but on a nonexclusive basis) for as
     long as necessary to allow OCLI to complete performance of any
     contract entered into during the period of the exclusive license.  The
     rights granted pursuant to Section 2.2(i)(B) may be sublicensed by
     OCLI, without the right to further sublicense or transfer on the part
     of the sublicensee, for the limited purpose of manufacturing for OCLI;
     provided, however, that any such sublicense shall contain reasonable
     confidentiality covenants and restrictions on use of the licensed
     technology to prevent competition with FLEX; and further provided that
     OCLI shall give SICPA notice of any such sublicense promptly after
     execution.

     Article IV of the License Agreement is hereby amended and replaced to
read in full as follows:

                                ARTICLE IV

                                 ROYALTIES


          4.1.  FLEX Running Royalties.  FLEX shall pay OCLI running
     royalties as set forth below based on Net Sales of FLEX:
      Contract Year (Commencing December 19, 1988)

       Royalty

          One                      10% of Net Sales during
                                             year one

          Two                      8% of Net Sales during
                                             year two

          Three                    6% of Net Sales during
                                             year three

          Four                     5% of Net Sales during
                                             year four

          Five and thereafter      4% of Net Sales during
                                             year five and any
                                             year thereafter

     Royalty payments, in accordance with this Section 4.1, shall,
     regardless of the TERM, continue to be paid by FLEX until such time as
     cumulative royalties equal to Thirteen Million Seven Hundred Thousand
     Dollars ($13,700,000) have been paid by FLEX to OCLI, at which time
     the license granted to FLEX under this Agreement shall be fully paid
     up.  FLEX shall have the right at any time to accelerate the payment
     of the foregoing royalties.

          4.2 OCLI Running Royalties.  OCLI shall pay to FLEX running
     royalties based on sales by OCLI and its affiliates of products
     pursuant to the license granted under Section 2.2(i)(B) as follows:

          Annual Net Sales              Royalty


          Up to $6,000,000                 0%

          $6,000,000 to $8,000,000         3%

          Greater then $8,000,000          2%

     Royalty payments, in accordance with this Section 4.2, shall,
     regardless of the TERM, continue to be paid by OCLI until October 31,
     2007.  OCLI shall also pay, at its sole cost and expense, all research
     and development costs incurred after October 31, 1997 relating to the
     technology covered by the license granted under Section 2.2(i)(B).

          4.3.  Net Sales Determination.  Net Sales shall be as determined
     in accordance with United States generally accepted accounting
      principles applied on a consistent basis.

          4.4.  Royalty Payments Due.  Royalty payments by FLEX shall be

     paid quarterly based upon financial statements for the respective
     periods, such quarterly payments to be due and payable forty-five (45)
     days and ninety (90) days after the close of each of the first three
     fiscal quarters and the fourth quarter, respectively.  Royalty
     payments by OCLI shall be paid annually ninety (90) days after the
     close of OCLI's fiscal year.
                                                
          4.5.  Maintenance of Records.  FLEX and OCLI shall keep, as long
     as the obligation to pay royalties continues, true and accurate
     records, files and books of account containing all of the data
     reasonably required for the full computation and verification of the
     amounts to be paid and the information to be given in the statements
     provided for herein.  FLEX shall, during usual business hours, permit
     representatives designated by OCLI, at OCLI's expense and by prior
     arrangement, adequately to inspect the same for the purpose of
     determining the amounts payable to OCLI pursuant to this Article IV.
     OCLI shall, during usual business hours, permit representatives
     designated by FLEX, at FLEX's expense and by prior arrangement,
     adequately to inspect the same for the purpose of determining the
     amounts payable to FLEX pursuant to this Article IV.

          4.6.  Finance Charge for Payments Past Due.  Without prejudice to

     any other rights and remedies, in law or in equity, or under the
     provisions hereof, to which either party may be entitled, each party
     shall pay an amount to the other party from the date due to the date
     of payment upon any and all amounts overdue and payable hereunder at a
     rate or rates which are one percent (1%) per year above the prime
     interest rate or rates prevailing at the Bank of America, San
     Francisco, California, from time to time during the period that any
     such amounts are overdue, provided that if such rate or rates shall be
     in excess of any legal limit thereon, then the rate shall be reduced
     to the highest rate legally allowed.

          4.7.  Payment in U.S. Currency.  All amounts payable hereunder

     shall be paid in United States Dollars, and shall be made at such
     places within the United States as OCLI may direct in writing from
     time to time.

          4.8.  Single Royalty Payment4.8.  Single Royalty Payment.  FLEX

     and OCLI shall only be required to make one royalty payment on any
     unit of product.

          4.9.  Allocation of Royalties for Products Incorporating AR

     Products.  Royalties due under Section 4.2 for products manufactured

     and sold under the license granted to OCLI pursuant to Section
     2.2(i)(B) shall be based on Net Sales of antireflective film by OCLI
     and its affiliates to non-affiliated customers.  In the event
     antireflective film manufactured under the license granted pursuant to
     Section 2.2(i)(B) is incorporated as a component into other products
     which are then sold by OCLI, the royalties due under Section 4.2 for
     the antireflective film utilized in the manufacture of such other
     products shall be based upon the weighted average price of
     antireflective film sold by OCLI to non-affiliated customers during
     the annual period for which royalties are due.  In the event there are
     no sales of antireflective film by OCLI to non-affiliated customers
     during such annual period, the royalty due under Section 4.2 shall be
     determined by multiplying the Net Sales of such other products by a
     fraction the numerator of which is the cost of manufacture of the
     antireflective film utilized in the manufacture of such other products
     and the denominator is the total cost of manufacture of the components
     of such other products.  For the purpose of this section, "cost" shall
     be determined in accordance with generally accepted cost accounting
     standards utilized by OCLI in the performance of United States
     government contracts.

     IN WITNESS WHEREOF, OCLI and FLEX have caused this First Amendment to
License Agreement to be executed by their duly authorized officers and
representatives as of the date set forth above.

                          OPTICAL COATING LABORATORY, INC.

                          By  /s/Joseph Zils


                          FLEX PRODUCTS, INC.


                          By  /s/Herbert M. Dwight, Jr.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission